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2. ABSTRACT 
 
The vital role of glial cells in the nervous system has only been revealed relatively 
recently as these cells are electrically silent. Technical advances that allow direct 
visualization of glial activity have therefore been paramount to the recent glial 
renaissance. One such technique, two-photon laser scanning microscopy (2PLSM), 
forms the basis of our thesis. 2PLSM offers the necessary spatial and temporal 
resolution to study glial cells in intact living brain. Exploiting the strengths of 
2PLSM, we chose to examine key roles of glial water and ion homeostasis in health 
and disease. Our first study (Paper I) delineated a novel aquaporin-4 (AQP4) 
mediated glial signaling pathway that is activated in response to hypo-osmotic brain 
edema, and which may contribute to the high mortality of this condition. In the 
second study (Paper II) we showed that AQP4 plays a crucial role in oxygen 
microdistribution during cortical spreading depression (CSD), a wave of tissue 
depolarization closely linked to migraine. In the next study (Paper III), we found that 
general anesthetics directly suppress astrocyte calcium signals, and this effect may 
explain some of the sedative effects of these drugs. In Paper IV we explored the 
paravascular circulation of cerebrospinal fluid (CSF) through brain, and found that 
this compartment served both as a highway for selective lipid transport and signal 
mediation between astrocytes. In Paper V we used 2PLSM to show a pathological 
activation of microglia in the advanced stages of hepatic encephalopathy (HE), which 
may be linked to the development of fatal brain edema in severe cases of this 
condition. Finally, in Paper VI we use a congenital disorder of ammonia handling to 
show that the immediate neurotoxicity of ammonia is mediated by a direct short-
circuiting of astrocyte potassium buffering. This secondarily causes an impairment of 
inhibitory neurotransmission, and is not related to astrocyte swelling as was 
previously hypothesized. Blocking the downstream accumulation of chloride in 
neurons using Na+-K+-2Cl- cotransporter subtype-1 (NKCC1) inhibitor bumetanide, 
we were able to reverse ammonia neurotoxicity and thus develop a clinically relevant 
therapy. Taken together, using in vivo 2PLSM imaging we were able to elucidate 
important roles of glial cells in normal brain function and debilitating neurological 
disorders.  
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3. ABBREVIATIONS 
 
ΔF/F0 - change in fluorescence 
normalized to time 0 
1PLSM - one-photon laser scanning 
microscopy 
2PLSM - two-photon laser scanning 
microscopy 
AM - acetoxymethyl 
Aqp4 - aquaporin-4 gene 
AQP4 - aquaporin-4 protein 
ATP – adenosine triphosphate 
BAPTA - 1,2-bis(o-
aminophenoxy)ethane-N,N,N',N'-
tetraacetic acid 
BBB - blood-brain barrier 
CNS - central nervous system 
CSD - cortical spreading depression 
CSF - cerebrospinal fluid 
DAPC - dystrophin-associated protein 
complex 
EGABA - GABA reversal potential 
eGFP - enhanced green fluorescent 
protein  
EPSP - excitatory post-synaptic 
potential 
FITC - fluorescein isothiocyanate 
GABA - γ-aminobutyric acid 
GFAP - glial fibrillary acidic protein 
Gln - glutamine  
Glu - glutamate  
Glt1 - glutamate transporter 1 gene 
GLT1 - glutamate transporter 1 protein 
GS - glutamine synthetase  
HE - hepatic encephalopathy 
ICP - intracranial pressure 
ISM - ion-sensitive microelectrode 
IP3 - inositol-1,4,5-triphosphate 
IP3R2 - IP3 receptor 2 
KCC2 - K+-2Cl- cotransporter-2 
KO – knock-out 
[K+]o - extracellular potassium 
concentration 
mRNA - messenger ribonucleic acid 
mGluR5 - metabotropic glutamate 
receptor 5 
MSO - L-methionine sulfoximine 
NH4+ - ammonium 
NH3 - ammonia 
[NH4+]o - extracellular ammonium 
concentration  
NAD+ - nicotinamide adenine 
dinucleotide 
NADH - reduced NAD+ 
NKA - Na+-K+-ATPase 
NKCC1 - Na+-K+-2Cl- cotransporter-1 
NMR – nuclear magnetic resonance 
Otcspf-ash - ornithine transcarbamylase 
deficient mouse with sparse-fur and 
abnormal skin and hair 
ROI - region of interest 
RVD - regulatory volume decrease 
shRNA - short hairpin ribonucleic acid 
Slc12a2 – NKCC1 gene 
Vm - membrane potential 
WT - wild-type
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5. INTRODUCTION 
 
“What is the function of glial cells in neural centers? The answer is still not known, 
and the problem is even more serious because it may remain unsolved for many years 
to come until physiologists find direct methods to attack it.” Santiago Ramon-y Cajal 
 
These words by Cajal rang very true in both his day and for the century that followed 
(Ransom et al. 2003). Because scientists did not possess adequate tools to directly 
explore the functions of glial cells, they were quickly forgotten amidst the vast array 
of data accumulated on neurons, where electrophysiology provided concrete 
endpoints to study. Like many other discoveries in science, the realization of the 
importance of glial cells coincided with the invention and subsequent application of 
new techniques to the field. One such technique that has gained momentum since the 
1990s is two-photon laser scanning microscopy (2PLSM) (Denk et al. 1990), and this 
is the primary method of investigation used in our thesis. Imaging in live animals has 
traditionally been dominated by techniques such as functional magnetic resonance 
imaging and positron emission tomography, which have relatively poor temporal and 
anatomical (spatial) resolution (Lauritzen 2005; Schafer et al. 2012). High-resolution 
analyses have, on the other hand, been restricted to light and electron microscopy in 
fixed tissue sections or slices. Thus, high temporal and anatomical resolution has long 
been incompatible with analyses of living animals (Misgeld and Kerschensteiner 
2006). The introduction of 2PLSM changed this, and now allows anatomical 
structures as small as dendritic spines to be studied in living brains over days and 
even weeks (Holtmaat et al. 2009). 2PLSM studies in intact animals thus allow 
investigators to address important biological questions in clinically relevant manner, 
significantly shortening the distance from bench to bedside (Dirnagl 2006).   
Glial cells are by far the most numerous cell-type in the brain, outnumbering 
neurons 10:1 (Ransom et al. 2003). However, until around 30 years ago glial cells 
were only thought to act as a form of glue providing structural support for neurons. 
Glial involvement in normal brain function and their roles in neurological disorders is 
therefore a relatively new field of research. Additionally, studies that increase our 
understanding of glial cells are highly salient for the general field of neuroscience, as 
they can open up a completely new set of therapeutic targets for brain disorders 
(Nedergaard et al. 2010; Verkhratsky et al. 2012b). Glial cells have already been 
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implicated in a number of diseases, including stroke, epilepsy, Alzheimer, Parkinson, 
spinal cord injury, traumatic brain injury, brain edema, macular edema and migraine 
(Fuhrmann et al. 2010; Manley et al. 2000; Reichenbach et al. 2007; Takano et al. 
2007; Tian et al. 2005; Verkhratsky et al. 2012b). They have also been shown to have 
key roles in regulating physiological parameters critical for neuronal function, such as 
extracellular potassium ([K+]o) and other ion homeostasis, volume regulation, 
neurotransmitter recycling, cerebral blood flow and energy metabolism (Attwell et al. 
2010; Caesar et al. 2008; Haj-Yasein et al. 2012; Kirischuk et al. 2012; Mathiesen et 
al. 2012; Nedergaard and Verkhratsky 2012; Paulsen et al. 1988b; Pellerin et al. 2007; 
Takano et al. 2006; Wang et al. 2012a). More studies focusing on how glial cells can 
generate and influence central nervous system (CNS) disorders are therefore clearly 
needed. Our thesis aims to use the advantages of 2PLSM to help address this ‘glial 
knowledge gap’ with the hope of elucidating novel therapeutic approaches.  
 
Two-photon imaging using femtosecond-pulsed lasers  
Before introducing the neurobiological background for our thesis studies, we first 
want to review the central aspects of 2PLSM imaging. Starting with the basic 
principles of fluorescence imaging – light is a form of electromagnetic radiation that 
can be described as both a particle, called a photon, or a wave. The wavelength of 
light describes its energy content; the shorter the wavelength the higher the energy of 
individual photons. Fluorescence imaging relies on the interaction of light with a 
molecule that then absorbs the light energy, raising the molecule to a higher energy 
(excited) state. The molecule, called a fluorochrome, then loses some energy through 
mechanical vibration, before emitting the rest of its energy as a new photon and 
returning to its basal ‘unexcited’ state. The emitted photon is always of lower energy 
(red-shifted) compared to the exciting photon due to the energy lost in vibration 
(Christensen and Nedergaard 2011). In a biological setting, relevant fluorochromes 
are frequently bonded to macromolecules to attain desired chemical properties, such 
as lipid solubility, and are then called fluorophores (Paredes et al. 2008). 
 The resolution of traditional light microscopy has been significantly improved 
with the advent of the laser, which is an acronym for ‘light amplification by 
stimulated emission of radiation’ (Maiman 1960). In laser scanning microscopy, a 
collimated (parallel rays) coherent (in phase) beam of monochromatic (only 1 
wavelength) photons is scanned across the specimen of interest, usually in a raster 
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pattern using galvanometric mirrors (Duemani Reddy et al. 2008). However, an early 
issue with laser scanning microscopy was that extensive light excitation occurred 
above and below the focal point of the microscope, introducing noise to the collected 
image. This issue was greatly improved by the introduction of confocal laser scanning 
microscopy, where a strategically placed pinhole effectively cuts out all light emitted 
from outside the focal point. The pinhole also gives confocal microscopy its other 
important feature; the ability to collect optical sections from the specimen. However, 
the major issue with confocal microscopy that has made it largely incompatible with 
in vivo studies is the large amount of light energy delivered to the tissue both in and 
around the focal point (Misgeld and Kerschensteiner 2006). Another aspect of this 
problem, is that due to light scattering at the wavelength required to excite 
biologically relevant fluorophores confocal microscopy is unable penetrate tissue 
much deeper than 50 μm (Christensen and Nedergaard 2011).   
 
 
 
Figure 1. Optical principles of 1PLSM and 
2PLSM. Left: Differences between pulsed 
2PLSM and continuous wave 1PLSM imaging. 
Right: Jablonski diagram of two-photon vs. 
one-photon absorption and emission.  
 
Although theoretically conceived almost a century ago, 2PLSM was only 
made possible in the 1990s through the development of powerful femtosecond pulsed 
lasers (Denk et al. 1990). 2PLSM is based on the principle that if a pulsed laser emits 
a high enough concentration of photons, 2 or more photons may excite the same 
molecule simultaneously. Denk et al. were the first to successfully apply this concept 
to laser scanning microscopy (Denk et al. 1990). Since multiple photons are used to 
excite the target, each individual photon can have a relatively low energy, i.e. long 
wavelength (Fig. 1). This has several advantages over conventional confocal 
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microscopy in that the longer wavelengths used, frequently in the infrared band (800-
1000 nm), achieve much deeper tissue penetration (500-1000 um) and exert much less 
photodamage (injury due to light) (Helmchen and Denk 2005). The latter issue 
becomes even more important when conducting fluorescent imaging, as the 
fluorophores used can generate free radicals when excessively stimulated by light 
causing phototoxicity (Bestvater et al. 2002; Christensen and Nedergaard 2011). 
Finally, the transfer of light energy in 2PLSM is non-linear, and only in the focal 
point of the beam will a critical concentration of photons be achieved sufficient to 
excite (or damage) the tissue (Table 1). This means that 2PLSM has inherent optical 
sectioning and noise reduction properties, and thus does not require a pinhole to block 
out-of focus light as with confocal microscopy.  
 
Table 1. Summary of the salient 2PLSM and 1PLSM parameters. 
 2PLSM 1PLSM 
Laser wave Pulsed Continuous 
Wavelength 800-1000 nm 400-600 nm 
Tissue penetration 500-1000 um 20-50 um 
Excitation Non-linear Linear 
Phototoxicity Limited to focal point Entire cone of light 
Emission All photons useful Out-of-focus photons 
generate noise 
XY resolution 
Z resolution 
½ λ (e.g. 450 nm) 
λ (e.g. 900 nm) 
½ λ (e.g. 250 nm) 
λ (e.g. 500 nm) 
  
Neuroglia – more than just glue 
The major difference between glial cells and neurons are that glia lack electrical 
excitability and therefore cannot fire action potentials. The lack of an easily 
measurable form of activity in glia is also one of the major reasons for the previously 
neurocentric focus of brain research (Ransom et al. 2003). The term glia was first 
coined by Rudolf L. K. Virchow (1821-1902), who thought that glia were a 
connective tissue ‘glue’ whose function was to provide structural support to neurons. 
Later, in 1851, Heinrich Müller made the first drawing of a glial cell in the retina, 
now known as the Müller cell. In the spinal cord, Jakob Henle was the first to 
describe star-like ‘stellate cells,’ which we now know as astrocytes. These findings 
were later elaborated upon by numerous eminent histopathologists, including Camillo 
Golgi (1843-1926) and Santiago Ramón y Cajal (1852-1934) (Verkhratsky and Butt 
2007). We now know that glia are a heterogeneous group of cells that can generally 
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be divided into macro- and micro-glia on the basis of morphology. The latter cell type 
is of mesenchymal origin and migrates to the brain in embryology, differentiating to 
become the resident immune-cell of the CNS (Kettenmann et al. 2011). Macroglial 
cells are of ectodermal origin and the sub-types include oligodendrocytes in the CNS 
and Schwann cells in PNS, which both provide the myelin sheath to neuronal axons 
(Barres 2008). However, the most numerous macroglial cell type and the major focus 
of our thesis are astrocytes. These complex and heterogeneous cells perform many of 
the essential homeostatic functions that the more specialized neurons cannot perform 
(Fig. 2) (Matyash and Kettenmann 2010). Astrocytes are capable of complex 
signaling and recent discoveries have led many to suspect that these cells may play an 
active role in CNS signal transmission (Agulhon et al. 2008).  
 
 
Figure 2. Cellular composition of the CNS and PNS. Left: Overview of the different cell types and 
their relative proportions in the human nervous system. Right: Early illustrations of cellular 
heterogeneity in the brain created using the silver impregnation method. Modified from Retzius, 
Biologische Untersuchungen, 1894. 
 
Astrocytes – stars of the brain  
Astrocytes were named because of their star-like appearance, owing primarily to their 
high expression of cytoskeletal glial-fibrillary acidic protein (GFAP) (Ransom et al. 
2003). Astrocytes can be divided up into two main subgroups, stellate and radial 
(elongated) cells. Stellate astrocytes in the grey matter are called protoplasmic 
astrocytes, and in the white matter fibrous astrocytes (Matyash and Kettenmann 
2010). Radial astrocytes are further divided into Müller cells (in the retina) and 
Bergmann glia (in the cerebellum) (Nimmerjahn et al. 2009; Reichenbach et al. 2007). 
Radial astrocytes, apart from those in retina and cerebellum, are commonly present 
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during development in the brain and are thought to be involved in neural migration 
(Regan 2007). Protoplasmic astrocytes are the cell-type seen most frequently in the 
cerebral cortex of adults, and our thesis focuses primarily on this sub-group 
(Oberheim et al. 2012). Astrocytes, although named after their star-like appearance in 
early histological preparations, are in fact more bush-like, and extend a multitude of 
fine processes that almost entirely fill a 3-dimesional domain (Fig. 3). This astrocyte 
domain usually encompasses thousands of synapses, multiple blood vessels and 
usually does not overlap with neighboring astrocyte domains except during 
pathological conditions such as epilepsy (Oberheim et al. 2008). Astrocyte processes 
that extend to synapses are termed peri-synaptic and those extending to blood vessels 
are called perivascular endfoot processes (Simard and Nedergaard 2004). Astrocytes 
are thus strategically located in a domain-structure that can integrate local synaptic 
activity with metabolic supply from the blood (Oberheim et al. 2008). Moreover, 
because the extracellular space is of very limited size in the CNS, astrocytes are also 
ideally constructed to influence both the content and volume of the extracellular space 
locally, regulating neurotransmitter and ion concentrations (Thorne and Nicholson 
2006).  
 
      
Figure 3. Astrocyte complexity distinguishes advanced nervous systems. Left: GFAP-stained 
protoplasmic astrocytes from mouse (inset) and human, illustrating the dramatic increase in the 
complexity of these cells through evolution. Right: Mouse (inset) and human astrocytes labeled with 
intracellular dye reveals a more ‘bush’ than ‘star’-like structure compared to GFAP staining. Scale bar 
20 um. Modified with permission from Oberheim et al. 2009. 
 
Finally, astrocytes are extensively coupled to each other via gap-junctions, 
thus forming a vast syncytium of cells. Recent research has indicated that this may 
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help astrocytes act as effective conduits for redistributing metabolites or ions between 
active and inactive synapses (Giaume et al. 2010; Rouach et al. 2008). All of these 
anatomic specializations would lead one to suspect that highly developed astrocytes 
might be a pre-requisite for more complex nervous systems. Interestingly, glial 
complexity increases much more steeply than neuronal complexity from lower to 
higher species, perhaps indicating that highly evolved astrocytes are necessary to cope 
with high synapse densities (Oberheim et al. 2006). Additionally, some disease states 
in brain and retina are characterized by a reduction in the glia/neuron ratio early in the 
disease, perhaps indicating that common neurological disorders are primary 
gliopathies (Verkhratsky et al. 2012b).  
There has been a vast increase in our understanding of the subset of channels 
and receptors expressed by astrocytes in recent years. Notably, astrocytes express 
abundant channels and transporters for potassium (e.g. inward rectifying K+ channel 
Kir4.1, Na+-K+-ATPase, NKA), sodium, chloride, water (e.g. aquaporin-4, AQP4), 
metabolites (e.g. monocarboxylate transporters), amino acids (e.g. system N 
transporter 1, SN1) and neurotransmitters (e.g. glutamate transporter 1, GLT1) 
(Kirischuk et al. 2012; Lovatt et al. 2007; Paulsen et al. 1988b). These membrane 
proteins are principally involved in what we now believe to be key astrocyte 
functions, including [K+]o buffering, neurotransmitter clearance and recycling at the 
synapse (especially glutamate and γ-aminobutyric acid, GABA), cerebral blood flow 
regulation, water transport and feeding neurons with lactate via the glucose-lactate 
shuttle (Bak et al. 2006; Haj-Yasein et al. 2012; Iliff et al. 2012; Paulsen et al. 1988a; 
Pellerin et al. 2007; Takano et al. 2006). Additionally, immunogold and in situ studies 
have indicated that astrocytes might be capable of directly influencing synaptic 
processing via vesicular or non-vesicular (e.g. connexin hemichannel) 
neurotransmitter release, or so-called ‘gliotransmission’ (Bezzi et al. 2004; Hamilton 
and Attwell 2010; Jourdain et al. 2007; Zhang et al. 2004). In conclusion, several 
lines of evidence indicate that astrocytes can actively modulate neuronal function and 
thus regulate information transmission in the CNS, perhaps coupling this to local 
metabolic factors (Attwell et al. 2010). These seminal observations have led to a 
revision of the classical neurocentric view of the synapse, and prompted the inclusion 
of astrocytes into a ‘tripartite synapse’ (Araque et al. 1999). Our thesis seeks to 
extend this work and use 2PLSM to address two related ways that astrocytes can 
influence synaptic function: the control of extracellular ion and volume homeostasis.  
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Astrocyte water homeostasis and AQP4 
A tightly regulated water homeostasis is essential for normal brain function (Amiry-
Moghaddam and Ottersen 2003). An excessive influx of water into the brain 
parenchyma will cause swelling, called brain edema. Because the brain is enclosed in 
a rigid cranium this swelling will raise intracranial pressure, which can then set up a 
vicious cycle where venous drainage from the brain is compressed and pressure rises 
further until the brain herniates through the base of the skull. Brain edema is therefore 
associated with significant mortality and morbidity, and current treatments are 
unfortunately limited to only partially effective and quite old approaches such as 
hyperosmotic infusions or corticosteroids (Grande and Romner 2012).  
Water can be transported through biological membranes via several 
mechanisms. Initially, water transport was thought to occur exclusively through 
passive diffusion directly through the lipid bilayer. However, this assumption was 
dispelled through Nobel Prize winning work by Peter Agre and co-authors, who 
isolated an ancient family of membrane channels in erythrocytes that are highly 
permeable to water (Preston and Agre 1991; Preston et al. 1992). Subsequent work 
has shown that almost all animals and plants express a family of water channels, 
called aquaporins, and to date no less than 12 isoforms have been identified in 
mammals (Agre et al. 2004). More recently, it has also been shown that membrane 
transporters (e.g. EEAT) and ion channels can contribute to active and passive water 
flux (MacAulay and Zeuthen 2010), and these critical observations also need to be 
incorporated to generate a comprehensive model of transmembrane water transport 
(Fig. 4). 
 
Figure 4. Multiple pathways for water transport across the lipid bilayer. Aquaporins and several types 
of ion channels can increase plasma membrane H2O permeability. Most cotransporters also move H2O 
with every cycle of substrate transport. 
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Aquaporins are a family of transmembrane proteins that selectively permeate 
water, and can thus increase water flux across cell membranes manifold (King et al. 
2004). Water transport across aquaporins is mediated by osmotic gradients, and hence 
diffusion is passive and bi-directional. A sub-group of aquaporins also permeate other 
substances in addition to water, such as urea, ammonia or glycerol, but the 
physiological role of this metabolite permeability is incompletely understood (King et 
al. 2004). Aquaporins are expressed in a range of tissues including blood 
(erythrocytes), kidney (renal tubules), lens, retina and brain. The principal types of 
aquaporins expressed in brain are AQP1 (choroid plexus epithelial cells), and AQP4 
(astrocytes and ependymocytes) (Agre et al. 2004). Some aquaporins appear capable 
of gating the degree of water permeability (e.g. AQP2 via vasopressin in kidney) 
(Moeller et al. 2011). However, it is somewhat controversial whether AQP4 is 
capable of gating. Several studies have indicated that phosphorylation of different 
sites on the AQP4 molecule can increase or decrease water permeability (e.g. in 
response to glutamate, erythropoietin, vasopressin and potassium) (Gunnarson et al. 
2009; Gunnarson et al. 2008; Illarionova et al. 2010; Moeller et al. 2009; Niermann et 
al. 2001; Song and Gunnarson 2012). However, subsequent structural determinations 
have contradicted these observations (Mitsuma et al. 2010). 
 
              
 
Figure 5. AQP4 expression in astrocytes is polarized to endfeet and peri-synaptic processes. Left: 
Immunogold labeling for AQP4 (black dots) showing sub-pial endfeet and peri-synaptic enrichment. 
Modified with permission from Nielsen et al. 1997. Right: Individual AQP4 channels permeate water. 
4 AQP4 channels can assemble into tetramers, which have central pore that may permeate other 
molecules. Numerous AQP4 tetramers join together into orthogonal arrays of particles that almost 
completely cover astrocyte endfoot membranes.  
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AQP4, which is the main aquaporin explored in our thesis, is expressed to 
such a large extent by astrocytes that formations of AQP4 proteins clustered in so-
called orthogonal arrays of particles can be seen by freeze fracture EM to cover 
almost the entire surface of astrocyte processes (Fig. 5) (Rash et al. 2004). AQP4 is 
thought to be permeable primarily to water, and no other solutes, although there is 
some debate whether the central pore formed between tetramers can act as a gas-
channel (Fang et al. 2002; Wang et al. 2007; Wang and Tajkhorshid 2010). 
Additionally, AQP4 is selectively enriched in distinct subcellular domains, including 
perivascular endfeet and peri-synaptic processes, indicating that AQP4 may have a 
role in dissipating osmotic gradients generated near the synapses to the vasculature 
(Fig. 6) (Amiry-Moghaddam et al. 2003a; Binder et al. 2006; Frydenlund et al. 2006; 
Nagelhus et al. 1999; Nielsen et al. 1997). The peri-vascular localization of AQP4 in 
brain is controlled by the dystrophin-associated protein complex (DAPC), and 
disruption of this complex in a mouse model of myotonic dystrophy is associated with 
a loss of the perivascular enrichment (Amiry-Moghaddam et al. 2004; Frigeri et al. 
2001; Vajda et al. 2004). However, a recent study that AQP4 anchoring mechanism 
may differ between macroglial cell types (Enger et al. 2012).  
 
   
Figure 6. The subcellular localization of AQP4 is ensured by the DAPC-complex. Left: Illustration 
showing the expression pattern of AQP1 (blue) and AQP4 (red) in the human brain. Right: AQP4 is 
anchored to distinct membrane domains in astrocytes via the DAPC-complex. Adapted with permission 
from Amiry-Moghaddam and Ottersen 2003. 
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AQP4 has been implicated in the pathophysiology of a range of CNS 
disorders, including hypo-osmotic brain edema, stroke, epilepsy, hydrocephalus, 
migraine, and meningitis (Amiry-Moghaddam et al. 2003b; Binder et al. 2004; Binder 
et al. 2006; Manley et al. 2000; Padmawar et al. 2005; Papadopoulos et al. 2004; 
Papadopoulos and Verkman 2005). Constitutive Aqp4 knock-out (KO) mice have for 
instance been shown to have reduced hypo-osmotic brain edema and reduced stroke 
infarct size, which is hypothesized to be related to decreased astrocyte swelling and 
secondary dysfunction (Manley et al. 2000). A glia-specific Aqp4 KO has also 
recently been created, and observations from these animals are strikingly similar to 
constitutive KO, indicating that most of the functional AQP4 is expressed in 
astrocytes and not e.g. endothelial cells (Haj-Yasein et al. 2011c). Although there is 
an expanding literature exploring AQP4 functions in the CNS, several critical 
questions remain unanswered, including: 1) Are all forms of astrocyte swelling 
AQP4-dependent, or is this phenotype only evident in cell culture or acute brain slices 
from young animals? 2) Does AQP4 play a role in astroglial signaling through 
sensitizing these cells to small volume changes near the synapse or blood vessels? 3) 
Does AQP4 mediate astrocyte volume changes at the level of the individual cell or is 
the role of AQP4 instead to facilitate more global water and cerebrospinal fluid (CSF) 
flux (Iliff et al. 2012)? 4) Does AQP4 only permeate water or can it also act as a gas 
channel to for instance O2? Because this is a rapidly evolving field, the current thesis 
has restricted itself to addressing only a subset of these questions. 
 
Astrocyte regulation of [K+]o homeostasis in the brain 
Rapid and efficient potassium homeostasis is vital in maintaining normal neuronal 
function, and is thought to be one of the primary functions of astrocytes (Kofuji and 
Newman 2004). Interestingly, the blood-brain barrier (BBB) is highly impermeable to 
potassium ions, ensuring that [K+]o in the CNS is regulated internally and is 
minimally affected by systemic fluctuations (Hansen et al. 1977). Astrocytes have 
multiple passive and active potassium transport mechanisms, and similar to most 
mammalian cells the potassium gradient is largely responsible for their negative 
(more so than neurons, ~85 mV) membrane potential (Kofuji and Newman 2004). 
Moreover, astroglia including Müller cells likely have a much greater permeability to 
and capacity for buffering [K+]o than neurons, although this permeability may be 
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restricted to functional micro-domains (Newman et al. 1984; Walz 2000). Astrocyte 
potassium buffering is thought to be divided into two main mechanisms: local 
potassium uptake and spatial buffering (Fig. 7) (Kimelberg and Nedergaard 2010; 
Kofuji and Newman 2004).  
 
 
Figure 7. Two proposed mechanisms for 
astrocyte potassium homeostasis. Top: 
Potassium spatial buffering involves astrocyte 
uptake of increased potassium from the 
synaptic cleft down its electrochemical 
gradient to the vasculature. This mechanism is 
thought to involve potassium channel Kir4.1 
and potentially AQP4. Bottom: Local 
potassium accumulation coupled with sodium 
pumping and sodium/chloride cotransport to 
remove excess K+ released from neuronal 
activity. This mechanism is thought to involve 
NKCC1 / KCC2 and the NKA. Modified with 
permission from Kimelberg and Nedergaard 
2010. 
 
Ion pumps, cotransporters or potassium channels can all mediate local 
potassium uptake. This mechanism is thought to be temporary and the influxed 
potassium ions are eventually released back into the extracellular space, restoring the 
ionic composition of the various cellular compartments. Cotransporters and ion 
pumps usually couple K+ influx to anion (e.g. Cl-) influx or cation (e.g. Na+) efflux, to 
maintain electroneutrality. The NKA pump and (Na+)-K+-Cl- cotransporters are 
thought to be the main proteins responsible for short-term buffering of increases in 
[K+]o following neuronal activity (Andersson et al. 2004; Kofuji and Newman 2004; 
Miyakawa-Naito et al. 2003; Olson et al. 1986; Xiong and Stringer 2000). The NKA 
exports 3Na+ and imports 2K+ causing it to be mildly electrogenic (hyperpolarizing 
the membrane potential, Vm) and is sensitive to inhibition by several drugs, such as 
the plant-toxins ouabain and digitalis. Previous studies have indicated that the 
astroglial isoform of NKA is more effective in buffering [K+]o than the neuronal 
isoform (Grisar et al. 1983; Reichenbach et al. 1987). (Na+)-K+-Cl- cotransporters 
move all relevant ions in an electroneutral manner, and are highly expressed in 
secretory epithelia and ependymal cells, and to a lesser extent in both neurons and 
astrocytes (Delpire et al. 1999; Rivera et al. 2005). There are several important types 
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of (Na+)-K+-2Cl- cotransporters, including Na+-K+-Cl- cotransporter-1 (NKCC1) 
expressed at a high level in early development when it imports Cl-, and K+-2Cl- 
cotransporter-2 (KCC2) expressed later in development when it exports Cl-. The 
ontogenic expression patterns of these two cotransporters are thought to represent a 
developmental switch in the action of GABA, from depolarizing in early development 
to hyperpolarizing in adulthood (Rivera et al. 2005; Rivera et al. 1999). NKCC1 but 
not KCC2 is highly sensitive to low doses of the clinically used diuretic bumetanide, 
whilst both transporters are inhibited by the diuretic furosemide (Kimelberg 1987; 
Kofuji and Newman 2004).  
The second mechanism for astroglial for potassium clearance is spatial 
buffering (Chen and Nicholson 2000; Xiong and Stringer 2000). This mechanism 
entails astrocytes redistributing local increases in [K+]o from areas of high neuronal 
activity through the gap junction-coupled astrocyte syncytium to areas of less activity 
with lower [K+]o. The driving force for the potassium current is the difference 
between the local potassium equilibrium potential (EK) and the glial syncytium 
membrane potential (Vm) (Chever et al. 2010; Djukic et al. 2007; Haj-Yasein et al. 
2011a; Heuser et al. 2012; Karowski and Proenza 1977; Nagelhus et al. 2004; 
Newman et al. 1984). Potassium siphoning is a variant of spatial buffering that 
involves redistribution of increased [K+]o to specific subcellular compartments due to 
polarized potassium channel expression, such as in retinal Müller cells (Newman 
1985; Newman et al. 1984). One of the main advantages of this mechanism is that it 
allows the redistribution of potassium ions with little increases in potassium inside 
individual astrocytes. However, though this model provides an astrocyte-specific 
mechanism for buffering [K+]o, there are many faults with the theory including the 
lack of a sufficiently strong electrochemical gradient to push a potassium current 
between astrocytes (Meeks and Mennerick 2007). In the brain the potassium channel 
subtype Kir4.1 is highly enriched in astrocytes, where it has a polarized expression 
similar to AQP4, principally being present in endfeet and peri-synaptic membranes. It 
therefore seems likely that there is some functional coupling between potassium and 
water homeostasis in these specialized astrocyte membrane domains (Amiry-
Moghaddam et al. 2003b; Chever et al. 2010; Djukic et al. 2007; Nagelhus et al. 1999; 
Strohschein et al. 2011). Any spillover or siphoning of excess potassium beyond the 
local uptake at the individual synapse is thought to be a hallmark of pathology or an 
artifact of experimental preparations (e.g. epilepsy or spreading depression) (Kofuji 
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and Newman 2004). Potassium homeostasis in the brain is a controversial topic and 
further studies are clearly warranted to help ascertain the relative importance of the 
various mechanisms involved in [K+]o buffering. 
 
Cortical spreading depression (CSD) and migraine 
CSD is a self-propagating wave of depolarization and neurodepression that spreads 
through cortical grey matter at a slow rate of 2-5 mm min-1 (Lauritzen 2001; Leao 
1947). Waves of CSD can be evoked in experimental animals by intense neuronal 
stimulation, local application of potassium or tissue injury (Takano and Nedergaard 
2009).  
 
Figure 8. Model of migraine pathophysiology. The illustration shows a human cortex with a wave of 
CSD spreading across it. The CSD wave itself (yellow) is accompanied by neurodepression (decreased 
electrocorticogram amplitude), depolarization (increased [K+]o), hyperemia, hypoxia and will typically 
manifest as visual phenomena called an aura. This period is followed by prolonged oligemia, slow 
restoration of neuronal activity and activation of trigeminal nociceptive afferents causing the 
characteristic headache (green). Modified with permission from Takano et al. 2009.   
 
CSD has been closely linked to the pathophysiology of migraine headaches, 
where sufferers often experience a phenomenon called aura that manifests as sensory 
phenomena (e.g. scintillation-scotoma). These phenomena show a slow somato- or 
retino-topic spread across the cortex that is of an equivalent velocity to CSD 
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(Lauritzen et al. 2011). As the ‘aura wave’ subsides, the patient typically begins to 
experience throbbing headaches, which is thought to be related to secondary 
meningeal vasodilation with activation of trigeminal nociceptive afferents (Fig. 8) 
(Takano and Nedergaard 2009). However, the characteristic wave of depressed 
neuronal (electrocorticogram) activity seen during CSD is present in a very narrow 
zone of cortex, and thus cannot be detected non-invasively with external 
electroencephalogram electrodes in humans (Lauritzen et al. 2011). When functional 
imaging is used to measure cerebral blood flow during migraine attacks investigators 
again observe a brief and variable hyperemia (more prominent in anesthetized 
animals) followed by a characteristically slow wave of cortical oligemia (Lauritzen 
1994; Tfelt-Hansen and Koehler 2011). Finally, using more invasive recordings 
investigators have shown that human cortex is capable of generating and sustaining 
CSD waves following injury or experimental stimulation (Lauritzen 1994). Taken 
together, CSD is therefore likely to be a fundamental property of all densely packed 
nervous tissue, both animal and human. 
CSD is characterized by an increase in [K+]o of more than 50 mM, and re-
establishing the transmembrane potassium gradient thus presents a unique metabolic 
challenge for the brain parenchyma (Takano et al. 2007). Additionally, other 
electrolyte gradients are critically altered, with [Ca2+]o decreasing from 1.2 to 0.1 
mM, [Cl-]o decreasing from 120 to 70 mM and [Na+]o decreasing from 150 to 60 mM 
(Lauritzen et al. 2011). CSD waves are usually self-terminating and do not cause 
permanent brain injury (Takano et al. 2007). However, in the context of severe 
cortical injury (e.g. traumatic brain injury or stroke), so-called peri-infarct or anoxic 
depolarizations can be observed that persist and increase the area of brain that is 
permanently damaged (Lauritzen et al. 2011). Interestingly, when fluorocitrate is used 
to selectively injure astroglial by inhibiting the Krebs cycle this also causes CSD to 
induce irreversible neuronal dysfunction (Largo et al. 1997; Paulsen et al. 1987). The 
predilection for migraine attacks to originate in the striate (V1) cortex in humans may 
therefore relate directly to the relatively lower astrocyte-to-neuron ratio in this area 
(Lauritzen et al. 2011). 
To study this metabolic strain we chose to employ reduced nicotinamide 
adenine dinucleotide (NADH) imaging, which relies on the natural auto-fluorescence 
of NADH but not NAD+ (Fig. 9). NADH is critical co-enzyme in cellular metabolism, 
which is generated from NAD+ (reduction) during glycolysis, and to a larger extent 
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from Krebs cycle, and is used by the mitochondrial respiratory chain (oxidation). 
When used in conjunction with 2PLSM, NADH imaging can thus be used to generate 
detailed maps of local tissue red-ox state, where increased NADH signal intensity is a 
sensitive proxy of tissue hypoxia (Kasischke et al. 2011). Interestingly, NADH 
fluorescence in neuropil is highest in astrocytes, almost precisely outlining the entire 
cells (including processes), whilst showing little overlap with mitochondrial staining 
(Kasischke et al. 2004).  NADH imaging during CSD or hypoxemia reveals sharply 
defined cylindrical perivascular regions of high oxygen tension (low NADH signal) 
and irregularly shaped interspersed watershed regions of low oxygen tension (high 
NADH signal) (Kasischke et al. 2011; Takano et al. 2007). The steep sigmoidal 
NADH-pO2 curve with a p50 for O2 of 3.4 mmHg explains the sharp border between 
high and low NADH signal intensity in perivascular and watershed regions, 
respectively (Kasischke et al. 2011).  
 
  
Figure 9. 2PLSM imaging of tissue red-ox state using NADH fluorescence. Left: NADH, but not 
NAD+, is fluorescent and serves as a sensitive proxy of tissue hypoxia in the brain. Right: NADH 
imaging reveals increased NADH indicative of tissue hypoxia in geometrically shaped microwatershed 
regions of mouse cortex during brief and mild hypoxemia. Arteries and veins are pseudo-colored in red 
and blue, respectively. Modified with permission from Kasischke et al. 2011.  
 
Using in vivo 2PLSM NADH imaging Takano et al. in 2007 made a set of key 
observations regarding the micro-distribution of oxygen in CSD. The authors 
observed that in watershed areas tissue hypoxia causes and coincides with CSD, and 
critical hypoxia in these regions causes swelling along with dendritic spine distortion 
in neurons, but not astrocytes (Takano et al. 2007). The extent of astrocyte swelling is 
still somewhat more debated, but the much clearer swelling in neurons shown in this 
and other studies at least indicates that astrocyte volume regulation is much tighter 
(from unpublished observations in situ) (Risher et al. 2012) (Takano et al. 2007; Zhou 
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et al. 2010). More importantly, the NADH observations made by Takano et al. 
indicate that the self-propagating nature of the CSD wave might stem from a primary 
energy failure (i.e. NKA failure). This energy failure seems most likely to stem from 
excess energy consumption than from inadequate supply, as blood flow actually 
increases during the early phase of CSD. However, what sets up the CSD wave in the 
first place is a bit more uncertain. The wave itself is preceded by propagating field 
oscillations in glial and neuronal Vm, indicating that CSD might be initiated by 
neuronal hyperexciteability similar to seizures (Larrosa et al. 2006). Additionally, 
genetic analysis of patients with familial hemiplegic migraine has revealed mutations 
in genes encoding calcium channels (e.g. Cav2.1), the astrocytic Na+-K+-ATPase and 
sodium channels (e.g. SCN1) linked to maintaining Vm (Leo et al. 2011; Takano and 
Nedergaard 2009). In conclusion, CSD presents a unique metabolic challenge for 
astrocytes and neurons alike, and the self-sustaining slow propagation of the CSD 
wave appears to be caused by a vicious cycle of excess oxygen consumption, 
watershed hypoxia and a secondary failure of potassium homeostasis (Takano et al. 
2007).   
 
Calcium signaling in astrocytes 
The advent of calcium imaging using chemical calcium indicators (e.g. Fluo-3) was 
one of the major breakthroughs that alerted investigators to the active role of glia in 
brain information processing. It was known through histological studies since the 
1980s that astrocytes express a subset of glutamate receptors (Bowman and 
Kimelberg 1984; Kettenmann et al. 1984).  However, it was not until 1990 that 
Cornell-Bell et al. observed that cultured astrocytes are able to respond to locally 
applied glutamate by generating wide-spreading waves of elevated intracellular 
calcium (Cornell-Bell et al. 1990). This observation was critical to subsequent glial 
research because it showed that astrocytes have the ability to directly sense synaptic 
activity. Subsequently, co-cultures of astrocytes and neurons were used to show that 
astrocytes are not just able to respond, but also to alter neuronal signaling through 
intracellular calcium signals (Nedergaard 1994; Parpura et al. 1994). Finally, these 
observations of bidirectional astrocyte communication with neurons were validated in 
more intact preparations (acute hippocampal slices and retinal preparations) (Kang et 
al. 1998; Newman and Zahs 1998). More recent work has also indicated that in 
response to the activation of glutamatergic and purinergic receptors or alterations of 
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local ion concentrations astrocytes may be able to release neurotransmitters into the 
synaptic cleft, either via vesicular or non-vesicular mechanisms (e.g. connexin 
hemichannels) (Hamilton and Attwell 2010; Kang et al. 1998; Simard et al. 2003; 
Torres et al. 2012; Wang et al. 2012a; Wang et al. 2012b). This extensive astroglial 
signaling at the level of the individual synapse led to the development of the ‘tripartite 
synapse’ model, which incorporates an astrocytic process into the basic unit of 
information processing (Araque et al. 1999).  
 
 
Figure 10. Illustration of the molecular mechanisms governing intracellular calcium in astrocytes and 
neurons. Abbreviations: CBP: Ca2+-binding protein; ER: endoplasmic reticulum; GLT: glutamate 
transporter; GPCR: G-protein coupled receptor; InsP3R: inositol-1,4,5-trisphosphate receptor; LGCC: 
ligand-gated Ca2+ channel; NCX: sodium–calcium exchanger; PMCA: plasmalemmal Ca2+ ATP-ase; 
RyR: ryanodine receptor; SERCA: sarco(endo)plasmic reticulum Ca2+ ATP-ase; SOC: store-operated 
Ca2+ channel; VGCC: voltage-gated Ca2+ channel; ‘Maxi’ channel: high-permeability plasmalemmal 
channels (such as connexins or pannexins or P2X7 receptors or volume-regulated anion channels) that 
can act as a pathway for non-exocytotic gliotransmitter release. Modified with permission from 
Nedergaard et al. 2010. 
 
Intracellular transients of free ionized calcium (Ca2+) are an old form of 
cellular signaling that is present even in bacteria, and likely co-evolved with the use 
of adenosine triphosphate (ATP) as the primary intracellular energy source 
(Dominguez 2004). Intracellular calcium is tightly regulated in all mammalian cell 
types, and a rapid increase in this ion is used to among other things to mediate 
programmed cell-death (apoptosis) (Parpura and Verkhratsky 2012). Astrocytic 
calcium signals appear to derive primarily from endoplasmic reticulum (ER), where 
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the concentration of calcium is ~1000x higher than in the cytoplasm. Upon activation 
of metabotropic Gq-coupled G-protein coupled receptors, phospholipase C cleaves 
phosphatidylinositol-4,5-bisphosphate in plasmalemma, releasing inositol-1,4,5-
trisphosphate (IP3) to the cytosol and diacylglycerol in the membrane. IP3-dependent 
calcium release from the ER via the IP3 receptor type 2 (IP3R2) is thought to be the 
major pathway of calcium signaling in astrocytes; as opposed to neurons where 
voltage gated calcium channels mediate vesicular neurotransmitter release (Fig. 10) 
(Nedergaard et al. 2010). However, it is possible that smaller IP3-independent calcium 
signals in the small processes trigger IP3 signaling in so-called calcium-induced 
calcium release (Arcuino et al. 2002). IP3-independent mechanisms for calcium influx 
in astrocytes include plasmalemmal calcium channels (e.g. Cav1) and/or transporters 
(e.g. Na+-Ca2+-exchanger) (Nedergaard et al. 2010).  
Intracellular calcium transients are known to propagate as waves throughout a 
network of astrocytes joined by gap junctions (composed of two connexons), which is 
termed the astrocytic syncytium (Rouach et al. 2008). There are a number of 
mechanisms thought to be involved in calcium wave propagation, including the 
diffusion of Ca2+ or IP3 through gap junctions and paracrine ATP release activating 
neighboring metabotropic P2Y receptors (Verkhratsky et al. 2012a). Astrocytic 
calcium waves as observed in vitro and in situ propagate relatively slowly compared 
to axonal signals (4-20 μm s-1 vs. 10-100 m s-1) (Hartline and Colman 2007). For this 
reason, some authors would argue that astrocytic calcium waves may be too slow or 
could generate noise if they were to modulate individual synaptic events (Agulhon et 
al. 2008). Conversely, this temporal difference may indicate that astrocyte calcium 
transients are responsible for the integration of neuronal activity over a larger 
temporal (seconds) and spatial (thousands of synapses) scale, which is more relevant 
for neurovascular coupling (Iadecola and Nedergaard 2007).  
Through the application of 2PLSM to calcium imaging, investigators have 
recently been able to explore astrocyte calcium signals in intact living brains. In one 
of the seminal in vivo studies Wang et al. showed that physiological sensory 
stimulation (in the form of air-puffing whiskers) is able to elicit a coordinated calcium 
response that followed neuronal firing in the stimulated area of somatosensory cortex 
(Wang et al. 2006). The magnitude of this sensory-evoked astrocytic calcium 
response was directly correlated with the neuronal response and depended on 
   
 IN
activation of Gq-coupled metabotropic glutamate receptor 5 (mGluR5). Subsequent in 
vivo studies have elaborated on this observation, and shown that other forms of 
sensory stimulation (e.g. hindlimb electroshock), as well as local agonist application 
or stimulated neuromodulator release (e.g. acetylcholine and norepinephrine) can also 
elicit calcium activity in cortical astrocytes (Bekar et al. 2008; Navarrete et al. 2012; 
Takata et al. 2011; Winship et al. 2007). Astrocytes thus appear able to respond to 
several types of physiologically relevant signals in vivo.  
 
 
     
Figure 11. Astrocytic regulation of blood flow 
via calcium signals. Left: Illustration of the 
hypothetical role of astrocytes in connecting 
neuronal demand with blood flow supply via 
calcium signaling. Adapted with permission 
from Iadecola and Nedergaard, 2007. Right: 
Serial 2PLSM images taken at 3 s intervals of 
a cerebral arteriole showing functional 
hyperemia and associated calcium activity 
(pseudocolored rhod-2 intensity) in the awake 
mouse cortex (unpublished). 
 
 
Since in vitro and in situ work showed astrocyte-neuronal signaling is 
inherently bidirectional, the next question would be what neuronal changes do 
astrocyte calcium signals elicit in vivo. Unfortunately, on this critical issue the 
literature is quite divided. The previously discussed ‘tripartite synapse’ model states 
that astrocyte calcium activity triggers gliotransmitter release, which may in turn 
modulate neuronal activity (Araque et al. 1999). However, data that directly questions 
some of the key observations underpinning this model has emerged more recently 
(Agulhon et al. 2010; Agulhon et al. 2008; Nedergaard and Verkhratsky 2012; Sun et 
al. 2013). Another critical function for astroglial calcium transients is mediating 
neurovascular coupling (functional hyperemia) (Fig. 11). Stimulating astrocyte 
calcium transients or experimentally increasing intracellular calcium using uncaging 
triggers brisk vascular responses. However, both the type of response (vasodilation or 
constriction) and the mechanisms implicated are currently under intense debate, as 
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different experimental paradigms have generated divergent results (e.g. pre-
constricted blood vessels in brain slice vs. in vivo) (Attwell et al. 2010; Iadecola and 
Nedergaard 2007; Lauritzen et al. 2012; Takano et al. 2006).  
There are several important questions regarding astrocyte calcium signaling 
that remain unanswered. First, can we trust the data from in situ studies of young 
animals or are hippocampal slices not as good a model study astrocytes as it has been 
for neurons (Sun et al. 2013)? Second, in vivo imaging has a much higher signal-to-
noise ratio for calcium recordings and is often acquired at a lower temporal resolution 
(e.g. 1-10 Hz frame rate). This raises the question of whether we are in fact detecting 
all the relevant calcium signals or looking in the right places (e.g. soma v.s. 
processes). Two in situ studies have recently shown that short lasting low amplitude 
calcium transients in the processes occur even in response to individual synaptic 
events (Di Castro et al. 2011; Panatier et al. 2011). More recently, high-speed 2PLSM 
set-ups developed primarily for neuronal calcium imaging are breaching this barrier, 
allowing frame rates of up to 1000 Hz (Chen et al. 2011). Third, does neuronal 
activity generate multiple astrocytic calcium waves, and if so do these have different 
kinetics and functions (Torres et al. 2012)? Fourth, are we imaging deep enough in 
the cortex? Whisker activation principally stimulates layer IV, and we may be simply 
observing an axially propagated response in the more superficial layers. Finally, one 
major problem with the in vivo literature to date is that, with the exception of two 
studies, it has been carried out using anaesthetized animals, where neuronal activity is 
known to be significantly depressed (Greenberg et al. 2008). These two preliminary 
studies of calcium signaling in awake animals revealed profoundly different 
spontaneous and evoked activity patterns. These included synchronized ‘bursts’ 
(instead of waves) across hundreds of astrocytes and a much higher level of 
spontaneous activity (Dombeck et al. 2007; Nimmerjahn et al. 2009). Exploring 
calcium signaling in astrocytes in awake animals would no doubt give a more 
physiological view of how astrocytes signal and perhaps provide some more 
definitive answers to whether or how astrocytes can sense and modulate synaptic 
transmission. 
 
Cerebrospinal fluid microcirculation in the brain 
In most tissues of the body, a parallel lymphatic circulation accompanies blood 
vessels and supports normal hemodynamic function by resorbing interstitial fluid, 
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carrying immune cells and transporting lipids (Schmid-Schonbein 1990). The brain, 
however, is one of the few organs to be entirely devoid of an anatomically distinct 
lymphatic system. Through the selective barrier properties of the BBB, the 
composition of the CNS microenvironment is regulated very separately from the rest 
of the body (Abbott 2004). It has long been thought that CSF might serve the role of 
peripheral lymph in the CNS. Macroscopically, CSF circulates rapidly from the 
choroid plexi in the ventricles where it is produced and diffuses through the brain 
parenchyma by convective bulk flow, before being resorbed by the arachnoid 
granulations into venous sinuses (Figure 12) (Abbott 2004; Aukland and Reed 1993; 
Sakka et al. 2011). However, the extracellular space in the brain is extremely narrow 
and very tortuous, meaning that any bulk flow through this anatomical space should 
be much slower than the interstitial fluid diffusion rates we observe (0.1-0.3 µL min-1 
g-1) (Thorne and Nicholson 2006).   
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Figure 12: Paravascular CSF circulation in neuropil. Left: Macroscopic CSF circulation, illustrating 
para-arterial (Art., red) and para-venous (Ven., purple) PVS (blue) ensheathed by astrocyte endfoot 
(e.f.) processes. Paravascular CSF flow mediates convective bulk flow of interstitial fluid through the 
narrow and tortuous extracellular space. Right: Microscopic view of paravascular circulation of 
interstitial fluid (ISF) and lipids through putative transporters in glial endfeet. 
 
 These observations have led investigators to suggest that ‘highways’ for more 
rapid CSF flow through the parenchyma must exist, and the two most likely 
candidates are the para-axonal and paravascular pathways. The former is more highly 
developed in species with bigger axons, but diffusion-weighted MRI has also revealed 
that water flux along axons is a major pathway in the human brain (Abbott 2004; 
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Mori et al. 2009). Several groups have illustrated the latter pathway since the 1800s 
by injecting various tracer molecules (e.g. horseradish peroxidase) injected into the 
brain parenchyma, ventricles or subarachnoid CSF and performing serial histological 
sectioning. This method causes the tracer to strikingly outline a paravascular space 
(PVS) ensheathing the cerebral vasculature, although the choice of tracer determines 
how completely the vasculature will be outlined (Abbott 2004; Cserr et al. 1981; 
Cserr et al. 1986; Rennels et al. 1990; Szentistvanyi et al. 1984). Interestingly, a 
recent 3D EM reconstruction has revealed that astrocyte endfeet provide a complete 
ensheathment of cerebral blood vessels, ensuring the patency of this paravascular 
compartment (Mathiisen et al. 2010). 
 The paravascular CSF pathway was recently revisited by Iliff et al., who 
used 2PLSM to demonstrate that a range of water-soluble tracers and deuterated water 
(2H2O) itself pass rapidly along the separate anatomical space between astrocyte 
endfeet and the blood vessel wall in vivo (Iliff et al. 2012). The PVS is largest near the 
pial surface, where it is called the Virchow-Robin space, and becomes progressively 
narrower before almost disappearing at the capillary level (Abbott 2004). 
Interestingly, Iliff et al. also showed that water flow through this pathway was 70% 
slowed by deletion of Aqp4, indicating that one of the major roles of this protein 
could be facilitating CSF microcirculation (Fig. 13). It therefore appears that the brain 
has a distinct pathway for the microcirculation of water and water-soluble 
compounds. However, another major function of peripheral lymph is the transport of 
lipids from the gut to the liver and peripheral organs. Despite grey and white matter 
being composed of 38 and 58 % lipid, respectively (O'Brien and Sampson 1965a; 
O'Brien and Sampson 1965b), the BBB is largely impermeable to peripheral lipids 
and lipoproteins (Leoni et al. 2010). The essential lipids needed for myelin or synaptic 
membranes therefore need to be produced within the CNS (Mauch et al. 2001). 
Interestingly, astrocytes have been shown to orchestrate this vital process, by 
producing cholesterol and high-density lipoprotein-like molecules (Fagan and 
Holtzman 2000). The addition of fatty acid residues (palmitoylation) has important 
functions during neurodevelopment and synaptic plasticity (Fukata and Fukata 2010). 
Astrocyte lipid clearance to the blood is also likely to be important, and for instance 
cholesterol is cleared by conversion to 24S-OH-cholesterol (cerebrosterol), making it 
BBB permeable (Bjorkhem 2007). CSF is rich in astrocyte-produced lipoproteins, and 
mutations in genes related to this process (e.g. ApoE) have been linked to 
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neurodegenerative conditions such as Alzheimer disease (Leoni and Caccia 2011; 
Leoni et al. 2010; Riddell et al. 2008). Taken together, observations regarding lipid 
metabolism in the CNS indicate the existence of astrocyte-neuronal lipid (or 
cholesterol) shuttle, where astrocytes feed neurons with the necessary lipid for 
synaptic membranes (Nieweg et al. 2009). An important question that is unanswered 
in current literature is therefore whether the PVS serves as a conduit for rapid lipid as 
well as water microcirculation through the brain parenchyma. 
 
Figure 13.  Immunofluorescence micrograph of AQP4 and GFAP expression in the mouse cortex. 
Modified from Simard et al. 2003. 
Microglia - the double-edged sword of CNS immunity 
Microglia are a cell type that has come into focus relatively recently. They are the 
innate immune cells of the CNS and are of mesenchymal origin. Microglia are 
derived from peripheral macrophages and migrate to the brain during early 
development (Chan et al. 2007; Verkhratsky and Butt 2007). The function of 
microglia has been described as a ‘double-edged sword,’ as they have the capability 
of being both protective and harmful in health and disease. Under physiological 
conditions, microglia exist in the ‘resting state,’ which is morphologically 
characterized by the cells extending multiple thin processes from a small central cell 
body. However, in vivo 2PLSM recently showed that ‘resting’ microglial processes 
are in fact constantly moving, screening their territories, seeking out any signals that 
may indicate injury or inflammation (Davalos et al. 2005; Nimmerjahn et al. 2005). 
Like astrocytes, microglia show very little overlap between cells and seem to survey 
their own domain with their processes (Kettenmann et al. 2011). 
   
 JI

 
Figure 14. The changing states of microglia. Illustration showing resting microglia (left), microglial 
activation and BBB opening after a small injury (middle), and severe microglial activation (right) 
associated with amoeboid morphological appearance and phagocytic behavior in the context of a large 
injury. Note the surveillance capability of fine processes in resting microglia, thought to constantly 
scan for foreign antigens.  
 
In response to brain injury, infection or inflammation, microglia are known to 
change their morphology by transforming through an ‘alerted state’ to an ‘amoeboid 
state’ (Fig. 14). This morphological transition involves retraction of processes, which 
become fewer but thicker, increase in cell body size and production various cytokines 
along with other signals (Block et al. 2007; Davalos et al. 2005; Hanisch and 
Kettenmann 2007; Verkhratsky and Butt 2007). When activated, their morphological 
change aids phagocytosis and allows the removal of unwanted pathogens or dead host 
cells. The exact mechanism of how microglial activation is initially triggered is not 
fully understood, but we do know that microglia possess a number of neurotransmitter 
(including glutamate, GABA, adenosine and purine) and immune (including 
complement, cytokine and chemokine) receptors. Many of these receptors are 
involved in activating microglia during brain injury, but ATP in particular is thought 
to play a central role (Davalos et al. 2005; Kettenmann et al. 2011; Ohsawa et al. 
2007). Brain injury is thought to result in the release of vast amounts of ATP, which 
microglia respond swiftly to through activation of mainly P2X7 receptors (Burnstock 
and Verkhratsky 2010; Kettenmann et al. 2011; Verkhratsky and Butt 2007). 
Activation of these receptors promotes extension of microglial processes towards the 
perceived site of injury and the release of various cytokines and pro-inflammatory 
proteins. In addition to releasing pro-inflammatory markers (such as interleukins, 
tumor necrosis factor-α and transforming growth factor-β), microglia are thought to 
aid neurons in regeneration post-injury (Kettenmann et al. 2011). For example, they 
release a number of growth factors, including brain-derived neurotrophic factor and 
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nerve growth factor, which are thought to aid neurons in overcoming injury 
(Kettenmann et al. 2011).  
In their activated state, microglia have been shown to be effective in 
phagocytosing unwanted debris, but what happens if this immune response starts 
targeting host cells? In Alzheimer disease, microglia have been shown to phagocytose 
neurons, perhaps contributing to loss of cognitive function. Interestingly, knocking 
out Cx3Cr1 prevented neuronal loss in mice with Alzheimer (Fuhrmann et al. 2010). 
Additionally, the Alzheimer disease plaque is formed by amyloid-β deposits, 
astroglial processes, degenerated neurons and activated microglia. It is therefore 
poorly understood whether microglial activation is protective in various 
neurodegenerative diseases or whether they present a target for therapy. Activated 
microglia are known to be able to trigger robust calcium activity in astrocytes, an 
observation that may explain some of the neurotoxicity of activated microglia 
(Agulhon et al. 2012). Activated microglia have been observed following stroke, and 
it is unclear whether the immune response generated might in fact increase the 
necrotic infarcted area of brain tissue (Verkhratsky and Butt 2007; Wang et al. 
2012c). Interestingly, microglia have also recently been implicated in the role of 
chronic neuropathic pain. Peripheral nerve damage is known to cause activation of 
microglia in the spinal cord, which then leads to the activation of purinoreceptors, in 
particular P2X4 and P2Y12. These receptors have been shown to be necessary in 
producing allodynia and purinergic inhibition results in reversal of this chronic pain 
symptom (Inoue et al. 2007; Kobayashi et al. 2008; Tsuda et al. 2003). Additionally, 
microglia are thought to release brain-derived neurotrophic factor in response to 
peripheral nerve damage as a signaling molecule to neurons, and inhibiting this 
release may reverse the symptoms of neuropathic pain (Coull JA 2005). Finally, 
microglial activation has been shown during the final coma stage in hepatic 
encephalopathy (HE), coinciding with brain edema and BBB opening. However, these 
data have been collected using ex vivo methods and further investigation using in vivo 
methods to establish the timescale of these changes is warranted (Butterworth 2011; 
Jiang et al. 2009; Rodrigo et al. 2010). Taken together, these divergent observations 
regarding the role of microglia in disease may reflect the double role of help and harm 
that microglia have in the CNS. 
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Astrocyte ammonia handling in health and disease 
Ammonia is a ubiquitous waste product and vital building block in the body that is 
intimately linked to protein metabolism (Butterworth 2002a). At physiological pH and 
temperature ammonia exists as 99% NH4+ (ammonium) and 1% NH3 (ammonia) and 
has an acid dissociation constant (pKa) of 9.02 (Ott and Larsen 2004). In the brain, 
ammonia detoxification has a central role as it is necessary for the recycling of the 
principle excitatory neurotransmitter glutamate, and hence indirectly the generation of 
the principle inhibitory transmitter, GABA (Bak et al. 2006; Hertz and Kala 2007; 
Paulsen et al. 1987). The key step of this glutamine-glutamate-GABA cycle happens 
in astrocytes, which possess glutamine synthetase (GS), the only enzyme capable of 
detoxifying ammonia in the brain through condensation with glutamate (Hertz and 
Zielke 2004; Martinez-Hernandez et al. 1977).  
One of the major problems with studying ammonia directly is its volatility and 
the lack of specific tools to detect the molecule (e.g. ammonia-sensitive dyes or 
electrodes). Consequently, several investigators have used pH as proxy for ammonia 
movement, as NH4+ is a weak acid and NH3 is a volatile base. For instance, when 
astrocytes or neurons in vitro or in situ are exposed to elevated ammonia this causes a 
rapid intracellular alkalinization, thought to represent volatile NH3 crossing the lipid 
bilayer and reaching equilibrium, followed by a prolonged intracellular acidification 
caused by NH4+ entry through ion-channels (Boyarsky et al. 1993; Nagaraja and 
Brookes 1998). Reciprocal pH changes are usually recorded in the extracellular space, 
as we found in our study. In a set of very interesting experiments Coles et al. used this 
pH phenomenon in combination with ammonia ion-sensitive microelectrodes to show 
that light-stimulated neuronal firing in retina is associated with increased aerobic 
metabolism and a rapid rise in extracellular ammonia, which is then swiftly taken up 
by glial cells (Coles et al. 1996; Marcaggi and Coles 2000; Marcaggi et al. 2004). 
Thus, taken together with related data from cultured astrocytes and acute brain slices 
it is clear that physiological neuronal firing is associated with a significant release of 
ammonia along with glutamate into the extracellular space (Alger and Nicoll 1983; 
Waniewski 1992). Interestingly, glial GS has a higher affinity for ammonia than 
glutamate, suggesting that astrocytes prioritize the removal of ammonia over the 
potentially excitotoxic neurotransmitter (Ciani et al. 1996; Waniewski 1992). 
Ammonia was relatively widely studied in the 1960s - 80s, as in excess it was 
found to cause gross brain dysfunction, including encephalopathy and seizures 
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(Cooper et al. 1979; Lux and Schubert 1969; Martinez-Hernandez et al. 1977; Raabe 
and Gumnit 1975). The epileptogenic effect of GS inhibitor methionine sulfoximine 
(MSO) was also observed at this time in dogs accidentally fed MSO via biscuits with 
bleached flour (dogs are 100-times more sensitive to MSO than rodents and primates) 
(Paulsen et al. 1988b; Proler and Kellaway 1962). Since the realization that liver 
failure is characterized by an accumulation of ammonia in the blood 
(hyperammonemia), the brain dysfunction in this condition, termed hepatic 
encephalopathy (HE), has also been thought to be largely ammonia-related 
(Butterworth 2002a). Several different hypotheses have been suggested to explain the 
neurological effects of ammonia, and these include (Fig. 15): ammonia driving an 
accumulation of glutamine with secondary osmotic damage to astrocytes (glutamine 
hypothesis), impaired functional hyperemia or decreased overall blood flow, BBB 
opening with consequent edema, lactic acidosis or impaired pH homeostasis, a failure 
of energy (glucose/ATP) metabolism, altered ion homeostasis (intracellular 
accumulation of Na+ and Cl-, and extracellular increase of K+), microglial activation, 
glutamate excitotoxicity (although nuclear magnetic resonance, NMR, studies have 
subsequently shown that there is no net glutamate increase in the brain) and an 
impairment of GABA function (Alger and Nicoll 1983; Butterworth 2002b; Cooper et 
al. 1979; Folbergrova et al. 1969; Ganz et al. 1989; Gregorios et al. 1985; Jayakumar 
et al. 2006; Lux 1971; Norenberg 1977; Raabe 1981; Ratnakumari et al. 1994; 
Rodrigo et al. 2010).  
However, rather surprisingly none of these hypotheses have resulted in viable 
new therapies, and the current therapy for hyperammonemia still relies on older 
strategies such as increasing gut elimination with lactulose (Butterworth 2002a). We 
would suggest that part of the shortcoming in these studies is a failure to appreciate 
the limitations of reduced experimental preparations when used in isolation. Although 
most of these studies likely hold important clues to the cause of ammonia 
neurotoxicity, putting the whole story together may require the use of several 
methodologies spanning different areas of neuroscience, glial-science, 
electrophysiology, optical imaging and biochemistry. 
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Figure 15. Diagram summarizing the potential mechanisms for acute hyperammonemic 
encephalopathy based on a systematic review of the literature. Key: Red - blood vessel, blue - astrocyte 
and pink - neuron (pre- and post-synaptic processes). Excess blood ammonia crosses the BBB and 
principally enters astrocytes, where it is detoxified by enzyme glutamine synthetase.  
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6. HYPOTHESES AND AIMS 
 
Two-photon imaging is a technique that has only recently been applied to the study of 
glial cells in vivo. We used this technique to examine the glial regulation of ion and 
water homeostasis in the brain. Glia are thought to be the principle cell type 
responsible for regulating these processes. Tight regulation of ion and volume 
changes is essential for normal neuronal function. We therefore hypothesized that by 
sensing and regulating local ion and water movement, glial cells can detect and alter 
physiological neuronal activity. Additionally, we propose that CNS disorders 
involving an imbalance of water and/or ion regulation might be directly caused by 
glial dysfunction. Utilizing the strengths of 2PLSM, we aimed to examine these 
homeostatic mechanisms in vivo, at a subcellular level and in real-time. Our ultimate 
goal was of extending the observations from previous studies to develop new 
therapies for the neurological disorders studied in our thesis. 
 
Our specific aims were as follows: 
I. What is the role of AQP4 in astrocyte calcium signaling elicited by volume 
changes during brain edema?  
II. Does AQP4 affect oxygen micro-distribution during cortical spreading 
depression?  
III. What is the effect of general anesthesia on astrocyte calcium signaling in the 
cortex of awake behaving animals?  
IV. How are lipid molecules transported in the paravascular space and could this 
specialized gliovascular compartment play a role in astrocyte signaling?  
V. Is microglial activation an early feature of HE that can be directly associated with 
excess ammonia?  
VI. What is the role of astrocytes in acute ammonia neurotoxicity and can we identify 
an early step in this disease pathway that may be targeted for therapy?  
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7. METHODOLOGICAL CONSIDERATIONS  
 
The goal of our project was to study glial regulation of volume and ion homeostasis in 
normal and disease settings. To ensure our findings were relevant and translatable to 
normal adult physiology and pathophysiology we chose to employ largely in vivo 
mouse models. Several recent papers have highlighted the profound difference 
between cellular dynamics in vivo as compared to in situ, in vitro or histological 
specimens (Sun et al. 2013; Takano et al. 2006; Wang et al. 2006). For a subset of the 
experiments we also adapted recently published techniques for awake imaging to 
avoid the masking effect of anesthesia on endpoints such as seizures, astrocyte 
calcium activity and cognitive phenotype (Dombeck et al. 2007; Greenberg et al. 
2008; Nimmerjahn et al. 2009). To achieve sufficient temporal and spatial resolution 
in vivo without damaging the brain we took advantage of the aforementioned benefits 
offered by 2PLSM. This type of optical imaging employs a pulsed femtosecond laser 
to achieve specimen excitation with much longer wavelengths than conventional 
1PLSM. However, 2PLSM has some theoretical and practical drawbacks as a 
consequence of the optics employed, which we will outline below (Christensen and 
Nedergaard 2011). To achieve a more complete picture of the biology, several adjunct 
techniques were also used in our studies to complement the 2PLSM findings. The 
relative merits and shortcomings of these techniques will also be addressed.  
 
Limitations of two-photon imaging 
There are three main issues with 2PLSM. First, 2PLSM has a theoretical resolution 
limit that is close to one-half the wavelength of the exciting light (i.e. diffraction limit 
= λ / 2 x numerical aperture) (Christensen and Nedergaard 2011). Therefore, 2PLSM 
theoretically cannot resolve structures smaller than ~ 0.35-45 μm. Practically, 2PLSM 
imaging of living brain has further limitations due to aberrations along the optic 
pathway (e.g. optically dense neuropil). The effective resolution can therefore be 
approximated from the point spread function of an individual 2PLSM set-up, and 
usually has a radial resolution of ~ 0.6-1.0 and an axial resolution of ~ 3-5 (due to 
greater dispersion in this axis) (Dong et al. 2003; Drew et al. 2010). This resolution is 
still not sufficient to address ultrastructural questions, which for instance conventional 
transmission electron microscopy can address (resolution 0.2 nm) (Denk et al. 2012; 
Helmstaedter et al. 2008; Mikula et al. 2012). Additionally, new optical techniques 
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such as stimulated emission depletion (resolution 70-90 nm) microscopy have 
breached the diffraction limit of light and are currently allowing optical imaging of 
subcellular protein localization in cultured cells (Blom et al. 2012; Blom et al. 2011; 
Hell 2003; Willig et al. 2006). However, due to technical limitations such techniques 
have to our knowledge not yet been applied in vivo. The resolution limit of 2PLSM 
therefore imposes limitations on the questions that can be addressed using this 
technique, and for instance comparing the subcellular localization or trafficking of 
proteins between two closely apposed cell membranes is currently beyond the reach 
of 2PLSM.  
Second, 2PLSM has a technical limit on its temporal resolution; as it usually 
relies on the movement of galvanometric mirrors to raster scan the laser beam across 
the specimen (similar to confocal microscopy). These mirrors have too much inertia 
to allow imaging with a temporal resolution < 80-100 ms. Many important processes 
happen on a timescale that is orders of magnitude faster than the scan rate of most 
2PLSM set-ups, including neuronal signaling (Christensen and Nedergaard 2011). 
Most of the experiments used in this thesis were conducted using galvanometric 
mirrors, but the recent advent of random access multiphoton microscopy using 
acousto-optical deflectors is rapidly breaching this temporal resolution barrier (Chen 
et al. 2011; Duemani Reddy et al. 2008).  
Third, due to the optically dense nature of biological material such as brain, 
2PLSM is usually unable to image much deeper than 500 μm below the tissue surface. 
Maximum imaging depth is again a property of the wavelength used to excite the 
specimen, and recently the use of ultra-long wavelength lasers (e.g. 1280 nm) 
facilitated imaging as deep as 1 mm below the cortical surface (Kobat et al. 2009). 
Deeper imaging will undoubtedly open new avenues for discoveries, as most labs are 
currently limited to imaging down to layer IV of mouse brain cortex. White matter, 
subcortical nuclei, hippocampus and deeper cortical layers are thus rarely examined in 
vivo due to the technical limitations of imaging (e.g. 2PLSM).  
 
Surgical preparations for in vivo imaging  
Another critical consideration for imaging involving live animals is the surgical 
preparation. The typical surgical protocol we employed in our studies involved 
anesthetizing the animal, sterilizing the skin, fixing the skull to a metal mini-frame, 
creating a small cranial window (0.5-3 mm diameter), and sealing this window with a 
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cover glass ± agarose or saline (Fig. 16) (Dombeck et al. 2007; Drew et al. 2010; 
Holtmaat et al. 2009; Wang et al. 2006).  
 
   
Figure 16. Neurosurgical preparation for in vivo 2PLSM imaging. Left: Photograph of a cranial 
window preparation. Kindly provided by Prof. M. Nedergaard. Middle: Immunofluorescence 
micrograph showing the layers of the mouse cortex and outlining the microvasculature (white - AQP4, 
blue - DAPI). Right: Collapsed XYZ stack (25-175 μm depth) of fluorescein isothiocyanate (FITC)-
dextran labeled cortical blood vessels imaged using 2PLSM.  
 
Generally, we found two steps to be pivotal in this procedure. First, the cranial 
window had to be created with extreme caution to avoid injuring the underlying brain. 
Injuries might not be readily apparent during the surgery, but when we subsequently 
imaged the animal even minor injuries could significantly confound the processes we 
wished to study (e.g. calcium signaling) (Xu et al. 2007). One method to circumvent 
this problem and allow more chronic imaging is to thin the skull instead of generating 
a full thickness cranial window. This approach may cause more limited resolution, 
and requires a great amount of technical skill, but can potentially generate less 
microglial activity, reactive astrogliosis and dendritic spine loss (Drew et al. 2010; 
Holtmaat et al. 2009). Second, the overall physiological state of the animal strongly 
influenced many of the endpoints we wished to measure, and we therefore excluded 
all animals displaying problems with e.g. breathing, hypoxia and hypercapnia (Duffy 
and MacVicar 1996; Thompson et al. 2006). The latter issue was most critical when 
experimenting with anesthetized mice, as these small rodents easily develop 
complications from the anesthesia (e.g. inadequate ventilation).  
To address some of the issues mentioned above, we adapted a model to image 
brain cells in awake behaving mice (Dombeck et al. 2007; Nimmerjahn et al. 2009). 
Extreme care needed to be taken not to cause pain and stress to the animal, and this 
model had some issues of its own. Our main concern was to avoid causing any harm 
to the animal and the experiments were therefore planned and executed with great 
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care. To address the more specific issue of movement artifacts in awake mice, we 
developed a method of normalizing fluorescence signals (outlined in more detail in 
paper II). Related papers that imaged awake mice have also reported alternative 
methods of circumventing this issue, including post hoc algorithm corrections 
(Dombeck et al. 2009; Dombeck et al. 2010; Harvey et al. 2009; Ozden et al. 2012). 
In conclusion, a careful surgical preparation is critical for validity of the results 
obtained from in vivo 2PLSM imaging. 
 
Ethical considerations for in vivo imaging  
Several key agreements including Nuremberg (1947) and Helsinki (1974) have 
highlighted the need for an ethical framework to regulate the conduct of medical 
research. The following is an account of the ethical issues that we encountered during 
our doctoral research and how we addressed them. We chose to use a mouse 
experimental model because of the similarity of the brain pathophysiology for the 
conditions we wished to study between mice and humans (translational potential) and 
the availability of transgenic mice and the. When designing our experiments we have 
used the three Rs outlined by Russel and Burch (1959) to minimize both the use of 
animals and any potential distress inflicted (Wolfensohn and Lloyd 2003). We 
strongly feel this should be a key priority to emphasize to junior researchers at an 
early stage. In addition, the ethical treatment of experimental animals is pivotal for 
both obtaining trustworthy results and the continued existence of basic research. With 
regards to our thesis work, we encountered the most ethical and practical challenges 
when it came to designing and implementing the in vivo experiments.  
Firstly, animal experiments should never be performed if other means exist 
that will adequately address the research question. Unfortunately, our scientific 
questions could not be addressed without animal experimentation (replacement). 
Modeling of the glial homeostatic system would for instance not help us test our 
hypotheses, as the basic properties of this system are still not delineated clearly and 
clinical outcomes cannot be measured in certain reduced preparations. Secondly, we 
wished to minimize the number of mice needed to challenge our hypotheses 
(reduction). An important part of achieving this goal was careful planning, including 
an exhaustive literature search to avoid unnecessary duplication of previous results 
and statistical power calculations to exactly plan the numbers of animals needed.  
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Finally, and perhaps most importantly, we spent a long time refining our 
experimental methods. Whenever possible we performed experiments on fully 
anesthetized animals, which has the benefit that the animal has full analgesia, 
anesthesia and amnesia. However, for a subset of experiments the use of anesthesia 
would mask the end-points we wished to examine, and we were forced to adapt a 
relatively new technique for awake imaging in habituated animals (Dombeck et al. 
2007). As awake experiments have the potential of causing significant stress to the 
animal, they should never be performed without careful consideration of whether the 
research questions can be addressed in any other way. We found this to be a major 
ethical burden as well as a practical challenge, also when interpreting the 
experimental results. We therefore spent extensive efforts when designing these 
experiments to minimize any pain or distress the animal might experience. Challenges 
included ensuring adequate anesthesia for the surgical implantation of a cranial 
window, whilst ensuring the animal could recover completely from the anesthetic. 
Moreover, adequate postoperative analgesia had to be achieved, and the mice that 
were imaged multiple times over longer periods had to be carefully assessed for signs 
of discomfort or distress (Cooper et al. 2000; Langford et al. 2010; Richardson and 
Flecknell 2005). Finally, during the imaging experiments themselves we had to ensure 
absolute silence, darkness, adequate warmth and hydration, without the mice getting 
wet from any of the solutions used (1994). Throughout the design and implementation 
of these methods we were continuously in contact with the veterinarians at the 
department of animal health to optimize the animals’ well being. We also relied 
heavily on advice from researchers with previous experience from similar 
experiments, and previously published protocols on in vivo experimentation 
(Dombeck et al. 2007; Nimmerjahn et al. 2009). 
 
Fluorescent imaging using chemical dyes and transgenic animals 
Fluorescent molecules are generally either chemicals (e.g. tetramethylrhodamine 
derivatives) or proteins (e.g. fluorescent eGFP isolated from jellyfish). The former 
can frequently be toxic to living cells at high doses, while the latter are better 
tolerated as they are frequently derived from living animals (Paredes et al. 2008; 
Regan et al. 2007). The efficiency of two-photon fluorophore excitation and optimal 
excitation wavelength cannot be directly extrapolated from one-photon spectra, and 
likely depends on other factors such as the local electric field (Bestvater et al. 2002; 
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Drobizhev et al. 2011). We used a combination of transgenic mice expressing 
fluorescent proteins under cell-specific promoters and loading of fluorescent dyes that 
label cells of interest. The former technique is largely limited by the selectivity and 
strength of the gene promoter used. Glt1 is the promoter for the astrocyte specific 
glutamate transporter GLT1 (mouse ortholog of excitatory amino acid transporter 2), 
and eGFP expressed by this promoter labels astrocyte soma, principal processes and 
endfeet sufficiently well (Fig. 17) (Regan et al. 2007). However, the finer peri-
synaptic processes were less well resolved and this limited our ability to examine 
these subcellular microdomains in more detail. 
 
   
Figure 17. 2PLSM images showing eGFP expressing astrocytes and texas red dextran outlined 
vasculature at different magnifications. Note the bright eGFP signal in the soma and primary processes, 
but relatively poor signal-to-noise ratio in the smaller processes. 
    
Several hydrophobic dyes were used to selectively label astrocytes (e.g. 
SR101 and Texas red hydrazide) or monitor intracellular calcium fluctuations (e.g. 
rhod-2, fluo-4, Oregon green BAPTA, 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-
tetraacetic acid) (Table 2) (Paredes et al. 2008). The former dyes serve as excellent 
morphological markers (Nimmerjahn et al. 2004), but have relatively recently been 
shown to trigger epileptiform activity in hippocampal brain slices (Kang et al. 2010). 
The aforementioned calcium sensitive dyes are acetoxymethyl (AM)-ester linked, 
allowing the molecule to cross cell membranes by virtue of their lipid solubility. AM-
dyes are then trapped inside the cell through the activity of intracellular esterases, 
which cleave the AM group and render the dye hydrophilic (Paredes et al. 2008). The 
mechanism for the selective loading of these dyes mainly into astrocytes is still 
largely a mystery, and one cannot exclude that the dyes themselves have some 
biological effects on the cells they label (Reeves et al. 2011). The calcium indicators 
employed in our studies are for instance all BAPTA-based calcium chelators, and 
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might therefore dampen fluctuations of free Ca2+ inside the cell (Paredes et al. 2008; 
Reeves et al. 2011). Our own experience was therefore to try and minimize the 
amount of calcium dye loaded, to avoid cell saturation with the dye as this effectively 
abolished spontaneous calcium transients. Additionally, all chemical calcium 
indicators need to be loaded over a period of 30 - 45 min into astrocytes either 
through application on exposed cortex or via pressure injection into the parenchyma. 
This loading process may itself generate a mild inflammatory response in the brain, 
adversely effecting recordings (Agulhon et al. 2012). Finally, different calcium 
indicators have different dissociation constants that determine how long they bind free 
Ca2+ ions, and setting a practical limit on the temporal resolution of imaging. Several 
investigators have recently found a way to circumvent dye use by generating 
transgenic mice expressing calcium indicators (e.g. genetically-encoded calcium 
modulated protein) under astrocyte specific promoters (e.g. GFAP) (Mao et al. 2008; 
Shigetomi et al. 2010; Tong et al. 2012). In conclusion, both chemical and transgenic 
fluorescent proteins have inherent limitations that need to be considered when 
interpreting imaging results.  
 
Table 2. 1PLSM and 2PLSM excitation/emission spectra of relevant fluorophores. 
 
 2P excitation 1P excitation Emission 
eGFP 927 nm 488 nm 509 nm 
Texas red 780 nm 582 nm 602 nm 
SR101 905 nm 586 nm 605 nm 
Fluorescein 800 nm 508 nm 519 nm 
Rhod-2 810 nm 553 nm 576 nm 
Fluo-3,4,5 810 nm 493 nm 520 nm 
Oregon green 
BAPTA 
810 nm 492 nm 523 nm 
Nile red 810 nm 559 nm 640 nm 
 
Data sampling and analysis for 2PLSM 
To ensure that all the 2PLSM imaging data we collected were comparable we paid 
strict attention to maintaining consistent imaging parameters. All 2PLSM images 
were collected >70 μm below the pial surface in layer I-II of the cerebral cortex. 
Within individual experiments the depth of imaging, laser power and photomultiplier 
tube settings were kept within a narrow range. Laser power was generally kept below 
40 mW to avoid phototoxicity to the tissue. This is especially important for calcium 
imaging, as transients can be artificially induced by high laser power (Wang et al. 
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2006). All the data was analyzed using either ImageJ (National Institute of Health) or 
custom-made MatLab software (NedLabAnalysis). For calcium imaging, the software 
allowed simultaneous quantification of fluorescence intensity in multiple regions of 
interest (ROIs) from an XYT scan with a tracking function (i.e. ROI tracking to 
correct for XY displacement). To further reduce confounding due to XY or Z 
displacement (e.g. movement artifact) most calcium indicator intensity traces were 
also normalized to Glt1-eGFP intensity. For volumetric analysis the software used 
XYZT scans, and quantified the number of pixels over a semi-automated threshold 
value within a manually defined ROI. The pixels were then added up for each XYZ 
scan and multiplied by the scale factor to get an estimate of cell volume. The principal 
limitation of this volumetric analysis was the resolution of 2PLSM, to allow accurate 
thresholding of the cell. We optimized the resolution by using a high magnification 
and high numerical aperture lens, adequate laser power, and maximally clear optical 
media (e.g. thin layer of agarose) in the cranial window.  
 
Electrocorticograms, ion-sensitive microelctrodes (ISMs) and patch clamp 
Neuronal activity causes distinct changes in local voltage due to the ion currents 
associated with action potentials and post-synaptic potentials (Vanderwolf 1992). In 
most of our 2PLSM experiments we used electrophysiology to monitor neuronal 
activity in parallel with the astrocyte imaging. However, it is also possible to image 
both neuronal and astrocyte activity simultaneously with 2PLSM using dyes like 
Oregon green BAPTA (Dombeck et al. 2007). We largely obtained our recordings by 
placing a glass microelectrode into the cerebral cortex and completing the circuit with 
a ground placed in the fluid bathing the brain. The resultant signals were filtered to 
yield either local field potential or electrocorticogram recordings (Wang et al. 2006). 
Additionally, electrocorticogram traces can be analyzed both in terms of morphology 
(e.g. amplitude of whisker electrocorticogram response) and the relative activity in 
different frequency bands (usually represented as power spectra). Electrocorticogram 
activity largely represents the sum of pyramidal neuronal activity in the region where 
the electrode is placed, and increased activity in different frequency bands can 
represent either wakeful, asleep or anesthetized patterns of neuronal firing (Table 3) 
(Schwilden 2006). These techniques have excellent temporal resolution, and for 
instance allowed us to record individual EPSPs, but not unexpectedly lack spatial 
resolution. The accurate placement of electrodes is therefore paramount, as 
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inconsistent electrode placement between experiments can introduce significant bias. 
To aid and monitor the placement of these microelectrodes we relied on 2PLSM, 
which allowed us to visualize the FITC-dextran containing electrodes. It was thus 
possible to accurately place microelectrodes within a consistent distance of the 
imaged field.  
For a subset of experiments we used ISMs to record changes in extracellular 
ion homeostasis. ISMs are based on the principle that some hydrophobic resins are 
selective for certain ion currents (e.g. K+), and if these resins are placed in the tip of a 
microelectrode one can record currents that are principally due to the movement of 
this ion (Nicholson 1993). As with the field electrodes, the ISMs lack spatial 
resolution and their placement within the brain needs to be accurate. ISMs also have a 
number of technical issues. For example, over time the resin from the electrode tip 
leaks, thus reducing sensitivity. It is therefore important to calibrate ISMs before and 
after each experiment with regard to sensitivity, and discard all recordings where the 
after-calibration deviates >5%. Moreover, changes in field recordings need to be 
subtracted from ISM traces to avoid confounding due to local changes in voltage. A 
field electrode therefore needs to be placed close to, or ideally in the same location as 
the ISM, which is most frequently achieved by making double-barreled electrodes 
(Borrelli et al. 1985). Unfortunately, these electrodes have a much higher failure rate 
than using two single barreled electrodes, as they are more complex to make and the 
resin can leak out more easily. Finally, ISM resins are never completely selective for 
the ion they are meant to measure, and can respond to a lesser extent to other ions. 
This last issue is especially relevant if the ions have a similar hydrated radius and 
charge. It is therefore important to check the selectivity coefficient for each resin 
used, and calculate the interference due to the predicted change of other interfering 
ions so they may be subtracted from the ISM recording (Nicholson 1993). Due to all 
these pitfalls and limitations we also piloted alternative techniques for measuring 
extracellular ion changes, including ion- and pH-sensitive dyes (e.g. BCECF, 
SNARF-4, TAC-Red) (Boyarsky et al. 1993; Mariot et al. 1991; Padmawar et al. 
2005). These dyes have the benefit of granting spatial resolution, albeit at the cost of 
reduced temporal resolution. Although several dyes are commercially available, we 
were unable to make these chemicals load brain cells sufficiently in vivo to allow 
accurate recordings of ion changes.  
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Table 3. Characteristics of the different waveforms seen in the electrocorticogram. 
Type Frequency Physiology Pathology 
δ (delta) 0-4 Hz Slow wave sleep Encephalopathy 
θ (theta) 4-8 Hz Drowsiness Encephalopathy 
α (alpha) 8-13 Hz Relaxed awake Coma 
β (beta) 13-30 Active awake Sedatives 
γ (gamma) 30-100+ Memory Dementia 
 
For a subset of the experiments experienced electrophysiologists in our lab 
(Fushun Wang, Qiwu Xu and Ning Kang) performed patch clamp analyses. Briefly, 
this method that gained its developers Erwin Neher and Bert Sakmann a Nobel Prize 
in 1991 is based on placing a ∼1μm tip glass microelectrode on the cell membrane of 
e.g. a neuron and applying suction so that a 109 (giga) Ω (ohm) resistance seal is 
formed between the membrane and the electrode (Neher et al. 1978). The high-
resistance seal allows the investigator to monitor electrical activity from just a few 
ion-channels in the little patch of membrane covered by the electrode without 
interference (noise) from the rest of the cell (Fig. 18). Investigators can either control 
the membrane potential (voltage clamp) or the movement of ions (current clamp) to 
measure what changes this induces in the non-clamped parameter, e.g. in voltage-
clamp mode you can vary the membrane potential across a range and see what current 
flow this induces, thus generating an I-V (current-voltage) curve for a particular ion 
channel (Sakmann and Neher 1984).  
There are several variations of patch clamping; including whole-cell where the 
membrane patch is ruptured allowing the electrode to measure the electrical activity 
of the whole cell. This method has several advantages over sharp microelectrode 
recordings used previously (where a very small diameter tip electrode is used to 
impale the cell); including better electrical access to the cell due to the larger 
electrode tip diameter. However, the large tip diameter also implies that the whole-
cell patch electrode will over a period of >10 min dialyze the contents of the cell 
(Verkhratsky et al. 2006). Another variation of patch clamping also used in our study 
is a perforated patch. This is where the electrode is placed on the cell membrane and a 
giga-Ohm seal is formed, but the membrane patch is not ruptured. Usually agents 
such as nystatin and gramicidin are used to perforate the membrane patch (as opposed 
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to antimicrobial agents like amphotericin B), giving the investigator electrical access 
to the cell that is more selective (depending on what the perforations are permeable 
to) than with a whole-cell patch (Akaike 1996). A gramicidin patch is for instance 
very well suited to studying chloride currents, because the perforations are mainly 
permeable to monovalent cations and uncharged molecules (Kyrozis and Reichling 
1995). The drawbacks of a perforated patch are its technical difficulty (the perforated 
membrane is weakened and a bit unstable), the amount of time it takes for the 
antibiotics to form adequate perforations (10 - 30 min) and the greater access 
resistance (= Relectrode + Relectrode-cell junction) that causes less signal-to-noise.  
 
  
Figure 18. Patch clamp recording. Left: Illustration of various patch clamp techniques outlined in the 
text. Right: 2PLSM image of a whole-cell patched Purkinje cell outlined with Alexa fluor 488 from the 
patch micropipette, kindly provided by Qiwu Xu.   
 
Supporting techniques 
Gene knock-out or knock-down. Several of the studies in our thesis use gene deletion 
(KO) or silencing (knock-down) to explore the molecular mechanisms of disease. 
Generally speaking gene deletion (KO) is accomplished through a sequence of steps, 
including (Gaveriaux-Ruff and Kieffer 2007): 1) Sequencing and cloning the gene of 
interest. 2) Altering the sequence of the gene to make it inoperable (that can produce 
splice variants) or flanking the important exons with sequences (e.g. LoxP) that 
promote site-specific recombination (e.g. excision or translocation of the flanked 
exons). 3) Embryonic stem cells are isolated from the mouse blastocyst, grown in 
vitro, and the altered gene is inserted by homologous recombination using 
electroporation. At this stage only embryonic stem cells that have taken up the altered 
gene can be selected if a gene conferring antimicrobial resistance (e.g. to neomycin) 
has been included in the inserted construct. 4) Embryonic stem cells with the altered 
gene are then inserted into a recipient mouse blastocyst, generating chimeric 
offspring, which when bred with wild-type (WT) mice in the next generation will 
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generate some offspring heterozygous for the deleted or dysfunctional gene. In the 
case of gene excision using gene floxing (flanked by LoxP sites), a mouse expressing 
the floxed gene is bred with a mouse expressing Cre-recombinase (potentially under a 
tissue or cell specific promoter), so that only cells expressing Cre will excise the 
floxed gene. In contrast to the previous gene deletion strategies where the KO is 
permanent from birth (called constitutive), it is also possible to make the final 
recombination step inducible by a drug of choice (e.g. tamoxifen or tetracycline), for 
instance by using a modified form of Cre-recombinase that requires a drug to activate 
the enzyme (van der Weyden et al. 2002). The inducible (or conditional) KO strategy 
has the benefit of allowing deletion of genes that is incompatible with mouse survival 
into adulthood (Pascual et al. 2005). Additionally, inducible KO avoids the unknown 
confounding factors associated with developmental adaptation to the constitutive gene 
deletion.  
As an alternative to conventional gene KO, it is also possible to knockdown or 
silence genes by expressing e.g. short-inhibitory or short-hairpin ribonucleic acid 
(shRNA), which contain a complimentary sequence to the messenger RNA (mRNA) 
from the gene of interest (Haas and Sontheimer 2010). There are several benefits to 
this strategy, including no need to go through multiple generations of mouse breeding, 
the ability to induce gene knock-down at any stage of development, and gene knock-
down often has less cost associated with it than developing and maintaining a separate 
KO mouse colony. Conversely, the limitations of gene silencing include a much lower 
and more variable efficiency of ‘knock-down’ (e.g. 10-70%), challenges with delivery 
and expression of the silencing RNA construct in the cells of interest (e.g. requires 
strong highly cell-specific promoter), and relatively high percentage of silencing 
constructs that work in situ not working in vivo (Ge et al. 2006; Haas and Sontheimer 
2010; Jayakumar et al. 2011a; Koyama et al. 2012). For in vivo gene silencing 
investigators often employ viral vectors that are relatively specific to the cells of 
interest (e.g. pyramidal neurons), and packaged these with a construct that includes 
the silencing RNA, a reporter gene (e.g. eGFP), and a sequence recognized by a cell 
specific promoter (e.g. GFAP). In one of our studies (unpublished), we for instance 
attempted to use commercially available shRNA to Slc12a2 (coding NKCC1) that has 
previously been successfully used in glioma cultures. The strategy was to inject 
mouse pups (e.g. P20) intracortically with high-titer lentivirus (targeting pyramidal 
cells) expressing Slc12a2 shRNA and eGFP under the pGIPZ promoter (Haas and 
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Sontheimer 2010). However, eGFP expression was too week to detect, likely due to 
weak pGIPZ promoter activity in vivo. Some authors have circumvented this problem 
by illustrating not direct eGFP expression in confocal micrographs, but rather 
antibody against eGFP (Haas and Sontheimer 2010). However, we needed to be able 
to visualize the eGFP on our electrophysiology set-up so as to patch affected cells, 
and were thus unsuccessful in this project. Moreover, there is no assurance that 
reporter gene expression (i.e. eGFP) means effective gene silencing or vice versa, 
therefore these types of experiments usually require a lot of controls to ensure that 
observed changes are a result of gene silencing, and e.g. not simply an effect the viral 
vector. Taken together, although gene silencing is popular in high tier journals as a 
supplement to pharmacology (to show molecular specificity), this strategy has several 
pitfalls ensuring that results need to be interpreted with caution.  
 
Whisker stimulation. Unlike humans, mice devote a large proportion of their brain to 
process information from their whiskers (also called mystifacial vibrissae) (Schubert 
et al. 2007; Wang et al. 2006). The part of the cerebral cortex in mice that received 
whisker information has a columnar organization similar to the primate visual cortex, 
with whisker ‘barrels’ receiving input from individual whiskers in a 1:1 ratio 
(Borgdorff et al. 2007). To examine the response of glial cells to physiological 
sensory stimulation in vivo, we therefore adapted a protocol developed by Wang et al. 
that uses small air puff stimulate the whiskers whilst simultaneously imaging the 
relevant whisker barrel with 2PLSM (Wang et al. 2006). The benefit of air puff 
whisker stimulation over for instance electrical stimulation is that it is non-painful, 
and can thus be used in awake mice. However, other methods such as electromagnetic 
movement of microbeads or electrical nerve stimulation may be superior overall 
(Borgdorff et al. 2007). The benefit of whisker stimulation compared to other forms 
of sensory stimulation (e.g. hindlimb electroshock) is that whisker sensation in mice 
is a highly developed sensory modality that takes up a large part of the cortex 
(Winship et al. 2007). Somatotopic mapping of individual whiskers to their respective 
whisker barrels is also highly specific (Fig. 19). The difficulty with this form of 
stimulation is to avoid stimulating other whiskers than the one of interest (usually 
accomplished by trimming them) and to avoid stimulating the face (accomplished by 
puffing parallel to the snout) (Wang et al. 2006). In conclusion, we found that whisker 
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stimulation was a good non-invasive way of generating neuronal activation in the 
sensory cortex.  
    
 
Figure 19. The somatotopic mapping of whiskers to cortical whisker barrels in rodents. A. Diagram 
illustrating the convention for labeling individual whiskers and their projection via trigeminal ganglion 
cells in the brain stem and thalamic projection neurons to whisker barrels in layer IV of the 
somatosensory cortex. B. Cytochrome oxidase stained tangential section of layer IV barrel cortex. C. 
Dodt gradient contrasted acute coronal section through rodent barrel cortex showing the cortical layers 
(I-VI) and individual whisker barrels (star). Adapted with permission from Schubert et al. 2007.  
 
Immunohistochemistry. In several of our studies, we used immunohistochemistry to 
allow the accurate anatomical and cellular localization of putative molecular targets. 
This technique is based on the principle that when one cuts thin specially preserved 
slices of brain tissue; these slices can be stained with a primary antibody specific for 
the molecule of interest. A secondary antibody that binds the primary antibody and is 
cross-linked to for instance a fluorescent molecule then visualizes the primary 
antibody (Saper and Sawchenko 2003). Immunohistochemistry has several 
limitations, including a complete lack of temporal resolution (unless serial 
immunohistochemistry is performed at different time points). Moreover, the spatial 
resolution depends directly on the method used to visualize the 
immunohistochemistry. Confocal immunofluorescence microscopy is, for instance, 
limited by the aforementioned theoretical limit of resolution for the wavelength of 
light used. Transmission electron microscopy is, on the other hand, usually only 
limited by the size of the primary and secondary antibody complex employed for e.g. 
immunogold labeling (Ottersen et al. 1996). Finally, immunohistochemistry is 
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primarily limited by the sensitivity and specificity of the antibodies used. 
Unfortunately, many of antibodies that are commercially available are of poor quality. 
Several steps are routinely run to control for unspecific labeling, e.g. adding 
human/bovine serum albumin or milk powder to the antibody solution, omitting 
primary antibody and reabsorbing the primary antibody solution with the peptide used 
for immunization (Fritschy 2008). However, many investigators feel one cannot truly 
know the antibody specificity until tissue from mice where the molecule of interest is 
knocked out is stained and the staining found to be entirely negative (see paper I). 
 
Laser Doppler Flowmetry. This is an optical technique where a collimated laser beam 
is split, and the two coherent laser beams are focused on red blood cells passing 
through blood vessels (Carter 1991). Because the laser scattered from the red blood 
cells will be Doppler shifted proportionate to the velocity of the cells, it will not be 
coherent with the incident light and generate interference. This causes the intensity of 
the reflected light that the device detects to fluctuate with a frequency that is 
proportional to the Doppler shift and thus the velocity of the red blood cells. The 
name of this technique is thus a misnomer, as the device actually measures velocity 
and not flow. Laser Doppler flowmetry as a measure of cerebral blood flow has 
several sources of error. Most importantly, the optics is dependent on the incident 
laser light being at right angles to the blood flow that one wishes to measure. 
Additionally, it is not possible to get an absolute measure of blood flow, but only 
record changes in blood velocity. Finally, laser Doppler flowmetry is heavily 
influenced by blood flow in meningeal vessels superficial to the brain, and these 
vessels may not necessarily directly reflect cerebrovascular changes. 
 
Evans blue extravasation. Evans blue is a chemical dye that has a high affinity for 
blood albumin, and which fluoresces at 680 nm when excited between 470-540 nm 
(Vise et al. 1975). The BBB is largely impermeable to macromolecules such as 
albumin. Systemic administration of Evans blue is therefore frequently used as an 
assay of BBB opening in disease states (Kaya and Ahishali 2011). The principal 
limitation of this technique for studying BBB permeability is that not all BBB 
opening may be characterized by increased permeability to macromolecules such as 
albumin. A more extensive characterization of BBB permeability thus often involves 
using other chemicals of different sizes. Finally, it can be beneficial to use Evans blue 
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pre-bound to albumin as in our study, since some of the chemical may remain 
unbound to albumin and can cross the BBB.  
 
Brain water content. To obtain a measure of overall brain water content we used the 
extensively published wet/dry-brain weight method. The method is based on the 
comparison of brain weight immediately after removal from the animal (wet weight) 
with the brain weight after all water content has been evaporated in an 80oC oven for 
24 hours (dry weight). Percent brain water content can then be computed by: wet 
weight-dry weight/wet weight. The main issue with this method is the reproducibility 
depends heavily on brain extraction, drying and weighing having been conducted in 
the exact same way. Delays in brain extraction can for instance rapidly reduce brain 
water content through evaporation (Haj-Yasein et al. 2011b).  
 
Intracranial pressure (ICP). When significant brain edema is allowed to accumulate, 
pressure will begin to build up inside the rigid confines of the skull. This increase in 
ICP can be monitored clinically in neurosurgical patients by the implantation of 
pressure probe through a small craniotomy. We employed a similar approach in our 
mice, and implanted a pressure probe in the cerebral hemisphere to monitor ICP 
changes during conditions thought to elicit brain edema (Statler et al. 2001). ICP has a 
characteristic waveform pattern reflecting the pressure fluctuations in the cardiac 
cycle. The sources for error when using ICP probe include failure to calibrate the 
probe properly (cannot get absolute reading), failure to allow the ICP recording to 
stabilize (results in drift) and manipulation of the transducer wire (causes false ICP 
fluctuations). Finally, to accurately interpret ICP recordings it is essential to also 
record mean arterial pressure. We did this by implanting a catheter in the femoral 
artery connected to an external pressure probe. Using ABP it is possible to calculate 
cerebral perfusion pressure, using the formula: cerebral perfusion pressure = mean 
arterial pressure – ICP. Normally, cerebral blood flow stays within a narrow range 
despite variation in blood pressure due to cerebrovascular autoregulation. However, 
when ICP reaches critical levels cerebral perfusion pressure can become insufficient 
to supply adequate blood to the brain.  
 
NMR spectroscopy. Atomic isotopes that contain an odd number of protons and 
neutrons act as small magnets (e.g. 1H). When these isotopes are placed in a strong 
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externally applied magnetic field, their magnetic poles will tend to align with the 
field. NMR spectroscopy exploits the principle that if a radiofrequency pulse of a 
specific frequency is applied to this magnetic field it will tend to disturb the alignment 
of the isotopes (Behar et al. 1993). The frequency required is the resonance frequency 
of the isotope, and this will typically bring the isotope to a higher energy state. The 
isotope will after a time emit the energy in the form of electromagnetic radiation to 
return to its alignment in the magnetic field. The resonance frequency not only varies 
from isotope to isotope, but each individual isotope will also have different resonance 
frequencies depending on their atomic microenvironment. The latter is termed a 
chemical shift, and can be referenced to a ‘standard’ where there is little distortion 
from nearby atoms. In our study, we used 1H-isotope that is abundantly present in 
biological tissue and water. When the 1H-NMR signal intensity is plotted against 
chemical shift (‘NMR spectrum’), several peaks representing 1H present in different 
molecules (e.g. lactate, glutamate). A major issue with 1H-NMR is that biological 
tissues are largely made up of water, generating a large 1H-NMR signal. This is 
usually addressed by dehydrating tissues and reconstituting them with deuterized (2H) 
water. Standard 1H-NMR is therefore incompatible with in vivo analyses, and is 
performed on homogenated tissue. Because it uses homogenates, however, care needs 
to be taken to stop enzymatic reactions immediately after extracting the tissue. This is 
usually achieved by freezing the tissue, followed by denaturing enzymes with a strong 
acid. Another source of error is that 1H-NMR spectra are very sensitive pH or free 
protons, and changes in pH can cause some 1H-NMR peaks to overlap. It is therefore 
essential to ensure consistent pH between specimens, and use the pH ideal for 
resolving the peaks of interest without overlaps. Finally, 1H-NMR results are 
frequently reported as concentrations of molecules of interest per unit brain volume. 
However, NMR can only detect relative amounts of molecules from the signal 
intensities, and concentrations need to be inferred e.g. by using a standard. This latter 
step can also introduce some variability to the results (Zwingmann et al. 2003).   
 
Disease models 
Acute hyponatremic brain edema: Hyponatremia is a reduction in the concentration of 
sodium in the blood. When this occurs acutely it leads to the accumulation of water in 
the brain; termed osmotic brain edema (Manley et al. 2000; Verbalis 2010). Common 
causes of hyponatremia in a clinical setting include salt loss in marathon runners, 
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aggressive intravenous fluid therapy in hospitalized patients and endocrine disorders 
such as syndrome of inappropriate anti-diuretic hormone (Verbalis 2010). We adapted 
a method to induce hyponatremic brain edema in mice by acutely injecting 20% (200 
mL kg-1) of the mouse body weight as distilled ion-free water i.p. This model 
generates robust brain edema, and has previously been used by several other groups 
as a model of osmotic brain edema (Nase et al. 2008). Previous groups have also 
added anti-diuretic hormone (vasopressin) analogue desmopressin (DDAVP) to the 
infused water, but in our hands this was unnecessary and might unintentionally alter 
AQP4 function (Manley et al. 2000; Moeller et al. 2009; Niermann et al. 2001). Our 
in vivo model of hyponatremic brain edema in mice closely resembles related 
conditions in humans except for one key aspect. Clinical cases of hyponatremia 
frequently have a more protracted time-course, with more potential for CNS and 
extra-CNS (e.g. renal) compensation. Unfortunately a longer time course might be 
more difficult to image accurately, as calcium indicators are internalized and 
metabolized in the course of 2-3 hours. These sets of experiments therefore represent 
a compromise between a more ideal model of hyponatremia, and a model that 
progresses rapidly enough to allow study by 2PLSM.  
 
Hepatic encephalopathy (HE): HE is brain impairment, ranging from confusion to 
coma, caused by the accumulation of waste products including ammonia in liver 
failure (Butterworth et al. 2009). In a clinical setting, hepatic encephalopathy is most 
frequently seen as a complication of alcoholic liver disease or as acute drug-induced 
liver failure (e.g. paracetamol overdose). We used the liver toxin azoxymethane to 
induce acute liver failure and consequent hepatic encephalopathy in mice. 
Azoxymethane was first discovered in 1960 in Guam, and was isolated as the active 
ingredient that causes ingested cycad palm nuts to be carcinogenic and hepatotoxic 
(Bélanger et al. 2006; Matkowskyj et al. 1999). This chemical model of HE has 
several benefits, in that it is very reproducible and encompasses all the relevant 
clinical and biochemical features of human HE. Azoxymethane is also one of the few 
models of HE that can be used in mice, which was an important prerequisite for our 
study that intended to use transgenic animals (Fig. 20) (i.e. Cx3Cr1-eGFP) (Bélanger 
et al. 2006). Conversely, surgical models of HE (e.g. portocaval anastomosis) usually 
require the use of larger animals (Butterworth et al. 2009). However, in all chemical 
models of HE one cannot exclude that the drug itself has some CNS effects. 
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Moreover, most human HE is due to entirely different liver toxins (e.g. alcohol, 
paracetamol), and different toxic substances can generate quite disparate phenotypes. 
Finally, alcohol related HE frequently occurs in the context of acute-on-chronic liver 
failure, which again this model does not adequately depict (Butterworth et al. 2009). 
 
   
Figure 20. The phenotype of azoxymethane-induced hepatic encephalopathy. Photographs of Evans 
blue injected mouse brains illustrating the increased BBB permeability in azoxymethane-induced HE; 
left (control) and middle (hepatic encephalopathy). Right: Hyperbilirubinemia in hepatic 
encephalopathy causes autofluorescent labeling of brain cells that can be imaged by 2PLSM in vivo 
(unpublished observation). 
 
Acute hyperammonemia encephalopathy: Hyperammonemic encephalopathy is 
neurological dysfunction that results from elevated blood ammonia levels, and in a 
clinical setting this is most frequently seen in patients with liver disease (Cagnon and 
Braissant 2007). However, patients with liver failure also have a plethora of other 
biochemical disturbances, which likely contribute to the neurological phenotype and 
make it difficult to dissect out the role of ammonia. We therefore chose to examine a 
model of isolated acute hyperammonemia using a X-linked recessive condition called 
ornithine transcarbamylase (Otc) deficiency (Ratnakumari et al. 1992). Because the 
enzymatic detoxification of ammonia in the liver via the urea cycle is compromised, 
both mice and humans with this condition are prone to developing rapid rises in 
plasma ammonia. Although these Otc mice can develop spontaneous 
hyperammonemic episodes, or dietary-induced episodes (e.g. protein load), we chose 
to induce acute hyperammonemic encephalopathy by giving a parenteral ammonia 
load (Moscioni et al. 2006; Ye et al. 1997). This ensured both reproducibility and a 
short time course ideal for 2PLSM imaging. The plasma ammonia concentrations we 
recorded using this model was within the range reported for clinical cases (Cagnon 
and Braissant 2007). However, a major limitation of this model is that time course 
ammonia intoxication may be more hyperacute than that seen in human cases.  
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8. SUMMARY OF RESULTS  
 
I. Critical role of aquaporin-4 (AQP4) in astrocytic Ca2+ signaling events elicited 
by cerebral edema 
 
Hypo-osmotic brain edema is a potentially fatal condition where swelling occurs as a 
result of a decreased concentration of osmolytes such as sodium. We used 2PLSM to 
explore the role of astrocyte swelling and volume related calcium signaling in this 
condition.  
First, we showed that acute hypo-osmotic stress causes brief (5-10 min) 
astrocyte swelling in situ, followed by a prolonged regulatory volume decrease. The 
initial swelling, but not the volume decrease, was AQP4-dependent. Additionally, 
severe osmotic stress led to irreversible astrocyte swelling and cell lysis. Second, we 
demonstrated that hypo-osmotic brain edema increased the frequency and prolonged 
the duration of astrocyte calcium transients, which was also AQP4-dependent. We 
therefore hypothesized that Aqp4 deletion suppressed the calcium response by 
limiting water influx and thus volume changes associated with hypo-osmotic stress. 
Third, we found that applying purinergic P2 receptor antagonists suppressed calcium 
transients evoked by astrocyte swelling. Finally, we showed that cultured Aqp4+/+ but 
not Aqp4-/- astrocytes exposed to hypo-osmotic stress released significant amounts of 
ATP. 
We concluded that during hypo-osmotic brain edema AQP4 is necessary for 
astrocytes to sense osmotic changes and generate volume related signals. These 
included calcium transients evoked by ATP release that would contribute to a worse 
clinical outcome by triggering the release of excitotoxic neurotransmitters.  
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II. NADH fluorescence imaging indicates effect of aquaporin-4 deletion on 
oxygen microdistribution in cortical spreading depression  
 
CSD is a wave of tissue depolarization linked to migraine, which is accompanied by 
tissue hypoxia in regions furthest away from the vasculature (microwatershed areas). 
We used 2PLSM imaging of intrinsic NADH fluorescence during CSD to reveal a 
previously unrecognized role of AQP4 in cortical oxygen distribution.   
We found that deletion of the astrocyte water channel Aqp4 causes a selective 
increase of NADH fluorescence in microwatershed areas, indicating greater hypoxia 
in these regions. Using laser Doppler flowmetry and oxygen sensitive microelectrodes 
we demonstrated that this hypoxia is not a result of decreased overall oxygen or blood 
supply. Next, we tested whether Aqp4 deletion worsens oxygenation through 
increasing the metabolic demand. The profound increase in [K+]o that is the hallmark 
of CSD is believed to cause a unique strain on ion and volume homeostasis in the 
brain. Using potassium ion sensitive microelectrodes we show that Aqp4 deletion 
slows [K+]o recovery, which might cause oxygen overuse. Alternatively, our data 
could indicate that AQP4 acts as a gas channel, facilitating oxygen diffusion from the 
vasculature to microwatershed regions.  
In conclusion, our results suggest a novel role for AQP4 in oxygen micro-
distribution during CSD. Our data indicate that this AQP4 related hypoxia is either a 
result of AQP4 mediated gas diffusion or AQP4 facilitated potassium ion transport. 
 
 
 
 
 
 
 
 
 
 
 
 
   
 LP
III. General anesthesia selectively disrupts astrocyte calcium signaling in the 
awake mouse cortex 
 
General anesthesia is thought to induce sedation and unconsciousness by exclusively 
interfering with neuronal signaling. However, the effects of anesthesia on glial cells 
have not previously been systematically explored. We therefore proceeded to use 
2PLSM to explore the effect of several commonly used anesthetics on astrocyte 
calcium signals in awake behaving mice. 
We found that all three anesthetics tested in our study potently suppressed 
spontaneous calcium signals both in the soma and processes of neocortical astrocytes. 
The anesthetics also altered the pattern of astrocyte calcium signaling; from highly 
synchronized in the awake state to largely unsynchronized with anesthesia. 
Additionally, we demonstrated that calcium signals evoked by physiological sensory 
(whisker) stimulation were also strongly suppressed by anesthesia. Several lines of 
evidence indicate that our observations were not secondary effects of the anesthetics 
silencing neuronal activity: a) Astrocyte signals were suppressed by lower doses of 
anesthesia than those required to block neuronal activity. b) A local blockade of 
neuronal activity using TTX or CNQX/AP5 completely suppressed neuronal but not 
glial signals. c) Similar to previous studies we observed a delay of 0.5-5s between 
cortical neuronal activation and the astrocyte calcium transients. This delay suggests 
that astrocyte signaling may be mediated by extra-synaptic events. Finally, we show 
that the anesthetic effect on astrocytes could be explained by a direct impairment of 
calcium mobilization via IP3R2-dependent mechanisms, as astrocyte calcium 
signaling in response to local agonist (ATP) was also selectively reduced by 
anesthesia.  
In conclusion, anesthetics appear to selectively suppress astrocyte calcium signals. 
It is therefore possible that some of the sedative effects of these drugs may be 
mediated via glial targets that are not fully exploited by current pharmacology.  
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IV. Paravascular microcirculation facilitates rapid lipid transport and astrocyte 
signaling in the brain 
 
Unlike peripheral organs, the brain is entirely devoid of a separate lymphatic system 
to resorb interstitial fluid and transport lipids. A recent study identified a 
paravascular circulation of hydrophilic molecules in the anatomically distinct PVS. 
However, the paravascular transport of lipophilic substances has not been explored in 
vivo. Our study aimed to address two related unanswered questions: does the PVS 
mediate rapid lipid transport and can the PVS act as a separate signaling 
compartment to coordinate glial communication? 
 We administered lipid tracers into subarachnoid CSF via the cisterna magna 
and demonstrated that they move rapidly through the brain parallel to blood vessels. 
We found that the circulation of lipid tracer was highly restricted to the PVS, 
indicating that the PVS may serve as a dynamic barrier to lipid diffusion into the 
brain parenchyma. The lipid tracer entered the brain via a para-arterial and exited via 
a para-venous route. We were able to enhance the intra-cellular delivery of lipophilic 
tracer molecules by surgically depressurizing the subarachnoid space. Finally, 
depressurizing the PVS caused an impairment of desynchronized calcium signaling. 
To further test this hypothesis of the PVS acting as signaling compartment, we took 
advantage of one of the most widely used astrocytic calcium wave agonists - ATP. 
ATP was injected into both the PVS and surrounding parenchyma. Interestingly, the 
propagation of the calcium wave in astrocytes elicited by PVS ATP administration 
was much faster and covered a larger diameter than intraparenchymal administration.  
 Taken together, we demonstrated a novel pathway for the rapid and highly 
selective microcirculation of lipophilic molecules through paravascular CSF. We 
show that the PVS acts as a signaling highway between astrocytes, and when 
knocked causes a pathological pattern of glial communication. 
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V. Real-time analysis of microglial activation and motility in hepatic and 
hyperammonemic encephalopathy 
 
The role of microglial activation and/or dysfunction in hepatic encephalopathy is 
incompletely understood and has only been studied ex vivo. We used 2PLSM in 
Cx3cr1-eGFP mice to image dynamic changes in microglial morphology and 
surveillance behavior in real-time.  
 We used a model of isolated hyperammonemia that generated robust but 
reversible encephalopathy (lethargy, ataxia and myoclonic seizures). Contrary to 
some previous reports, we found no BBB opening or brain edema in this condition. 
Additionally, we were unable to detect any microglial activation or change in 
surveillance behavior. Next, we adapted a chemical mouse model of hepatic 
encephalopathy using azoxymethane, characterized by a slower plasma ammonia 
increase. Phenotypically the mice progressed through successive stages of 
encephalopathy including lethargy, ataxia and finally coma, but no seizures. Contrary 
to the acute hyperammonemia model, we found both increased BBB permeability 
(leakage) and brain edema at the coma stage. Using 2PLSM imaging, we 
demonstrated microglial activation and decreased microglial surveillance during the 
coma stage, but not prior to the onset of neurological dysfunction.  
In conclusion, our data suggest that microglial activation does not contribute 
to the initial neurological dysfunction seen in isolated hyperammonemia. Conversely 
microglial activation is present during the coma stage of hepatic encephalopathy, 
where it coincides with BBB opening and brain edema. Microglial activation may 
therefore contribute to overall mortality in hepatic encephalopathy by accelerating the 
progression to brain edema and coma. 
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VI. Ammonia compromises astrocyte potassium buffering and impairs neuronal 
inhibition without causing swelling in vivo 
 
Ammonia is both a vital building block and a lethally neurotoxic compound if 
allowed to accumulate. To explore the molecular mechanisms underlying the acute 
neurotoxicity of ammonia we employed a combination of biochemical, 
electrophysiological, genetic and optical imaging methods in vivo. 
 We chose to use a mouse model of congenital Otc deficiency, a childhood 
condition in which liver ammonia detoxification is dysfunctional, causing elevated 
plasma ammonia. Otcspf-ash mice have cognitive and motor deficits at baseline that 
significantly worsened following an ammonia challenge and were accompanied by 
generalized seizures. We showed that ammonia induced seizures originate in the 
cortex, and are associated with a dysfunction of inhibitory neurotransmission. Using 
in vivo 2PLSM we demonstrated that this neuronal dysfunction was secondary to an 
impairment of astrocyte calcium signaling, [K+]o handling, but not astrocyte swelling 
(as previously hypothesized). This severe dysfunction of astrocyte potassium 
buffering was likely due to the competition of ammonium with potassium for 
membrane transport. Finally, we showed that the elevated [K+]o and/or [NH4+]o 
increase the electrochemical gradient Cl- import via NKCC1, depolarizing the reversal 
potential of GABAA receptor (EGABA). Using either the highly selective NKCC1 
antagonist bumetanide or Slc12a2 KO, we were able to rescue the shift in EGABA and 
reverse the disease phenotype.  
 In conclusion, we demonstrate a novel molecular mechanism for the acutely 
neurotoxic effects of ammonia, which are primarily results of a profound dysfunction 
astrocyte ion homeostasis. By specifically targeting this disease mechanism we were 
able to treat this fatal childhood neurological disorder.  
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9. DISCUSSION AND FUTURE DIRECTION 
 
In the last 20 years the application of new experimental tools such as calcium imaging 
and 2PLSM has revealed that normal brain function requires both neuronal and glial 
cells acting in concert (Nedergaard and Verkhratsky 2012). The late realization that 
glial cells play an active role in brain function likely reflects the unique challenges 
faced when studying glial neurobiology. For instance, glial research requires 
techniques offering both high temporal and spatial resolution, as well as being 
sensitive to tissue distortion or injury (Agulhon et al. 2012). Although several new 
techniques such as 2PLSM have been applied to glial research in recent years, many 
of the basic disease models that have been studied are adaptations of neurocentric 
research paradigms. Such models, including acute hippocampal slices and primary 
cell culture, may not be equally representative of glial physiology (Sun et al. 2013). In 
an attempt to overcome these obstacles and increase the translational potential of our 
research, we primarily employed in vivo animal models. The following is a discussion 
of what our studies add to current understanding of glial neurobiology, the critical 
limitations of the data and the important questions that remain open for future study.  
 
AQP4 and astrocyte volume homeostasis. Since the Nobel-prize winning set of first 
experiments, it has been known that cells expressing aquaporins undergo rapid 
volume change in response to osmotic stress (Preston et al. 1992). Several prominent 
studies have subsequently suggested that by virtue of their high AQP4 expression, 
astrocytes are more likely to swell than other brain cells. AQP4 has therefore been 
suggested as a novel therapeutic target in brain edema (Amiry-Moghaddam and 
Ottersen 2003; Manley et al. 2000). However, the data supporting this hypothesis 
have several limitations, including using reduced preparations (e.g. cultured 
astrocytes) and post-mortem studies of cell volume (e.g. electron microscopy). 
Additionally, studies of Aqp4 KO mice have revealed that the water channel may be 
either beneficial or detrimental depending on the type of brain edema elicited 
(Papadopoulos and Verkman 2007). Finally, imaging studies that have attempted to 
show astrocyte swelling in living tissue have either had technical limitations (Nase et 
al. 2008) (did not assess tissue perfusion) or have not found significant volume 
change (Risher et al. 2012; Takano et al. 2007; Zhou et al. 2010). Could there more to 
the story than AQP4 rendering astrocytes prone to passive swelling? Since the 1980s 
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it has been known that primary cultured astrocytes respond dynamically to hypo-
osmotic stress, first swelling and then undergoing regulatory volume decrease (RVD) 
(Kimelberg 1987; Olson et al. 1986). The latter process is incompletely understood, 
but believed to involve the activation of volume-regulated channels, leading to the 
efflux of amino acids, ATP, glutamate, K+ and Cl-. Although volume-regulated anion 
channels can be inferred using electrophysiology, their actual molecular identity is 
still unknown (Okada et al. 2009; Takano et al. 2005).  
In an attempt to address the role of AQP4 in astrocyte volume regulation, we 
developed a method for high-resolution astrocyte volumetry in acute cortical slices 
using 2PLSM. Similar to the original in vitro studies, we found that the response of 
astrocytes to hypo-osmotic stress is dynamic. We observed a very brief AQP4-
dependent initial swelling, followed by robust RVD that was nominally AQP4-
independent. The volume dynamics we observed in situ were even faster and smaller 
than those previously reported in vitro. Thus at least in the context of healthy brain 
slices, astrocytes are capable of very tight volume control that is AQP4-dependent. 
Conversely, when the degree of osmotic stress was increased, astrocytes underwent 
passive AQP4-dependent swelling before inevitable cell lysis.  
However, our study has several limitations. First, we employed an in situ and 
not in vivo model to achieve higher-resolution volume measurements in a setting 
where we could control osmotic stress precisely. Conversely, the astrocytes were 
exposed to trauma in the cutting process, had depressurized blood circulation and 
were derived from young mice that express a different subset of proteins (Sun et al. 
2013). Our results also showed that the type of astrocyte response depended on the 
degree of osmotic stress and the health of the tissue. All of these factors may 
contribute to altered astrocyte volume dynamics, perhaps resulting in a slower RVD 
than in vivo. We suggest that the lack of direct evidence of astrocyte swelling and 
RVD in vivo may reflect the high speed at which these events occur in intact perfused 
brain (Takano et al. 2007; Zhou et al. 2010).  
Our results raise several new questions. First, do astrocytes swell and/or 
undergo RVD in vivo? As the temporal and spatial resolution of imaging improves, 
we may be able to better address this question, and also examine volume changes in 
microdomains (i.e. individual processes) (Haj-Yasein et al. 2012). The polarized 
AQP4 distribution in endfeet could indicate that this microdomain senses or 
modulates volume changes associated with fluctuations in blood flow. Additionally, 
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the high AQP4 expression in astrocytes but not neurons could imply a specialized 
function in rapid and tight volume regulation, instead of the aforementioned 
interpretation that astrocytes swell easily. Hence, if astrocyte swelling is not 
responsible for the brain edema observed in hypo-osmotic conditions, could the 
increase in tissue water content reflect neuronal swelling? It is conceivable that in the 
evolutionary division of labor between astrocytes and neurons, that the latter have 
sacrificed tight volume regulation to attain more specialized signaling functions. 
Astrocytic RVD may represent a compensatory mechanism for this and avoid 
detrimental extracellular space shrinkage (with increased ion and neurotransmitter 
concentrations)? If AQP4 does not solely mediate increased brain edema through 
facilitating astrocyte swelling, then why is Aqp4 deletion beneficial in these 
conditions? Could the increased and pathological astrocyte calcium activity observed 
in our study, with associated release of excitotoxic transmitters, explain some of this 
phenotype? The answers to these questions will be essential when designing new 
therapies for brain edema targeting AQP4 (Amiry-Moghaddam and Ottersen 2003). 
Finally, what is the molecular identity of volume-regulated anion channels in 
astrocytes? The answer to this question may be closely related to current contention 
around the notion of gliotransmission and connexin hemichannels, as neuronal firing 
causes brisk extracellular space shrinkage and several of the molecules released by 
volume-regulated anion channels have direct actions on neurons (Okada et al. 2009).  
 
AQP4 and cerebral oxygen microdistribution. CSD is a curious and highly 
reproducible phenomenon where a self-sustaining cortical wave of neurodepression 
and depolarization can be elicited by focal cortical application of concentrated KCl 
(Leao 1947). Although the relationship is not clear, CSD has been linked the initiation 
of migraine headaches, often being cited as an electrochemical correlate of the 
migraine aura (Lauritzen et al. 2011). Similar self-sustaining waves of spreading 
depolarization can also be elicited in a range of other neurological conditions, 
including stroke (anoxic depolarization), traumatic brain injury, intracerebral and 
subarachnoid hemorrhage (Lauritzen et al. 2011). Additionally, CSD pathophysiology 
shares several features with epilepsy. Both are episodic disorders that have been 
linked to mutations in ion channels or transporters that alter neuronal excitability 
(Takano and Nedergaard 2009). Experimentally, it is possible to trigger either 
seizures or CSD in vivo with intermediate (10-20 mM) or high (>50 mM) potassium 
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concentrations, respectively (unpublished observations). CSD therefore appears to 
occur only when local [K+]o reaches a threshold that is such a large strain on ion 
homeostasis that all neurons in an area remain depolarized and refractory for a 
sufficient time to prevent recurrent excitatory loops arising.  
Several studies have suggested that vasoconstriction and impaired 
neurovascular coupling may explain parts of the hypoxia and potassium 
dyshomeostasis seen in CSD (Chuquet et al. 2007; Piilgaard and Lauritzen 2009). 
However, CSD is initially characterized by significant global and capillary-level 
hyperemia when the tissue is most hypoxic in animal studies (Lauritzen and Fabricius 
1995; Takano et al. 2007). The almost therapeutic effects of anesthesia in CSD might 
explain part of this inconsistency between awake human and anesthetized animal 
studies. General anesthesia reduces neuronal exciteability, decreases cerebral 
metabolic rate and likely as a consequence reduces baseline blood flow so that the 
initial hyperemia response to CSD becomes more obvious (Lauritzen et al. 2011; 
Sonn and Mayevsky 2006). Taken together, insufficient blood supply does not appear 
to cause the initial hypoxia seen in CSD.  
As tissue depolarization precedes the hypoxia this in turn suggests that the 
inadequate oxygenation is a result of the large the metabolic strain of potassium re-
uptake (presumably via the NKA). NADH imaging demonstrates that this excess 
metabolic activity occurs primarily close to blood vessels, effectively depriving areas 
far from the circulation of oxygen (i.e. microwatersheds). Conversely in anoxia, tissue 
hypoxia precedes the wave of depolarization and there is no characteristic biphasic 
pattern of NADH signals, such as that seen in CSD (Takano et al. 2007). Subsequent 
NADH studies have also shown that mild hypoxemia or increased neuronal activity 
can also be used to reveal these geometrically shaped biphasic NADH responses. 
These fundamental observations are likely a biochemical (NADH) correlate of the 
theoretical Krogh oxygen diffusion cylinders that surround oxygen-rich vessels (i.e. 
arterioles). Moreover, these limits of oxygen tissue diffusion likely explain key 
aspects of microvascular anatomy, such the ‘cylinder’ of low capillary density 
surrounding oxygen rich arterioles in brain and retina (Kasischke et al. 2011). Since 
the physical limitations of oxygen diffusion and potassium re-uptake are so 
fundamental to the vascular microanatomy of nervous tissue, we therefore asked 
whether any molecular adaptations exist to improve microwatershed oxygenation.  
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Using in vivo NADH imaging we showed that during the unique metabolic 
strain elicited by CSD, AQP4 is necessary for efficient oxygenation of watershed 
areas. Our observations have several limitations and potential explanations. First, this 
study was carried out in anesthetized animals, where neuronal excitability would be 
strongly affected by the choice of anesthetic (i.e. urethane in this case), which might 
confound the results (Sonn and Mayevsky 2006). However, CSD is arguably such an 
overwhelming phenomenon that it should be less biased by anesthetics than for 
instance seizures (Sonn and Mayevsky 2006). Second, ours and other recent NADH-
studies have unfortunately lacked cellular resolution, so we are unable to say what 
cell types become most metabolically compromised. Conversely, the morphological 
data from Takano et al. seem to indicate that neurons, which show swelling and loss 
of dendritic spines, are more severely affected than astrocytes (Takano et al. 2007). 
Third, our study was conducted in constitutive Aqp4 KO mice, and AQP4 expression 
in other cells or organs could hypothetically explain the excess hypoxia. On the other 
hand, recent work on glial conditional Aqp4 KO has revealed that these mice have an 
almost identical phenotype (although CSD has not been explored) (Haj-Yasein et al. 
2011c).  
Finally, given that we detected a hyperemic response similar to Takano et al. 
(i.e. adequate blood supply), there are two competing hypothesis that could explain 
our results. 1) AQP4 may be necessary for the energy efficient function of potassium 
transporters, such as NKA, by rapidly dissipating any osmotic gradients that are built 
up. Other forms of AQP4-facilitated potassium transport (e.g. Kir4.1 mediated spatial 
buffering) are likely to play a lesser role, as the [K+]o increase is so global that 
redistribution would be ineffective (Padmawar et al. 2005). 2) Alternatively, the 
central pore formed by AQP4 tetramers may enhance the O2 permeability of astrocyte 
membranes. Aquaporin-assisted gas diffusion is a controversial hypothesis, but one 
that may be particularly relevant in a subset of membrane microdomains such as the 
astrocytic endfeet. The protein density in endfoot membranes is extremely high, 
mainly due to AQP4 orthogonal arrays, and this may decrease the rate of O2 diffusion 
across the lipid bilayer (Wang et al. 2007). Per unit weight brain and retinal tissue 
have the highest oxygen consumption in the body (Kur et al. 2012). The AQP4 central 
pore could therefore represent an evolutionary adaptation to enhance oxygen diffusion 
across protein-enriched membranes such as astrocytic endfeet. Hypothetically AQP4-
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assisted O2 diffusion would increase the size of arterial Krogh cylinders, and improve 
watershed oxygenation (Fig. 21). However, the hypothesis that aquaporins increase 
gas diffusion across the lipid bilayer is still very contentious, and unfortunately our 
data cannot conclusively differentiate this hypothesis from the alternative ion-
transport model (Fang et al. 2002; Musa-Aziz et al. 2009; Wang and Tajkhorshid 
2010).  
   
Fig 21. Effect of AQP4 deletion on cortical oxygenation. Left 2 panels: Representative false color 
images of NADH signal intensity in cortex of WT and AQP4 KO mice during CSD. FITC-dextran 
labeled vasculature is shown in white. Key: red represents +60% and green -60% NADH signal 
intensity normalized to baseline. Right 2 panels: Illustration of the hypothetical interplay between 
AQP4, potassium buffering and microwatershed oxygenation in CSD. 
 
Astrocyte calcium signaling in wakefulness and anesthesia. In 1990 Cornell-Bell 
et al. showed that astrocytes respond to glutamate by generating waves of increased 
intracellular calcium (Cornell-Bell et al. 1990). This seminal study opened the 
possibility that astrocytes might contribute to synaptic signaling on an equal footing 
to neurons, leading to the tripartite synapse hypothesis (Araque et al. 1999). Using 
2PLSM imaging this hypothesis has subsequently been tested in in vivo, where it was 
demonstrated that astrocytes respond to physiological sensory stimulation in a 
glutamate-dependent fashion (Wang et al. 2006; Winship et al. 2007). However, most 
of our current understanding of astrocyte calcium signaling still derives from cultured 
astrocytes, brain slices or anesthetized whole animals. Because of inherent limitations 
in each of these methods, several investigators have recently begun to question the 
fundamental tenets of the tripartite synapse model (Agulhon et al. 2008; Nedergaard 
and Verkhratsky 2012). The main receptor (mGluR5) implicated in astrocyte-
neuronal signaling is, for instance, only expressed in young mice used for acute brain 
slices (Sun et al. 2013). More recently, two groups have independently developed 
methods to image glial calcium signals in the cerebellum and motor cortex of awake 
head-restrained mice (Dombeck et al. 2007; Nimmerjahn et al. 2009). Both these 
studies found greater spontaneous calcium activity that was highly synchronized, in 
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stark contrast to the individual infrequent calcium signals seen in anesthetized mice. 
We therefore proceeded to image astrocyte calcium activity in the sensory cortex of 
awake and anesthetized mice, to see if this would provide further clues as to 1) the 
direct effects of anesthetics on astrocytes and 2) the nature and mediators of 
physiological astrocyte calcium signals.  
To start with the first question, we asked whether anesthetics might mediate 
some of their sedative effects via astrocytes, instead of neurons. General anesthetics 
are a class of sedative drugs used to induce a reversible sleep-like loss of 
consciousness (hypnosis), amnesia, immobility and insensitivity to painful stimuli 
(analgesia). The principal targets for the sedative effects of these drugs are thought to 
be neuronal receptors or channels, but recently some anesthetics have also been 
reported to affect astrocyte signaling ex vivo (Mantz et al. 1993; Miyazaki et al. 1997; 
Tian et al. 2005; Yang et al. 2008). Our data demonstrate that: 1) Three commonly 
used anesthetics with putatively different neuronal targets all cause a similar global 
suppression and desynchronization of astrocyte calcium signals. 2) Anesthesia begins 
to affect astrocyte before neuronal signaling, although this result should be interpreted 
a bit more cautiously as we are comparing astrocyte calcium imaging with electrical 
neuronal activity. 3) Anesthesia also suppresses astrocyte calcium signals elicited by 
sensory stimulation and direct agonist (ATP) application.  
The biggest challenge with interpreting our data is distinguishing the direct 
effects of anesthesia on astrocytes from those that occur secondary to neuronal 
changes. Perhaps the strongest argument supporting a direct effect of anesthesia on 
astrocytes, was the marked suppression of agonist-evoked calcium responses. ATP 
application is known to trigger astrocyte calcium transients without requiring 
neuronal firing (Cotrina et al. 1998). Our results are also supported by previous in 
vitro work that has demonstrated anesthesia can directly impair astrocyte calcium 
mobilization and signal propagation (Mantz et al. 1993; Miyazaki et al. 1997; Yang et 
al. 2008). Thus, in conclusion, our findings have two important implications with 
regards to future research: 1) Further study on the effects of anesthesia on astrocyte 
signaling is needed, as this could lead to a better understanding of current anesthetic 
agents and more important reveal novel glial pharmacological targets. 2) We also 
strongly suggest that future studies of astrocyte calcium signaling approach the use of 
anesthesia cautiously, as they can fundamentally confound results.  
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 Another question we addressed in our study is what characterizes 
physiological calcium signaling in the awake cortex. Our study revealed a more than 
10-fold greater frequency of spontaneous calcium transients in awake than 
anesthetized animals, which were highly synchronized, and appeared more like 
sudden bursts than the typical waves described in vitro. The pattern of calcium 
activity we observed in the somatosensory cortex was very consistent with what the 
two previous awake imaging studies from motor cortex and cerebellum (Dombeck et 
al. 2007; Nimmerjahn et al. 2009). Moreover, similar synchronized bursts across 
hundreds of astrocytes can also be elicited in lightly anesthetized animals with 
whisker stimulation (Wang et al. 2006). In our study we expand on these 
observations, and showed that sensory-evoked astrocyte calcium signals disappear 
altogether with increasing doses of anesthesia (Schummers et al. 2008). Additionally, 
we found that sensory-evoked calcium signals occur at a delay of 1-5 s relative to the 
firing of cortical neurons, and that these responses are entirely dependent on IP3R2 
signaling (Dombeck et al. 2007; Nimmerjahn et al. 2009; Wang et al. 2006). 
Conversely, spontaneous and evoked astrocyte calcium signals were highly resistant 
to a blockade of local purinergic or glutamatergic activity (using TTX, 
PPADS/suramin or CNQX/AP5), as has also been reported in cerebellar Bergman glia 
(Nimmerjahn et al. 2009). At first glance these observations appear to challenge 
several key elements of the tripartite synapse model, which predict that a local 
neuronal or purinergic blockade abrogates astrocyte signals.  
However, there are several important considerations with ours and the 
previous two awake imaging studies, which may help explain these results. First, our 
imaging was conducted only in layers 1 and 2 of the cortex, and our electrophysiology 
suggested that surface drug application primarily affected these layers. It is therefore 
possible that astrocyte calcium signals originating deeper in the cortex can propagate 
radially via mediators that act on IP3R2 receptors, but are not dependent on axonal 
transmission, glutamate or ATP (Nimmerjahn et al. 2009). This form of radial 
propagation could also explain the faster bursts observed in awake cortex, as 
compared to the slower waves seen ex vivo. Second, several diffuse neuromodulatory 
systems exist that are activated concurrently with salient stimuli (e.g. whisker 
stimulation) and release neurotransmitters diffusely and synchronously via 
varicosities throughout the cortex. Stimulation of brain stem nuclei for noradrenergic 
and cholinergic systems have, for instance, both been shown to elicit robust cortical 
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astrocyte calcium responses in anesthetized animals (Bekar et al. 2008; Navarrete et 
al. 2012; Takata et al. 2011). Third, the puzzling 1-5 s astrocyte-neuronal delay could 
imply either a very slow response to local neuronal firing (e.g. slow neurotransmitter 
spillover from the synaptic cleft) or that a slower indirect pathway (e.g. noradrenergic 
system) triggers the calcium responses. The delay could for instance also serve a 
purpose if it reflects the time it takes for neuronal firing to deplete ATP stores, when 
astrocyte calcium signals might be required promote neurovascular or neuro-
metabolic coupling (Takano et al. 2006). Fourth, our first study (Paper I) revealed 
that astrocyte volume changes evoke calcium signals in vivo. Since astrocyte endfeet 
have the highest AQP4 expression and thus would be the most volume sensitive, it is 
possible that astrocyte calcium signals occur in response to the mechanical distortion 
caused by functional hyperemia, which occurs on a 1-5 s timescale (Takano et al. 
2006). Finally, two recent in situ studies that used high-resolution 2PLSM have 
revisited the interesting idea that calcium signals in individual processes may be more 
relevant to brain or synaptic function the signals in the cell body (Di Castro et al. 
2011; Wang et al. 2006). Although the conclusions of these studies need to be 
interpreted cautiously due to the ontogenic changes in mGluR5 expression (Sun et al. 
2013), the general idea of processes signaling independent of the soma is potentially 
important. We therefore also examined calcium signals in the processes in the awake 
mouse cortex, and found that although all processes were generally involved in the 
synchronized bursts, individual processes would also display more frequent isolated 
signals (Wang et al. 2006). Further exploration of the kinetics and function(s) of these 
localized calcium signals in awake cortex will be an important next step for our 
understanding of astrocyte signaling.  
In conclusion, our study demonstrates that anesthesia can directly suppress 
astrocyte signaling. More importantly, we show that calcium signals in the awake 
cortex are faster, more frequent and synchronized than those observed in situ and in 
vitro. Our observations highlight important questions regarding the tripartite synapse 
model, as it is based on studies carried out primarily in reduced preparations or 
anesthetized mice. We would therefore suggest that the fundamental question of how 
astrocytes and neurons communicate at the level of the individual synapse still 
remains unanswered (Nedergaard and Verkhratsky 2012; Perea and Araque 2007). Do 
astrocytes contribute to synaptic transmission by vesicular or non-vesicular 
neurotransmitter release (Hamilton and Attwell 2010)? How can astrocytes contribute 
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to signal transmission if their response time is so slow? Could some of the previous 
observations of astrocyte-neuronal signaling be artifacts of the experimental 
preparations (e.g. pup brain slices, traumatic cranial windows) (Agulhon et al. 2012; 
Sun et al. 2013)? Are synaptic signals somehow integrated within astrocytic 
microdomains, individual astrocytes or do we need to consider whole astrocytic 
syncytia (Rouach et al. 2008)? 
 
Rapid microcirculation of water and lipids through the PVS. The brain is one of 
the few organs entirely devoid of a lymphatic system parallel to the blood circulation 
(Abbott 2004). Macroscopically, the circulation of CSF through the subarachnoid 
space and ventricles is known to serve many of the functions of peripheral 
lymphatics. However, the microcirculation within the brain parenchyma is 
incompletely understood. It is unclear how excess interstitial fluid, waste products and 
signaling molecules are circulated (Abbott 2004). A recent study by Iliff et al. has 
shown that water and hydrophilic compounds circulate rapidly through the brain 
parenchyma via the PVS (Iliff et al. 2012; Rennels et al. 1990). In our study, we 
address two essential functions of peripheral lymphatics – the transport of lipids and 
signal molecules. We found that lipophilic tracers injected into subarachnoid CSF 
were rapidly transported via the PVS with very little diffusion out of this space into 
the brain parenchyma. This observation was surprising given the small size (<1 kDa) 
and cell permeability of these tracers. It is possible that the restricted lipid transport is 
a consequence of lipoprotein binding within the PVS. Indeed, the lipophilic tracers 
behaved more like large molecular weight hydrophilic tracers, similar in size to 
lipoproteins (Fagan and Holtzman 2000; Koch et al. 2001). Unlike the results of Iliff 
et al. we did not find that this lipid transport pathway was affected by AQP4-deletion, 
indicating that other mechanisms may govern lipid bulk-flow (Iliff et al. 2012).  
Moreover, we found that compromising the hydraulic integrity of the PVS 
enhanced the intracellular accumulation of lipophilic tracers and caused an abnormal 
pattern of astrocyte calcium signaling. Temporarily knocking out the PVS using a 
cisterna magna puncture, caused a desynchronization and increased frequency of 
calcium transients in astrocytes that may represent pathology. The second aim of our 
study was to examine whether the PVS can act as a separate astrocyte-astrocyte 
signaling compartment. The PVS is tightly ensheathed by astrocyte endfeet not more 
than 20 nm apart (Mathiisen et al. 2010).  It has previously been shown that a large 
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proportion of calcium transients initiate and propagate along the vasculature (Simard 
et al. 2003). When we injected ATP agonist into the PVS  in situ, we similarly 
observed a propagation of astrocyte calcium transients along the vasculature before 
spreading outwards. Interestingly, these paravascular calcium waves were faster and 
spread over a larger area than when ATP was injected directly into the parenchyma.  
Our data indicate that the PVS may act as an efficient highway for astrocyte-
astrocyte signaling. However, there are several limitations of our findings. First, the 
lipophilic molecules used, with the exception of palmitic acid, are chemical tracers 
and we can only infer that similar sized endogenous lipids circulate in the same 
manner. It is therefore possible that unknown chemical properties of these tracers 
interfere with their transport. On the other hand, we tested a range of chemical 
lipophilic tracers along with a biologically relevant lipid (palmitic acid) and received 
reproducible results. Second, in our model to assess intracellular delivery we had to 
apply tracers directly on the cortex on inject them intraparenchymally via a cranial 
window. As discussed previously, the surgical creation of a cranial window is 
associated with molecular, cellular and mechanical changes that may confound the 
results (e.g. inflammation, brain herniation, depressurized local subarachnoid CSF 
flow) (Holtmaat et al. 2009). Third, in our attempt to look at global movement of 
tracers through the brain we were forced to use serial slicing of perfusion fixed tissue. 
The data from these sets of experiments reveal some of the inherent issues with this 
technique, such as the post-perfusion diffusion of lipid soluble compounds. Having 
acknowledged these limitations, our observations could still have important 
implications for current understanding of paravascular lipid circulation, membrane 
lipid metabolism (e.g. cholesterol and palmitoylation) and diseases involving 
lipoprotein mutations (e.g. Alzheimer disease). Further studies are clearly warranted 
to explore the effects of lipid transport in the PVS (Leoni et al. 2010; Takano et al. 
2006). Although we demonstrated that the PVS is likely involved in astrocyte-
astrocyte signaling, an important question that remains unanswered in our study is 
whether this lipid microcirculation facilitates astrocyte-vascular communication. 
Additionally, it is possible that defining the molecular mechanisms responsible for the 
putatively AQP4-independent restricted lipid microcirculation might open new 
avenues for intracellular drug delivery across the BBB (Merian et al. 2012).  
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Microglial activation in hepatic encephalopathy. Microglia are innate immune cells 
that clear unwanted debris and mediate inflammatory responses in the brain. 
Microglia transition from a resting to an active state, and finally become phagocytic 
(amoeboid) when they detect brain injury or infection (Kettenmann et al. 2011). 
Microglial involvement in HE is incompletely understood. Different HE models have 
generated conflicting data, and almost all previous studies have been conducted in 
vitro, in situ or histologically (Bruck et al. 2011; Jover et al. 2006; Rodrigo et al. 
2010; Zemtsova et al. 2011). When microglial cells become activated by a perceived 
pathogen they alter morphology to aid migration and phagocytosis, expressing fewer 
and thicker processes. This microglial activation is correlated with increased secretion 
of pro-inflammatory cytokines (e.g. TNF-α), proteolytic enzymes (e.g. matrix 
metalloproteinase-9) in addition to displaying phagocytic behavior (Kettenmann et al. 
2011).  
Microglial activation has been identified histologically in bile duct ligation 
and hepatic devascularization models of HE (Jover et al. 2006; Rodrigo et al. 2010; 
Zemtsova et al. 2011). However, microglia did not become activated in a study of 
portal vein ligation, despite the mice experiencing severe encephalopathy (Bruck et al. 
2011). Furthermore, activation of microglia in HE has not previously been explored in 
vivo or in the azoxymethane induced model, which has the added benefit of being one 
of the most reliable and reproducible models also useable in transgenic mice. We 
therefore chose to investigate and compare microglial activation and motility in real-
time using 2PLSM imaging of Cx3cr1-eGFP mice in azoxymethane-induced HE with 
acute isolated hyperammonemia. Contrary to some previous reports, we found that 
microglia only become activated in the later stage of HE, after the onset of symptoms, 
but coincident with the onset of BBB opening and brain edema. Additionally, we 
found no change in microglia morphology or motility during isolated 
hyperammonemia. Thus, our study indicates that microglial activity may be involved 
in the onset of potentially fatal brain edema late in HE, but that it is not necessary for 
the neurological dysfunction seen in early HE or acute hyperammonemic 
encephalopathy.  
Our study has several limitations that one needs to consider when interpreting 
the results. Since in vivo 2PLSM of microglial activation has only been performed in 
few studies to date, the sensitivity of this method is unfortunately not completely 
known (Fuhrmann et al. 2010; Marker et al. 2010; Nimmerjahn et al. 2005). On the 
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other hand, 2PLSM has several benefits with regard to identifying microglial 
activation, such as improved anatomical resolution, the ability to compose 3D-stacks 
and the possibility to follow changes in the same cell over time. However, 
immunohistochemistry has the advantage of being able to detect the expression of 
surface markers of microglial activation that could be more sensitive (e.g. Iba1). 
Microglial motility or turnover rate (TOR) of processes is an incompletely understood 
behavior that microglia display in living brain tissue. It is thought to represent 
physiological surveillance of the surrounding environment but may also be associated 
with trauma from the cranial window itself (Fuhrmann et al. 2010; Nimmerjahn et al. 
2005). Hence the decreased TOR we observed in late HE needs to be interpreted 
cautiously until further studies shed light on this phenomenon. Regarding the mouse 
model of azoxymethane induced HE, it is well characterized both in our study and 
previous work. It also has a phenotypic and biochemical profile that is comparable to 
common forms of HE seen in humans. However, this chemically induced disease 
model presents some issues regarding possible confounding effects of the drug on the 
CNS directly. In summary, we believe there are several important questions that 
remain unanswered for future study including: Is real-time 2PLSM morphometric 
imaging of microglia an accurate and sensitive measure of activation? What is the 
function of microglial surveillance behavior in living brains and to what extent is the 
high turnover rate we observe an artifact of the surgical preparation? Does chronic 
low-grade hyperammonemia cause microglial activation, e.g. through prolonged 
reactive oxygen stress, and would inhibition of this improve clinically relevant 
outcomes in HE (Agusti et al. 2011; Cauli et al. 2007)?   
 
Ammonia – a ubiquitous building block and deadly toxin. Ammonia is known to 
be acutely neurotoxic in humans, and is thought to exert its toxic effects on the brain 
by causing astrocyte swelling and dysfunction (Brusilow et al. 2010; Cagnon and 
Braissant 2007). Astrocytes are thought to be most extremely sensitive to ammonia 
toxicity because of their privileged role as the only cell in the CNS able to detoxify 
ammonia via the enzyme GS (Martinez-Hernandez et al. 1977). Our first goal was 
therefore to characterize the extent of astrocyte involvement in ammonia toxicity and 
image for the first time in vivo the volume changes associated with this condition. We 
chose to address these questions in the Otcspf-ash model of hyperammonemia with no 
liver failure, which allowed us to study the CNS effects of ammonia in isolation (cf. 
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hepatic encephalopathy). Furthermore, following a detailed characterization of the 
symptomatology we chose to focus on the pathology in the cerebral cortex. This was 
because electrophysiology findings (myoclonic seizures) led us to suspect this as a 
major target of the ammonia toxicity. To our great surprise, doses of ammonia 
sufficient to trigger significant symptoms such as ataxia and seizures did not induce 
any astrocyte swelling in vivo. Additionally, deleting the main route of water influx 
into astrocytes, AQP4, had no effect on disease outcome in isolated ammonia toxicity, 
contrary to contemporary hypotheses (Rama Rao et al. 2010). Our data are therefore 
consistent with the previously discussed much tighter astrocyte volume regulation in 
vivo than for instance in vitro. Since the brain edema reported in ammonia toxicity 
could also be due to water accumulation in other compartments we measured overall 
brain water content. We found that moderate ammonia doses did not cause any 
overall brain edema in the acute setting (Brusilow et al. 2010). To ensure our volume 
assay was sufficiently sensitive, we then administered higher doses of ammonia and 
were able to replicate the previously described ammonia-induced astrocyte swelling 
and brain edema. The presence of symptoms with doses of ammonia insufficient to 
cause swelling led us to conclude that astrocyte swelling is not prerequisite for 
ammonia neurotoxicity.  
 Given our negative findings with regards to astrocyte swelling, we next 
wanted to explore alternative molecular mechanisms for the toxicity of ammonia. 
First, we used 2PLSM to look for signs of astrocyte dysfunction and chose to examine 
calcium signaling, which as discussed previously is linked to key homeostatic 
functions. Consistent with our initial hypothesis that ammonia is selectively toxic to 
astrocytes, we found a marked increase and desynchronization of astrocyte calcium 
signals following ammonia administration. Astrocyte calcium signals have recently 
been shown to be critical for buffering of [K+]o via the NKA in both cerebrum and 
cerebellum (Wang et al. 2012a; Wang et al. 2012b). Additionally, several studies 
from kidney, bee retina, acute brain slice and astrocyte cultures have indicated that 
ammonia may directly interfere with potassium homeostasis (Alger and Nicoll 1983; 
Brookes and Turner 1993; Marcaggi et al. 2004; Stephan et al. 2012; Sugimoto et al. 
1997). We therefore hypothesized that ammonia sequestered into astrocytes for GS 
detoxification might selectively impair potassium homeostasis in these cells causing 
an increase in [K+]o. Using K+ ISMs we were able to demonstrate the [K+]o increase in 
vivo (Alger and Nicoll 1983). However, the mechanism for the ammonia induced 
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[K+]o increase was still unknown, as it likely was not be mediated by the swelling-
related mechanisms proposed in the previous studies. Using in situ assays we 
demonstrated that the physical similarities of ammonium (NH4+) and potassium (K+) 
ions cause them to directly compete for transport across astrocyte membranes. This 
fundamental biochemical aspect of ammonia might explain why toxicity is observed 
in bacteria, to fish and ultimately humans (Marcaggi et al. 2004).  
To further explore the link between a failure of astrocyte potassium buffering 
and neurological impairment, we proceeded to correlate the kinetics of the [K+]o 
increase with symptom onset and severity. Consistent with our previous hypothesis, 
we found that [K+]o increased robustly prior to symptom onset in vivo, and that the 
magnitude of the potassium increase correlated closely with encephalopathy grade. 
Seminal previous studies between 1970-80 showed that neurons exposed to excess 
ammonia rapidly develop impaired post-synaptic inhibition (Aickin et al. 1982; Alger 
and Nicoll 1983; Lux 1971; Lux and Loracher 1970; Lux et al. 1970; Lux and 
Schubert 1969; Meyer and Lux 1974; Raabe and Gumnit 1975; Raabe 1981). To 
explore this hypothesis in vivo, we used paired-pulse whisker stimulation to show that 
ammonia toxicity is associated with a failure of cortical inhibitory transmission. 
Additionally, using in situ electrophysiology we were able to show that the failure of 
inhibitory transmission was due to excess extracellular NH4+ and K+ driving chloride 
influx via NKCC1 and causing a depolarizing shift in the Cl--based GABA 
equilibrium potential (EGABA) of pyramidal neurons. NKCC1 can be selectively 
inhibited by the clinically used diuretic bumetanide, which we found significantly 
reduced the severity of the ammonia phenotype and increased survival following 
lethal ammonia injections. Bumetanide has also recently been shown to improve 
clinical outcomes in HE, though the authors suggested this occurred due to an 
amelioration of astrocyte swelling (Jayakumar et al. 2008; Jayakumar et al. 2011b). 
Moreover, recent studies of neonatal and febrile seizures have revealed an important 
role of potassium and NKCC1 mediated EGABA depolarization that can be treated with 
bumetanide (Dzhala et al. 2005; Koyama et al. 2012).  
The molecular pathway delineated above led us to suspect that potassium 
alone might be sufficient to replicate many of the neurotoxic effects of ammonia. 
Since potassium is largely impermeable to the BBB (Hansen et al. 1977), we 
developed a model whereby either potassium or ammonia was superfused directly 
onto the cerebral cortex. Interestingly, we found that increasing [K+]o alone was 
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sufficient to depolarize EGABA and trigger myoclonic seizures. This observation is 
supported by recent studies showing that impaired potassium buffering in reactive 
astrocytes can mediate seizures in mesial temporal lobe epilepsy, neonatal and febrile 
seizures (Dzhala et al. 2005; Heuser et al. 2012; Koyama et al. 2012).  
In conclusion, we arrived at a novel molecular mechanism for ammonia and 
potassium neurotoxicity and isolated a molecular target with clear translational 
applications. We were able to describe how acute hyperammonemia causes a rapid 
increase in basal [K+]o, leading to myoclonic seizures. A major limitation of our study 
was the short timescale of hyperammonemia. Congenital hyperammonemia in 
children often leads to acute increases in plasma ammonia, though this frequently 
occurs on top of a low-grade encephalopathy and cognitive impairment (Cagnon and 
Braissant 2007; Lichter-Konecki et al. 2008). There has been limited experimentation 
regarding how chronic hyperammonemia might affect learning and memory in young 
animals. Additionally, it would be interesting to test whether NKCC1 antagonist 
bumetanide might improve any cognitive phenotype. Finally as ours and other recent 
studies have highlighted the link between impaired astrocytic [K+]o homeostasis, 
NKCC1 and seizures, further in vivo experiments are required to address whether this 
causal pathway might be involved in other types of seizure disorders, e.g. post-
traumatic and hypoglycemic seizures (Dzhala et al. 2005; Haj-Yasein et al. 2011a; 
Heuser et al. 2012; Koyama et al. 2012).  
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10. CONCLUSIONS 
 
In summary, exploiting the strengths of 2PLSM in vivo imaging we chose to examine 
several key aspects of glial function and dysfunction in the context of water and ion 
homeostasis. Our results demonstrate that glial cells perform homeostatic and 
signaling roles that are essential for effective brain function. Additionally, we found 
that early breakdown of these glial mechanisms was a hallmark of neurological 
dysfunction across the broad range of conditions examined in our studies. Our data 
thus illustrate that therapies targeting glial cells have the potential to create a 
paradigm change in the current clinical approach to treating neurological disorders.  
 
I. AQP4 is critical for calcium signaling evoked by swelling of astrocytes in 
response to hyponatremic brain edema. AQP4 thus increases astrocyte sensitivity 
to small osmotic changes and may therefore mediate volume related signaling. 
II. AQP4 deletion selectively worsens microwatershed hypoxia in cortical spreading 
depression, without affecting overall oxygenation or blood flow. This can be 
explained by either a role of AQP4 in O2 transport or AQP4 facilitating energy-
efficient potassium homeostasis.   
III. Several commonly used general anesthetics with nominally different molecular 
mechanisms selectively suppress astrocyte calcium signaling, prior to having a 
detectable effect on neurons. These observations raise the important question of 
whether anesthetics may exert some of their sedative actions via astrocytes, and 
not just neurons.  
IV. The paravascular space formed between astrocyte endfeet and the vasculature 
represents a novel lymphatic-like route for lipid transport and glial signaling in 
the brain.  
V. Microglial activation coincides with the onset of brain edema in the late stages of 
hepatic encephalopathy, which may increase mortality in this condition. 
Neurotoxic levels of ammonia alone were insufficient to activate microglia. 
VI. Neurotoxic levels of ammonia selectively short-circuit astrocyte potassium 
buffering, and secondarily impairs neuronal inhibitory activity by decreasing 
inward NKCC1-dependent GABAA-currents. Pharmacological inhibition with the 
clinically used diuretic bumetanide reverses this phenotype, improving clinically 
relevant end-points such as seizures and encephalopathy. 
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In vivo NADH fluorescence imaging indicates effect of aquaporin-4 deletion on 
oxygen microdistribution in cortical spreading depression 
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Abstract  
  
Using in vivo two-photon imaging we show that mice deficient in aquaporin-4 (AQP4) 
display increased fluorescence of )$*/$)($   )$)  $)0' */$  (NADH) when 
subjected to cortical spreading depression (CSD). The increased NADH signal, a proxy 
of tissue hypoxia, was restricted to micro-watershed areas remote from the vasculature. 
Aqp4 deletion had no effects on the hyperemia response, but slowed [K+]o recovery. 
These observations suggest that K+ uptake is suppressed in Aqp4-/- mice as a consequence 
of decreased oxygen delivery to tissue located furthest away from the vascular source of 
oxygen, although increased oxygen consumption may also contribute to our observations.  
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Introduction 
Aquaporin-4 (AQP4) is the principal brain water channel and is concentrated in astrocytic 
endfoot membranes at the brain-blood and brain-liquor interfaces.1 It is surprising that 
our understanding of the physiological roles of AQP4 has evolved so slowly given its 
abundance in brain. Although AQP4 is engaged in interstitial fluid dynamics under 
physiological conditions,2, 3 several lines of work show that animals must be subjected to 
severe stress for a clear Aqp4-/- phenotype to become apparent. The role of AQP4 in 
mediating water exchange across the blood-brain interface was for instance initially 
demonstrated in models of brain edema that entail pronounced osmotic stress.4  
 Here we used cortical spreading depression (CSD) as a model of severe metabolic 
stress to resolve whether oxygenation of brain neuropil depends on the presence of 
AQP4. Drawing on experience from studies of brain edema, we hypothesized that severe 
stress would be needed to disclose a link between AQP4 expression and tissue 
oxygenation.4 CSD is a slowly spreading wave of depressed neuronal activity associated 
with a massive buildup of extracellular concentration of K+ ions ([K+]o), thought to occur 
during migraine headaches. The recovery of [K+]o involves several mechanisms, 
including inward rectifying K+-channels, (Na+)-K+-Cl- cotransporters and the Na+,K+-
ATPase.5-7  
Two-photon imaging of nicotinamide adenine dinucleotide (NADH) fluorescence 
can be used to provide high-resolution maps of tissue redox state in vivo. Increased 
NADH signal is a sensitive non-linear proxy of tissue hypoxia.8 Our analysis shows that 
Aqp4 deletion leads to a more pronounced oxygen deficit in microwatershed areas and a 
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protracted [K+]o recovery. The most parsimonious explanation of these observations is 
that removal of AQP4 reduces oxygen supply and hence slows K+ re-uptake.  
 
Materials and Methods 
Mouse preparation. Aqp4-/- and Aqp4+/+ mice of either sex were generated as previously 
described and anesthetized using intraperitoneal urethane (1 g/kg) and α-chloralose (50 
mg/kg).9 The mice were prepared for in vivo 2-photon imaging as previously described.7 
CSD was evoked by either pressure injecting 1M KCl through a micropipette or surface 
application of 1M KCl (5 µl) through a small secondary craniotomy. Fixation of mice, 
preparation of tissue slices and immunohistochemistry were performed as described 
previously.9 All animal experiments were conducted in accordance with the ARRIVE 
guidelines and approved by the Animal Care and Use Committee of the University of 
Rochester. 
 
In vivo recordings. A Mai Tai laser (SpectraPhysics) attached to a confocal scanning 
system (Fluoview 300, Olympus) and an upright microscope (IX51W) with a 20X 
objective (0.95 NA, Olympus) was used. We performed combined imaging of NADH 
and intravascular fluorescein isothiocyanate (FITC)-dextran (2000 kDa, 5%, i.v.).7 
NADH was excited at 740 nm and emission was detected using a 460 nm filter (50 nm 
bandwidth), whilst FITC-dextran emission was detected using a 515 nm filter (50 nm 
bandwidth). The images were taken every 3 s at 50-150 µm depth. Images were filtered 
and converted to percent changes from baseline using ImageJ software (NIH) as 
described previously.7 The NADH fluorescence changes during CSD reveal a 
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characteristic biphasic response.7 This response has a complex geometry, and 
perivascular “cylinders” of low NADH signal can be seen whose size depends both on 
their vascular oxygen content and diameter.8 We therefore calculated the change in signal 
intensity of individual pixels normalized to values in a baseline image (∆F/F0), before the 
onset of CSD. By convention the regions where pixel values became more negative 
(∆F/F0 < 0) and positive (∆F/F0 > 0) during the CSD wave were defined as “Dip” and 
“Overshoot”, respectively.7 Direct current (DC) potentials and [K+]o were recorded using 
glass microelectodes and tissue pO2 (tpO2) was measured using a Clark-type 
polarographic oxygen microelectrode (OX-4, Unisense) as outlined before.7, 10 Cerebral 
blood flow was assessed using a fiberoptic laser Doppler probe (PF5010, Perimed) and 
connected to an infrared laser Doppler flowmeter. All signals were digitized (Digidata 
1332A, Axon Instruments) and analyzed (pClamp 10.2, Axon Instruments). 
 
Results 
Deletion of Aqp4 increases microwatershed NADH fluorescence during CSD 
We measured tissue NADH fluorescence, cerebral blood flow, tissue oxygen tension 
(tpO2), local field potentials (LFP), and [K+]o in living wild type and Aqp4-/- mice 
following induction of CSD (Figure 1A). Immunofluorescence confirmed high 
perivascular AQP4 expression in wild type mice and confirmed the efficacy of the gene 
knockout strategy (Figure 1B). The total and perivascular dip NADH responses in Aqp4-
/- animals did not differ from that in wild type during CSD (Figure 1C,D). However, the 
overshoot region of the NADH response was greater in the Aqp4-/- animals than in wild 
types almost from the onset of CSD, and became significantly higher ~ 2 min after onset 
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(Total neuropil: wild type 14.36 ± 4.02% vs. Aqp4-/- 19.61 ± 6.21%. Dip: wild type 17.33 
± 3.43% vs. Aqp4-/- 23.23 ± 4.78%. Overshoot: wild type 17.09 ± 3.71% vs. Aqp4-/- 39.48 
± 6.43%, all peak values, p<0.05 for 145 to 250 s post-CSD onset) (Figure 1E,F). The 
rising phase of NADH fluorescence overshoot lasted 187.50 ± 36.54 s in wild type and 
133.33 ± 49.09 s in Aqp4-/- animals, and was not significantly different (data not shown). 
Thus, our data suggest that Aqp4 deletion selectively impairs tissue oxygenation in areas 
furthest away from the vasculature. 
 
Deletion of Aqp4 does not influence hyperemia and vascular oxygen supply in CSD 
Cerebral blood flow is critical for maintaining adequate tissue oxygenation. Due to the 
strong AQP4 expression around blood vessels, we tested whether Aqp4 deletion 
influenced the vascular response to CSD. Neither the amplitude nor the duration of the 
hyperemia phase differed between wild type and Aqp4-/- animals (Peak: wild type 164.50 
± 4.57% vs. Aqp4-/- 162.57 ± 7.54%. Duration: wild type 174.50 ± 11.56 s vs. Aqp4-/- 
178.06 ± 6.09 s) (Figure 2A-C). Additionally, Aqp4 deletion did not affect overall tissue 
oxygen supply, which we assessed using oxygen sensitive microelectrodes that integrate 
tpO2 from a ~ 268-524 μm3 volume encompassing both NADH dip and overshoot regions 
(Baseline: wild type 38.60 ± 3.14 mmHg vs. Aqp4-/- 45.98 ± 4.88 mmHg. CSD: wild type 
9.14 ± 2.05 mmHg vs. Aqp4-/- 11.53 ± 3.03 mmHg. (Figure 2D).7 The kinetics of these 
tpO2 recordings was not significantly different (Figure 2E,F) (∆tpO2: wild type -29.46 ± 
4.98 vs. Aqp4-/- -34.45 ± 3.13. Declining slope: wild type -2.79 ± 1.22 mmHg/s vs. Aqp4-
/- -3.44 ± 0.74 mmHg/s. Recovery slope: wild type +0.67 ± 0.38 mmHg/s vs. Aqp4-/- 
+0.58 ± 0.12 mmHg/s). Finally, when we used tpO2 and blood flow recordings to 
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approximate the cerebral metabolic rate of oxygen (∆CMRO2) this was not significantly 
different between the two genotypes during CSD (wild type 281.50 ± 21.62 μmol/100g/ 
min vs. Aqp4-/- 292.50 ± 23.40 μmol/100g/min, data not shown). However, this 
calculation uses equivalent coefficients for oxygen diffusion through brain in both 
genotypes, which may be an incorrect assumption if AQP4 alters gas diffusion. Taken 
together, we found no evidence that deleting Aqp4 altered hyperemia or overall oxygen 
supply during CSD. 
 
Deletion of Aqp4 delays [K+]o recovery in CSD 
The amplitude of the DC potential shift, which is dependent on [K+]o, was significantly 
lower in Aqp4-/- than in wild type mice (Amplitude: wild type -18.71 ± 2.11 mV vs. Aqp4-
/- -12.80 ± 1.16 mV) (Figure 2G,H). In line with these data and the finding that Aqp4 
deletion increases basal ECS volume,11 the amplitude of the [K+]o increase was 
significantly lower in Aqp4-/- animals (Amplitude: wild type 75.54 ± 1.86 mM vs. Aqp4-/- 
64.49 ± 1.73 mM) (Figure 2I,J). The rising phase of [K+]o in CSD lasted 30.53 ± 1.76 s 
in wild type and 31.61 ± 4.75 s in Aqp4-/- animals, not significantly different (Figure 
2K). However, Aqp4-/- mice showed a slower [K+]o recovery compared to wild types 
(Recovery rate: wild type 1.79 ± 0.12 mM/s vs. Aqp4-/- 1.27 ± 0.08 mM/s. Duration of 
[K+]o elevation: wild type 130.32 ± 5.42 s vs. Aqp4-/- 153.86 ± 7.54 s) (Figure 2L,M), 
suggesting that the capacity for [K+]o clearance is reduced by Aqp4 deletion.  
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Discussion 
Our study provides the first line of evidence that AQP4 impacts oxygenation of brain 
tissue. Using CSD as a model of severe metabolic stress, we show that Aqp4 deletion 
increases NADH fluorescence in areas furthest away from cerebral microvessels. NADH 
fluorescence is a sensitive indicator of tissue hypoxia with a p50 of 3.4 mmHg,8 and our 
data thus demonstrate that Aqp4 deletion enhances the already critical microwatershed 
hypoxia seen in CSD.7 Measurements with laser Doppler flowmetry show that this 
impaired oxygenation was not due to inadequate blood supply, as Aqp4-/- and wild type 
mice had a comparable hyperemia response. Moreover, oxygen sensitive microelectrodes 
showed that the observed NADH changes did not reflect overall differences in tissue 
oxygenation, but were spatially restricted to microwatershed regions.  
The observed increase of microwatershed hypoxia in Aqp4-/- mice can be 
explained by either enhanced oxygen consumption or reduced oxygen diffusion. Aqp4 
deletion has previously been shown to impair [K+]o clearance during CSD, seizures and 
neuronal stimulation.2, 3, 5, 6, 12 AQP4 can impact [K+]o clearance in several ways, 
including regulating extracellular space volume, dissipating osmotic gradients arising 
from ion transport and enhancing interstitial bulk flow.2, 3, 6, 12 Aqp4 deletion might 
therefore increase microwatershed hypoxia by making perivascular [K+]o homeostasis 
less efficient and consume excess oxygen. However, this hypothesis would imply that 
Aqp4-/- mice have a larger perivascular NADH signal dip and a higher overall oxygen 
uptake, neither of which we found in our study. Additionally, the hypothesis would 
predict that [K+]o increases in the Aqp4-/- mice prior to the observed NADH changes, 
whereas our data indicate the opposite.  
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The alternative hypothesis entails Aqp4 deletion impairing oxygen diffusion 
across perivascular endfoot membranes. Experimental analyses in oocytes and modeling 
studies have suggested that AQP4 might serve as a gas channel.13, 14 Wang & Tajkhorshid 
suggested that the central pore of the AQP4 tetramer could conduct NO and O2.13 
However, the membrane permeability for gasses likely varies significantly depending on 
the type of gas studied (O2, CO2, NO), lipid composition of the membrane (e.g. endfoot 
vs. oocyte), and macromolecular organization of transmembrane proteins (e.g. AQP4 
tetramers). Aquaporin-facilitated gas transport is therefore an unresolved topic, where 
several studies have presented evidence for and against the hypothesis.13-15 If oxygen 
diffusion were rate limiting in our study we would hypothesize that microwatershed 
hypoxia would be increased and involve a larger area, which the NADH imaging 
supports. We might also expect that inadequate oxygenation precedes and potentially 
causes the slowed [K+]o clearance seen in Aqp4-/- mice, and our data show a tendency 
towards this. Finally, NADH is an indirect and non-linear indicator of tissue hypoxia that 
can be influenced by factors unrelated to oxygenation (e.g. cell swelling, hypoglycemia). 
As we were unable to detect an overall difference in tissue oxygenation using 
microelectrodes, our data therefore does not directly show that mitochondrial oxygen 
uptake is inadequate or rate limiting in the Aqp4-/- mice.   
In conclusion, our data suggest that Aqp4 deletion in CSD impairs the 
oxygenation of areas remote from brain microvessels. These observations are consistent 
with the hypothesis that AQP4 facilitates oxygen diffusion, but due to methodological 
limitations we cannot conclusively differentiate this from the alternative explanation that 
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Aqp4 deletion increases metabolic demand. Our study thus provides the first evidence to 
suggest that AQP4 is involved in facilitating oxygen diffusion in vivo.   
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Figure legends. “In vivo NADH fluorescence imaging…”. Thrane AS, Takano T, 
Rangroo Thrane V, Wang F, Peng W, Ottersen OP, Nedergaard M and Nagelhus EA 
 
Figure 1.  Deletion of Aqp4 increased NADH fluorescence in microwatershed areas 
during CSD. (A) Experimental setup. Following induction of CSD in living Aqp4-/- and 
wild type (WT) mice, we measured changes in NADH fluorescence with 2PLSM, 
cerebral blood flow (CBF) with laser Doppler flowmetry (LDF), extracellular 
concentration of K+ ([K+]o) with K+-ion-sensitive microelectrodes (ISM), DC potential, 
and tissue partial pressure of oxygen (tpO2) (not illustrated). (B) Immunofluorescence 
micrographs from WT and Aqp4-/- mice illustrating AQP4 expression in cerebral cortex. 
AQP4 (green), GFAP (red) and DAPI (blue). (C) Endogenous NAD+ and its reduced 
counterpart NADH are key coenzymes in glycolysis, the citric acid cycle, and the 
mitochondrial respiratory chain. Since only NADH is fluorescent (and not NAD+), two-
photon NADH imaging offers maps of tissue redox state that can be used as a proxy of 
tissue oxygenation. (D) Left: NADH fluorescence images of cerebral cortex in WT (75 
μm depth) and Aqp4-/- (105 μm depth) mice. Green is FITC-dextran labeled blood 
vessels. NADH fluorescence is largely uniform, except where NADH is made less visible 
by the presence of large pial vessels at the surface of the brain. Right: Representative 
false color images of change in NADH fluorescence (∆F/F0) from baseline intensity, 
during the early (CSD wave) and late phase of CSD (hypoxic phase), and after recovery. 
In the early phase of CSD, when DC potential dropped, cortical tissue showed a complex 
pattern of NADH decrease (dip, shown in green) and increase (overshoot, shown in 
red/orange), (8). At a later stage, when DC potential had normalized, all regions showed 
 
increased NADH fluorescence (hypoxic phase), before gradually returning to baseline 
level. Scale bar represents 50 μm. (E) Running average traces (ΔF/F0) for the biphasic 
NADH response during CSD, showing whole field (“total”), dip and overshoot in WT 
and Aqp4-/- mice. Duration of DC shift is indicated. *P < 0.05, n = 5 animals in each 
group, unpaired t test. (F) Bar graph representing the peak change in NADH fluorescence 
in WT and Aqp4-/- mice. P = 0.394 (total), 0.329 (dip) and 0.00762 (overshoot), n = 5 
animals in each group, unpaired t test. Data are shown as mean ± SEM. 
 
Figure 2. Deletion of Aqp4 did not affect vascular oxygen supply but delayed 
extracellular K+ clearance in CSD. (A) Representative laser Doppler recordings (black) 
and a running average of these recordings (red) demonstrating the hyperemic response 
during CSD in Aqp4-/- and WT mice. (B, C) Bar graphs summarizing the effect of Aqp4 
deletion on peak amplitude and duration of the CSD hyperemic response. P = 0.876 
(peak), 0.794 (duration), n = 22 (WT) and 41 (Aqp4-/-) stimulations from 7 (WT) and 12 
(Aqp4-/-) animals, unpaired t test. (D) Line graph showing mean cortical tpO2 before 
(basal) and during CSD in WT and Aqp4-/- mice, measured using oxygen sensitive 
microelectrodes. P = 0.264 (base), 0.555 (trough), n = 6 (WT) and 8 (Aqp4-/-) animals, 
unpaired t test. (E, F) Bar graphs showing mean cortical tpO2 slope decline and recovery.  
P = 0.641 (decline), P = 0.818 (recovery), n = 6 (WT) and 8 (Aqp4-/-) animals, unpaired t 
test. (G, H) Representative traces and bar graphs summarizing the effects of Aqp4 
deletion on amplitude of the DC-shift. *P = 0.0223, n = 6 (WT) and 8 (Aqp4-/-) animals, 
unpaired t test. (I) Running averages of extracellular concentration of K+([K+]o) during 
CSD for WT (black) and Aqp4-/- mice (red), acquired using K+-ion-sensitive-
 
microelectrodes (ISM). Inset: K+-ISM calibration curve. n = 7 (WT) and 12 (Aqp4-/-). (J-
M) Bar graphs summarizing the effect of Aqp4 deletion on peak [K+]o, time to peak, 
[K+]o recovery rate, and duration of [K+]o elevation in CSD. [K+]o peak is reduced and 
[K+]o recovery is delayed in Aqp4-/- mice. *P = 0.0459 (duration), **P < 0.001 (peak and 
recovery rate), P = 0.855 (time to peak), n = 22 (WT) and 41 (Aqp4-/-) CSD responses 
from 7 (WT) and 12 (Aqp4-/-) animals, unpaired t test. Data are shown as mean ± SEM. 
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Paravascular microcirculation facilitates rapid lipid transport and astrocyte 
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Abstract 
The paravascular circulation of cerebrospinal fluid (CSF) may serve as a lymphatic 
system in the brain. Using in vivo two-photon imaging we demonstrate that the 
paravascular space facilitates selective movement of small lipophilic molecules and 
rapid glial calcium signaling in the brain. Depressurizing the paravascular system 
leads to unselective lipid diffusion, intracellular lipid accumulation and pathological 
signaling in astrocytes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 3 
The brain, unlike other organs, lacks a separate lymphatic system to clear 
interstitial fluid, transport lipids and facilitate diffusion of signaling molecules. The 
extracellular space is narrow and highly tortuous in neuropil, and is incompatible with 
rapid fluid and solute movement1, 2. Hydrophilic tracers have recently been shown to 
circulate through the brain in cerebrospinal fluid (CSF) via the paravascular space 
(PVS)3. This anatomical space is completely ensheathed by astrocyte endfeet and is 
well-positioned to serve as a highway for glial-glial and glial-vascular 
communication2. However, the role of the PVS in lipid transport and signal 
transduction has not been investigated in vivo. Two related questions therefore remain 
unanswered: can the PVS facilitate rapid lipid transport and might the PVS act as a 
separate compartment for astrocyte signaling?  
To outline the CSF microcirculation, tracers were infused via the cisterna 
magna (Fig. 1a). Both the fixable lipophilic tracer Texas red hydrazide (TXR, 0.621 
kDa) and the hydrophilic tracer tetramethylrhodamine (TMR, 3 kDa) moved rapidly 
through the brain along cerebral blood vessels (tracer penetration: TXR 12.57 ± 4.41 
and TMR 38.71 ± 7.70% brain area at 30 min). Surprisingly, lipophilic tracers of 
small molecular weight showed as limited parenchymal penetration as large 
hydrophilic tracers (fluorescein isothiocyanate dextran, FITC, 2000 kDa) in cortical 
grey matter (tracer penetration 15.56 ± 2.81% brain area) (Fig. 1b)3.  
We used in vivo two-photon laser scanning microscopy (2PLSM) to further 
explore the highly selective paravascular movement of lipophilic tracers. This 
restricted movement is unexpected as biologically relevant lipid molecules, such as 
prostaglandins, cholesterol and palmitic acid, are small (< 1 kDa) and cell permeable 
4-8. We demonstrated that the movement of small (< 1 kDa) lipophilic tracers was 
highly selective to the PVS (palmitic acid, rhod-2, TXR, sulforhodamine SR101 and 
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Oregon green BAPTA-1 OGB) (Fig. 2a, Supplementary Fig. 1a). Intra-arterial 
Texas red dextran or FITC were used to morphologically distinguish cortical surface 
arteries and veins as well as penetrating arterioles and venules (Supplementary Fig. 
1a)3. Cross-sectional intensity projections of penetrating arterioles confirmed 
paravascular tracer selectivity (Fig. 2b). By analyzing regions of interest representing 
the PVS and the surrounding tissue (Fig. 2c), we showed that the lipophilic tracers 
were rapidly cleared via the PVS without gaining access to the surrounding tissue 
(normalized tracer fluorescence ratio of PVS to surround at 60 min: OGB 3.36 ± 0.79, 
SR101 3.50 ± 0.88, rhod-2 4.21 ± 1.35) (Fig. 2d). Deletion of the astrocyte water 
channel aquaporin-4 has recently been shown to slow the circulation of hydrophilic 
tracers in CSF, but did not affect lipophilic tracer movement (PVS to surround ratio in 
Aqp4-/- at 60 min: 4.83 ± 1.42) 3.  
We next examined whether lipopohilic tracers enter and exit the brain via 
similar arterio-venous paravascular routes as hydrophilic molecules3. Using NG2-
DsRed mice that have fluorescently labeled vascular smooth muscle in arterioles, we 
showed that the biologically relevant tracer palmitic acid entered via a para-arterial 
route (Fig. 2e). Moreover, using 2PLSM imaging we showed that lipophilic tracer 
(rhod-2) moved sequentially in the PVS surrounding surface arteries, penetrating 
arterioles, capillaries and venules following cisterna magna infusion (normalized 
fluorescence of rhod-2 to eGFP expressed under the astrocyte specific Glt1 promoter: 
30 min: arteriole 1.90 ± 0.38, capillary 0.45 ± 0.247, venule 0.23 ± 0.172; 60 min: 
arteriole 2.34 ± 0.44, capillary 0.94 ± 0.21, venule 0.44 ± 0.25; 90 min: arteriole 1.74 
± 0.32, capillary 0.72 ± 0.27, venule 1.33 ± 0.34) (Fig. 2f, g). These observations 
indicate that lipophilic molecules enter the brain via para-arterial and exit via para-
venous routes. 
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To investigate the consequences of disrupting the paravascular 
microcirculation, we temporarily depressurized the PVS by puncturing the cisterna 
magna (CMP) (Fig 3a). We took advantage of astrocyte specific calcium indicators 
(such as rhod-2), which are lipophilic tracers that become concentrated inside cells 
due to their acetoxymethyl group9, 10. This improved the sensitivity for detecting 
parenchymal influx. CMP accelerated intracellular accumulation of lipophilic tracer 
rhod-2 when applied to the cortical surface or injected intraparenchymally (eGFP 
normalized fluorescence of rhod-2 astrocyte labeling intensity at 30 min for sham 
control: 1.54 ± 0.36 vs. CMP: 4.01 ± 0.57) (Fig. 3b, c). Conversely, Aqp4 deletion, 
which slows paravascular water movement, did not enhance cellular tracer uptake 
(Aqp4-/- control at 30 min: 1.56 ± 0.27) (Fig. 3d). Thus, an intact PVS restricts lipid 
diffusion and cellular uptake. 
 To investigate the role of the PVS as a signaling compartment, we compared 
spontaneous astrocyte calcium activity in the cortex of awake mice subjected to CMP 
or sham surgery. Interestingly, depressurizing the PVS caused increased frequency 
and decreased synchronization of calcium signaling (ctrl 2.21 ± 0.19 vs. CMP 3.08 ± 
0.29 mHz cell-1; cell-cell correlation: ctrl 0.69 ± 0.03 vs. CMP 0.60 ± 0.03) (Fig. 3e-
g)10. Other aspects of astrocyte signaling were not affected (amplitude: ctrl 39.08 ± 
2.10% vs. CMP 39.98 ± 2.18%; duration: ctrl 21.29 ± 1.29 s vs. CMP 24.74 ± 1.62 s; 
P(active over 15 min): ctrl 75.83 ± 4.20% vs. CMP 7981.05 ± 4.18%) 
(Supplementary Fig. 1b-d). Astrocyte calcium activity has been shown to propagate 
along blood vessels and the waves are largely ATP mediated11-13. We therefore 
inserted a microelectrode into the PVS in situ and stimulated calcium transients by 
injecting ATP. The rapid movement of agonist in the PVS stimulated a brisk calcium 
wave spreading outwards from the blood vessel, which propagated faster and over a 
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larger area than when ATP was injected intraparenchymally (wave propagation: 
parenchyma 4.47 ± 0.56 vs. PVS 8.89 ± 1.22 μm s-1; wave diameter: parenchyma 
142.86 ± 12.50 vs. PVS 315.81 ± 51.42 μm) (Fig. 3h).  
To summarize, we show that the brain has a distinct paravascular 
compartment for lipid transport and glial signaling within the narrow confines of the 
neuropil. Lipid transport follows the arterio-venous circulation and is highly selective 
to the PVS. Compromising paravascular transport causes increased intracellular lipid 
accumulation and abnormal astrocyte calcium signaling. We speculate that lipid 
transport in the brain may be spatially restricted due to the high concentration of 
astrocyte secreted lipoproteins in CSF. Interestingly, lipoprotein mutations are the 
largest known risk factor for developing Alzheimer disease14, 15. Ours and previous 
data therefore suggest that the paravascular compartment may represent a lymphatic 
equivalent in the brain that resorbs interstitial fluid, selectively transports small lipid 
molecules and can act as a signaling highway for coordinated astrocyte 
communication.  
 
 
 
 
 
 
 
 
 
 
 7 
References 
1. Abbott, N.J. Evidence for bulk flow of brain interstitial fluid: significance for 
physiology and pathology. Neurochemistry international 45, 545-552 (2004). 
2. Sykova, E. & Nicholson, C. Diffusion in brain extracellular space. 
Physiological reviews 88, 1277-1340 (2008). 
3. Abbott, N.J., Patabendige, A.A., Dolman, D.E., Yusof, S.R. & Begley, D.J. 
Structure and function of the blood-brain barrier. Neurobiology of disease 37, 13-25 
(2010). 
4. Iliff, J.J., et al. A Paravascular Pathway Facilitates CSF Flow Through the 
Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid beta. 
Sci Transl Med 4, 147ra111 (2012). 
5. Iliff, J.J., et al. Brain-wide pathway for waste clearance captured by contrast-
enhanced MRI. The Journal of clinical investigation  (2013). 
6. Attwell, D., et al. Glial and neuronal control of brain blood flow. Nature 468, 
232-243 (2010). 
7. Slezak, M. & Pfrieger, F.W. New roles for astrocytes: regulation of CNS 
synaptogenesis. Trends in neurosciences 26, 531-535 (2003). 
8. Fukata, Y. & Fukata, M. Protein palmitoylation in neuronal development and 
synaptic plasticity. Nature reviews. Neuroscience 11, 161-175 (2010). 
9. Takano, T., et al. Astrocyte-mediated control of cerebral blood flow. Nat 
Neurosci 9, 260-267 (2006). 
10. Higashimori, H., Blanco, V.M., Tuniki, V.R., Falck, J.R. & Filosa, J.A. Role 
of epoxyeicosatrienoic acids as autocrine metabolites in glutamate-mediated K+ 
signaling in perivascular astrocytes. American journal of physiology. Cell physiology 
299, C1068-1078 (2010). 
11. Moore, C.I. & Cao, R. The hemo-neural hypothesis: on the role of blood flow 
in information processing. Journal of neurophysiology 99, 2035-2047 (2008). 
12. Paredes, R.M., Etzler, J.C., Watts, L.T., Zheng, W. & Lechleiter, J.D. 
Chemical calcium indicators. Methods (San Diego, Calif.) 46, 143-151 (2008). 
13. Thrane, A.S., et al. General anesthesia selectively disrupts astrocyte calcium 
signaling in the awake mouse cortex. Proceedings of the National Academy of 
Sciences of the United States of America 109, 18974-18979 (2012). 
14. Simard, M., Arcuino, G., Takano, T., Liu, Q.S. & Nedergaard, M. Signaling at 
the gliovascular interface. J. Neurosci. 23, 9254-9264 (2003). 
15. Thrane, A.S., et al. Critical role of aquaporin-4 (AQP4) in astrocytic Ca2+ 
signaling events elicited by cerebral edema. Proc. Natl. Acad. Sci. U. S. A. 108, 846-
851 (2010). 
16. Koizumi, S., Fujishita, K. & Inoue, K. Regulation of cell-to-cell 
communication mediated by astrocytic ATP in the CNS. Purinergic signalling 1, 211-
217 (2005). 
17. Parpura, V. & Verkhratsky, A. Homeostatic function of astrocytes: Ca(2+) and 
Na(+) signalling. Translational neuroscience 3, 334-344 (2012). 
18. Leoni, V., Solomon, A. & Kivipelto, M. Links between ApoE, brain 
cholesterol metabolism, tau and amyloid beta-peptide in patients with cognitive 
impairment. Biochemical Society transactions 38, 1021-1025 (2010). 
19. Castellano, J.M., et al. Low-density lipoprotein receptor overexpression 
enhances the rate of brain-to-blood Abeta clearance in a mouse model of beta-
amyloidosis. Proceedings of the National Academy of Sciences of the United States of 
America 109, 15502-15507 (2012). 
 8 
 
Figure legends 
Figure 1 Rapid paravascular movement of lipophilic tracers. (a) Experimental design 
for studying tracer (red) movement in paravascular space via cisterna magna. Inset: 
electron micrograph of penetrating arteriole (PA) with surrounding paravascular space 
(PVS). Scale bar represents 2.5 μm. (b) Epifluorescence montages illustrate 
distribution of Texas red hydrazide (TXR), fluorescein isothiocyanate dextran (FITC) 
and tetramethylrhodamine dextran (TMR). Top insets display auto-thresholded 
images. Scale bar represents 200 μm. (c) Quantification of brain parenchymal 
penetration. **P < 0.01, n = 6 animals for all groups, Mann-Whitney U. Data are 
shown as mean ± SEM. 
 
Figure 2 Lipophilic tracers selectively enter and exit brain via paravascular space 
surrounding arterioles and venules. (a) Left: in vivo two-photon image of rhod-2 
circulation via the paravascular space in Glt1-eGFP mouse. White circles indicate 
penetrating arterioles. Surface artery (SA). Scale bar represents 100 μm. Right: high 
magnification images of the paravascular space surrounding penetrating arteriole at 
serial depths. (b) Cross sectional intensity traces illustrating the paravascular space 
(rhod-2, red) and intravascular space (Texas red dextran) around a penetrating 
arteriole (PA). Endfoot (EF). Scale bar represents 7.5 (top) and 5 (bottom) μm. (c) 
Region of interest (left) and analysis of tracer intensity (right) in the paravascular 
space and surrounding parenchyma. Scale bar represents 10 μm. n = 24 arterioles 
from 7 animals, paired t test.  (d) Ratio of lipophilic tracer fluorescence in 
paravascular space to surrounding parenchyma at 60 min. Sulforhodamine (SR101), 
Oregon green BAPTA (OGB). n = 11 (OGB), 15 (SR101), 24 (rhod-2) and 12 (Aqp4-
/- rhod-2) arterioles from 16 animals (total), unpaired t test. (e) Immunofluorescence 
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micrographs from NG2-DsRed mouse show entry of palmitic acid lipid along the 
paravascular space. Antibody against lectin outlines vascular endothelium. White 
arrows indicate arterioles. Scale bar represents 100 μm. (f, g) Representative images 
and quantification of rhod-2 tracer in the paravascular space surrounding an arteriole, 
a capillary and venule. Scale bars represent 7.5 μm. n = 24 (arterioles), 14 
(capillaries) and 12 (venules) from 7 animals, paired t test. ***P < 0.001. Data are 
shown as mean ± SEM. 
 
Figure 3 Depressurizing the paravascular space impairs lipid transport and astrocyte 
signaling. (a) Cisterna magna puncture (CMP) temporarily depressurizes the 
paravascular space. Lipophilic tracer was applied to cortical surface or injected into 
parenchyma. (b, c) Two-photon images and quantification of lipid tracer labeling in 
eGFP expressing cortical astrocytes (circled) following sham control and cisterna 
magna puncture (CMP). Scale bars represent 75 μm. n = 45 cells from 5 animals for 
both groups, unpaired t test. (d) Normalized rhod-2 astrocyte labeling intensity. n = 
45 (Ctrl), 32 (Aqp4-/-) and 45 (CMP) cells from 14 animals (total), one-way ANOVA. 
(e) Representative traces of spontaneous calcium activity from cortical astrocytes in 
awake mice. Synchronized (red) and individual (green) transients. (f, g) CMP 
increases frequency and reduces synchronization of astrocyte calcium signals. n = 60 
(ctrl) and 52 (CMP) cells from 10 animals (total), unpaired t test. (h, i) ATP injection 
(visualized with FITC-dextran) into the paravascular space stimulates rapid and 
widespread astrocyte calcium wave spreading outwards from the blood vessel. n = 16 
(intraparenchymal, IP) and 9 (paravascular space, PVS) slices from 11 animals (total), 
unpaired t test. Scale bar represents 40 μm. *P < 0.05, **P < 0.01, ***P < 0.001. 
Data are shown as mean ± SEM. 
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Paravascular microcirculation facilitates rapid lipid transport and astrocyte 
signaling in the brain 
 
Vinita Rangroo Thrane1,2,3†*, Alexander S. Thrane1,2,3†, Benjamin A. Plog, 
Meenakshisundaram Thiyagarajan1, Jeffrey J. Iliff1, Rashid Deane1, Erlend A. 
Nagelhus2,3, Maiken Nedergaard1  
 
Supplemetary Figure 1 (a) In vivo two-photon image of the cortical vascular tree 
outlined using Texas red dextran. Collapsed z-stack from 0 - 200 μm, surface arteries 
(SA), surface veins (SV), penetrating arterioles (PA), penetrating venules (PV). Scale bar 
represents 100 μm. (b-d) Cisterna magna puncture (CMP) causes no alteration in 
amplitude (n = 54 ctrl and 49 CMP cells from 6 and 5 animals, respectively), duration (n 
= 55 ctrl and 49 CMP cells from 6 and 5 animals, respectively) and percent of active cells 
(n = 60 ctrl and 52 CMP cells from 6 and 5 animals, respectively) in astrocyte calcium 
signaling. Unpaired t test. Data are shown as mean ± SEM. 
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Supplemental Figure 1
Materials and Methods 
Animals. Glt-1-eGFP, NG2-DsRed and Aqp4-/- mice were generated as outlined 
previously,1, 2 and mice of either sex from 6-12 weeks used in conjunction with 
C57BL/6J wild-types (Jackson Laboratories) were used for experiments. All animals, 
except those used for awake imaging, were anesthetized with ketamine (0.12 mg g-1) and 
xylazine (0.01 mg g-1) intraperitoneally (i.p.). All animal experiments were approved by 
the Animal Care and Use Committee of the University of Rochester. 
 
Tracer preparation and intracisternal infusion. The hydrophilic tracers fluorescein 
isothiocyanate (FITC) dextran (0.5%, 2000 kDa) and tetramethylrhodamine (TMR) 
dextran (0.5%, 3 kDa) and the lipophilic, cell-permeant tracers palmitic acid (BODIPY® 
FL C16 1 mg ml-1, 0.474 kDa, Molecular Probes), Texas red hydrazide (0.4-2 mM, 0.621 
kDa), sulforhodamine SR101 acid chloride (0.2 mM, 0.607 kDa), rhod-2 AM 
(acetoxymethyl ester) (0.45-4.5 mM, 1.124 kDa) and Oregon-green BAPTA-1 OGB AM 
(0.5 mM, 1.258 kDa, acquired from Invitrogen and Sigma-Aldrich) were constituted in 
artificial cerebrospinal fluid (aCSF).1 These tracers were chosen because of their small 
size (comparable to endogenous lipids), relevance to in vivo imaging (e.g. as calcium 
indicators) and ability to cross cell membranes, such as the endfoot membrane that 
encases the PVS.1, 3 The mice were secured in a stereotaxic frame, and a 30G needle was 
inserted into the cisterna magna. Tracer dissolved in aCSF was delivered at a rate of 2 μL 
min-1 over 5 minutes with a syringe pump (Harvard Apparatus). The dyes were used at 
higher concentrations to allow the approximate dilution factor of 1:5 when 10 μL was 
infused into the total mouse CSF volume of 40 μL.4 The cisterna magna was punctured 
with a 30G needle to drain the CSF and depressurize the PVS. In sham control animals 
the cisterna magna was exposed without puncturing it. 
 
Ex vivo imaging. Mouse preparation was modified from published protocols.2 The 
animals were perfused transcardially with 4% paraformaldehyde in 0.1M phosphate 
buffered saline (pH 7.4) and post-fixed overnight. 100 μm vibratome brain sections were 
then cut and mounted on slides using PROLONG anti-fade gold with DAPI (Invitrogen).  
Epifluorescence multi-channel whole-brain montages were collected using a virtual slice 
module (Microlucida Software, Microbrightfield). Exposure and gain levels were 
maintained constant throughout the study. The percentage of brain tracer penetration was 
calculated using the area fraction function in ImageJ (NIH) on consistently thresholded 
images, as described previously.2 For EM experiments 0.1% glutaraldehyde was added to 
the perfusate/fixation solution and the ultra-thin Lowicryl sections were prepared as 
outlined previously.5 Images were obtained 125 μm below the surface in the barrel 
cortex. 
 
In vivo imaging. Anesthetized animals were intubated and artificially ventilated with a 
small animal ventilator (CWE), their temperature was maintained using a heating pad, 
and blood gasses were collected via a femoral arterial cannula to ensure physiological 
hemodynamic parameters.1 To visualize the cerebral vasculature FITC or Texas red 
dextran (Invitrogen) were administered intra-arterially. A steel frame was secured to the 
skull using dental cement, and a 2 mm craniotomy was opened over the somatosensory 
cortex with particular care being taken not to puncture the dura mater. To stabilize 
imaging, the craniotomy was then sealed with agarose (1.5%, type III-A, Sigma) and a 
coverslip. A Mai Tai laser (SpectraPhysics) attached to a confocal scanning system 
(Fluoview 300, Olympus) and an upright microscope (IX51W) were used. Tracers and 
eGFP were excited at 850 - 890 nm and emission was collected at 575 - 645 nm using a 
20x (0.95NA) lens. 512x512 pixel frames were collected from the pial surface to 200 μm 
depth at 20 μm z-steps. Superficial arteries and veins were distinguished based on 
morphology (e.g. arteries pass more superficially, and have fewer branches near the 
surface).2 Tracer movement was analyzed as outlined previously by defining doughnut 
shaped ROIs around penetrating arterioles.2  
 
Awake calcium imaging. Animal preparation was performed as described by the authors 
previously.3 Briefly, mice were anesthetized with isoflurane (1.0 - 1.5%), head-restrained 
with a steel mini-frame, and habituated to imaging through training sessions. The 
craniotomy was made as outlined above and rhod-2 (2 mM, Invitrogen) was loaded onto 
exposed cortex before applying the coverslip. Calcium signaling was imaged 75 - 125 μm 
depth and dual channel (rhod-2 and eGFP) frames were collected at 0.2 or 1 Hz. Calcium 
transients were analysed using previously described custom-made software (MatLab Inc.) 
and Image J (NIH)1, 3. 
 
In situ calcium imaging. Acute cortical slices were prepared from P10-20 mice as 
described previously.1, 6 Briefly, 400 um acute cortical slices were incubated with rhod-2 
(2 mM) for 20 min, before being transferred to a recording chamber where they were 
imaged and analyzed as outlined before.  
 Statistical analyses. All analysis was performed using IBM SPSS Statistics 19 and all 
tests were two-tailed where significance was achieved at α = 0.05 level (for details see 
supporting information). Wherever necessary a Bonferroni correction for multiple testing 
was done.  
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One sentence summary 
Ammonia impairs neural inhibition by compromising astrocyte potassium buffering, and 
inhibiting Na+-K+-2Cl- cotransporter 1 (NKCC1) can effectively block this neurotoxic process. 
 
 
Abstract 
Ammonia is a ubiquitous waste product that accumulates in numerous metabolic disorders, 
causing neurological dysfunction ranging from learning impairment, to tremor, ataxia, seizures 
and coma. The brain is particularly vulnerable to ammonia as it readily crosses the blood-brain 
barrier and rapidly saturates its only removal pathway, glutamine synthetase, located in 
astrocytes. Although ammonia is believed to exert its neurotoxic effects through astrocyte 
swelling, here we show that swelling is only a terminal feature of ammonia toxicity in vivo. 
Instead, our data indicate that ammonia rapidly compromises astrocyte potassium buffering, 
leading to an increase in extracellular potassium. The potassium overload in turn increases Na+-
K+-2Cl- cotransporter isoform 1 (NKCC1) activity and depolarizes the neuronal GABA reversal 
potential, thus impairing cortical inhibitory networks and causing severe neurological 
impairment. Inhibiting NKCC1 with the clinically used diuretic, bumetanide, potently treats the 
ammonia-induced neurological dysfunction. These data identify failure of potassium buffering in 
astrocytes as a central mechanism in ammonia neurotoxicity, and suggest that bumetanide may 
constitute a novel therapeutic option for disorders of ammonia handling. 
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Introduction 
 
Ammonia is a waste product of cellular metabolism that is constantly generated throughout the 
body. Existing as 99% NH4+ and 1% NH3 at physiological pH, ammonia is thus able to cross the 
blood-brain barrier by diffusing in its gas phase (NH3) (1). If allowed to accumulate, ammonia 
causes brain dysfunction ranging from mild cognitive impairment, to seizures, coma and death 
(2).  
Ammonia homeostasis is particularly important in the brain, as an equimolar amount of 
ammonia is simultaneously released with glutamate during neuronal firing (Fig. 1A) (3). Brain 
ammonia is almost exclusively detoxified by condensation with glutamate to form glutamine, a 
reaction catalyzed by glutamine synthetase (GS) with a rapid half-life of less than 3 s (4). GS has 
a higher affinity for ammonia than glutamate, suggesting that the removal of ammonia is 
prioritized over an excitotoxic neurotransmitter (5). 
The current literature points to astrocytes as the primary target of ammonia toxicity, as 
they are the only cell type in the brain that express GS (6). Histological preparations from 
animals exposed to elevated ammonia in the context of liver failure display astrocyte pathology 
in the form of swelling (7). However, it remains unclear whether astrocyte swelling contributes 
to the initial deterioration of neurological functions characteristic of acute ammonia toxicity (8).  
In order to elucidate the mechanisms responsible for ammonia toxicity in the brain, we 
use the Otcspf-ash mouse model. These mice have an X-linked mutation in the gene encoding 
ornithine transcarbamylase (Otc), a urea cycle enzyme essential for liver detoxification of 
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ammonia. Otcspf-ash mice are prone to developing rapid rises in plasma ammonia leading to severe 
neurological dysfunction and coma (9). Clinically relevant ammonia neurotoxicity can be studied 
in the absence of hepatic complications using the Otcspf-ash mouse model. Ammonia neurotoxicity 
in the context of acute liver failure, on the other hand, is associated with numerous ammonia-
independent changes (e.g. neuroinflammation) that alter the neurological phenotype (8). Otcspf-ash 
mice thus provide an optimal model to study the direct effects of ammonia on the brain. 
In this study we used in vivo optical imaging and electrophysiology in awake behaving 
Otcspf-ash mice and found that astrocyte swelling is only observed during the terminal stages of 
ammonia neurotoxicity. The earlier stages are, instead, characterized by a failure of astrocyte 
potassium buffering. The consequent increase in extracellular potassium ([K+]o) drives a Na+-K+-
2Cl- cotransporter isoform 1 (NKCC1)-dependent depolarizing shift in the neuronal γ-
aminobutyric acid (GABA) reversal potential (EGABA). GABA, the main inhibitory transmitter in 
the brain, principally exerts its rapid hyperpolarizing (inhibitory) action via anion-permeable 
GABAA receptors (10). The depolarized EGABA in ammonia neurotoxicity thus leads to a rapid 
impairment of neuronal inhibition. Bumetanide is a specific inhibitor of NKCC1 that is routinely 
used in clinical practice to treat fluid retention, with a favorable side-effect profile (11). In our 
awake mouse model, we found that inhibiting NKCC1 with bumetanide restored inhibitory 
transmission and protected the mice from ammonia-related neurological dysfunction. 
 
Results 
 
The Otcspf-ash mouse model is characterized by acute ammonia neurotoxicity 
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To characterize the effects of ammonia on brain function, we subjected awake adult male Otcspf-
ash mice to an acute systemic ammonia load (NH4Cl or NH4Ac, 7.5 mmol kg-1 i.p.). Shortly after 
the injection, the mice developed a stereotypical sequence of neurological impairments, 
including decreased spontaneous movement, hypersensitivity to sound (hyperacusis), imbalance, 
tremor, ataxia, seizures, and in severe cases coma followed by death (Fig. 1A) (12).  
The neurological phenotype in our model of OTC deficiency was accompanied by a brisk 
increase in the extracellular ammonia concentration ([NH4+]o) in plasma (from 0.32 ± 0.7 to 4.21 
±  0.59 mM) and brain (from 0.54 ± 0.18 to 4.83 ± 0.52 mM) (Fig. 1B,C, Fig. S1A). The excess 
ammonia, in turn, caused an accumulation of glutamine in the brain via enzymatic trapping in 
astrocytes by GS (9.25 ± 0.34 μmol g-1) (Fig. 1D, Fig. S1B) (1, 6). Similar to children born with 
OTC deficiency, the Otcspf-ash mice also had a baseline excess of both ammonia (plasma 0.32 ± 
0.073 mM, brain 0.54 ± 0.19 mM) and glutamine (7.58 ± 0.52 μmol g-1), and displayed some 
milder features of ammonia neurotoxicity, such as impaired learning (Fig.1 B-E, Fig. S1C, D) (2, 
9, 13).  
Next, we examined whether our disease model was characterized by any global 
hemodynamic changes, as this can occur in very severe ammonia toxicity (2). Cerebral perfusion 
pressure (CPP), cerebral blood flow (CBF), and intracranial pressure (ICP) were, however, all 
unchanged following the acute ammonia challenge (Fig. 1F). Finally, we employed several 
behavioral measures to track the progression and severity of ammonia neurotoxicity in a 
clinically relevant fashion. Using automated video tracking we found that spontaneous mouse 
movement decreased sensitively and early following the ammonia challenge (13.69 ± 1.48 vs. 
0.42 ± 0.22 m min-1) (Fig. 1H). We also developed a sensory-motor phenotype score that 
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allowed us to both track the onset of specific phenotypes (e.g. ataxia) and also grade their 
severity (0.53 ± 0.28 vs. 9.00 ± 0.46 out of 11) (Fig. 1H, Fig. S1E) (9, 14).  
 
Acute ammonia exposure causes a robust seizure phenotype 
In addition to cognitive, sensory, and motor impairment, children with OTC deficiency typically 
also develop seizures during episodes of transient increases in ammonia (2, 12). We used 
cortical, subcortical and muscle electrodes in awake mice to further explore this phenotype (Fig. 
2A) (8). Around weaning Otcspf-ash mice occasionally developed spontaneous myoclonuses, 
which are brief (< 2 s) involuntary jerk-like movements that can be caused by seizure activity in 
either the cortex or subcortical structures (15). However, these events were scarce and too 
variable to allow careful study. We therefore used the aforementioned acute ammonia challenge 
to precipitate a more robust seizure phenotype. The intermediate doses (7.5 mmol kg-1) 
employed in most of our study caused numerous myoclonic events (ME), whilst a lethal dose (10 
mmol kg-1) of ammonia also induced longer lasting generalized tonic-clonic seizures (Fig. 2B). 
We proceed to examine the ME in more detail, and found several lines of evidence 
indicated that these events were a form of centrally generated seizures. Firstly, we found that the 
myoclonic electroencephalogram (EEG) discharges consistently preceded the electromyogram 
(EMG) discharges by 19.42 ± 4.78 s, indicating that these events originated in the brain (Fig. 
2C). Secondly, we were able to detect 3-9 Hz poly-spike and wave (SWD) discharges typical of 
myoclonic epilepsy using EEG and the associated myoclonic jerks using video-analysis and 
EMG (Fig. S2A-C and Video 1) (16, 17). Finally, we found that the frequency of ME closely 
correlated with overall disease severity (assessed by the aforementioned phenotype score), which 
both showed similar dose-response curve (Fig. 2D). Importantly, both overall phenotype and ME 
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were entirely masked by anesthesia, emphasizing the need for recordings in awake animals in 
our study. 
 
Direct cortical application of ammonia reproduces the disease phenotype 
Next, we wanted to examine the anatomical origin of the ammonia-induced seizures. To do this 
we generated a new model where we applied ammonia (10 mM) directly on the cortex of awake 
mice. We found that the resultant cortical ammonia elevation was sufficient to reproduce the 
disease phenotype of systemic ammonia toxicity (Fig. 2E, F). The lower ME frequency in this 
compared to the systemic model likely relates to small area of cortex (1.5 mm cranial window) 
being exposed to ammonia. To define how deep into the brain the locally applied ammonia 
permeated we used NH4+ ion-sensitive microelectrodes (ISM). We found that the ammonia 
diffusion was surprisingly restricted, affecting mainly the superficial cortex (Fig. 2E). Seen in the 
context of previously radio-isotope studies, this observation most likely relates to the rapid 
metabolic trapping of ammonia in astrocytes by the enzyme GS (1). Consistent with this idea, 
when we inhibited GS with L-methionine sulfoximine (MSO, 1.5 mM) the cortical [NH4+]o 
gradient was reduced. It is therefore likely that cortical astrocytes take up most of the excess 
[NH4+]o in our model of focal ammonia toxicity. The importance of astrocyte ammonia 
sequestration is further illustrated by the increased ME frequencies we recorded when MSO was 
co-administered with ammonia (MSO 1.06 ± 0.26 vs. NH4Cl 2.66 ± 0.14 vs. NH4Cl + MSO 3.29 
± 0.19) (Fig. 2F). Astrocyte uptake of excess [NH4+]o in the cortex thus appears to play a critical 
role in generating the neurological dysfunction seen in ammonia neurotoxicity. 
Using both our systemic and cortical disease models, we proceeded to explore whether 
ammonia-related ME arise in the cortex or thalamus. Recent studies in humans and rodents have 
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suggested that several generalized seizure types, such as SWD (including ME and absence 
seizures) and tonic-clonic, may primarily originate in the cortex and secondarily invade the 
thalamus (18-20). To establish the origin of ammonia-induced seizures, we placed extracellular 
electrodes in the cortex and thalamus of awake mice. The dual recordings showed that ammonia-
induced SWD in the cortex preceded those in the thalamus by 7.87 ± 2.15 ms when ammonia 
was administered systemically, and 8.26 ± 2.11 ms when ammonia was applied cortically (Fig. 
2G) (21). In conclusion, several lines of evidence suggest cortical ammonia toxicity may be 
sufficient and necessary for ME generation, which in turn correlated closely with overall disease 
severity. 
 
Cortical ammonia exposure causes rapid disinhibition of neuronal firing 
Different and often inconsistent neuronal effects of ammonia have been described in the context 
of different disease models (in vitro, in situ and in vivo) and different time courses (acute, 
subacute and chronic) (22). Similar to previous 1H-NMR studies, we found no net change in the 
levels of neurotransmitters glutamate and GABA that could explain the neurotoxicity of 
ammonia (Table S1) (13, 23). In one of the few previous in vivo studies Lux et al. showed that 
inhibitory GABAergic neurotransmission is impaired when cats receive an acute ammonia 
challenge. However, this study looked primarily at spinal motor neurons and did not actually 
measure seizure activity. To extend these observations into a more clinically relevant analysis, 
we examined the effect of ammonia superfusion on cortical inhibitory networks in awake 
animals using paired-pulse whisker stimulation. This method has previously been used to study 
the maturation of inhibitory networks (24). The whisker stimulation paradigm we employed 
elicits two successive field excitatory post-synaptic potentials (fEPSP). The amplitude of the 
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second fEPSP is normally smaller than the first one, owing to activation of cortical inhibitory 
networks that suppress the second fEPSP. This is quantified by a paired-pulse ratio (PPR) of less 
than one. Ammonia superfusion, however, increased the PPR from 0.64 ± 0.13 in the control 
setting to 1.56 ± 0.24 (paired-pulse facilitation), which recovered to 0.61 ± 0.15 upon washout 
(Fig. 2H, I). For the first time we therefore demonstrate that ammonia causes a significant 
disinhibition of excitatory neuronal firing in the cortex and thereby provide a direct link to 
cortical seizure generation.  
 
Astrocyte swelling is only a terminal feature of acute ammonia neurotoxicity 
We next asked what role astrocytes might play in ammonia neurotoxicity. Much of recent 
literature has suggested ammonia-induced astrocyte swelling and brain edema are an important 
cause of the neurological impairment seen in ammonia neurotoxicity (7, 25-27). However, 
astrocyte swelling has to our knowledge never been demonstrated in vivo. We used two-photon 
laser scanning microscopy (2PLSM) in awake Otcspf-ash mice expressing eGFP in astrocytes 
under the Glt-1 promoter to examine real-time volume changes following an acute ammonia 
challenge (Fig. 3A). We found that ammonia caused no significant astrocyte swelling in vivo, but 
rather a transient yet significant shrinkage of 5.04 ± 0.85% (Fig. 3B). In addition, cortical slices 
acutely exposed to ammonia (10 mM) failed to show astrocyte swelling unless concentrations 
high enough to cause cell lysis (50 mM) were applied (Fig. 3C).  
To further investigate the role of astrocyte swelling, we examined mice deficient in 
aquaporin-4 (AQP4) water channels. AQP4 is the major influx pathway for water into astrocytes 
and knocking out this protein reduces astrocyte swelling (28). AQP4 has also been shown to be 
upregulated in ammonia neurotoxicity (29). However, when injected with ammonia, Aqp4-/- mice 
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displayed no improvement in the severity of phenotype or ME frequency (Fig. S3A, B). Finally, 
to determine whether global brain swelling is necessarily associated with all levels of ammonia 
neurotoxicity, we measured brain water content in Otcspf-ash and WT mice following different 
doses of ammonia.  We found that 5-7.5 mmol kg-1 of ammonia did not cause brain edema 
despite causing the previously illustrated significant neurological phenotype (Fig 3D, Fig. S3C). 
Swelling was only observed with a lethal ammonia dose of 10 mmol kg-1, consistent with data 
from patients with fatal ammonia toxicity (30). Taken together, our results indicate that astrocyte 
swelling is not a critical event in acute ammonia neurotoxicity. Moreover, the data demonstrate 
that the Otcspf-ash model used in our study is not associated with significant edema, even though 
the mice exhibit all the clinical and biochemical signs of ammonia neurotoxicity.  
 
Astrocytes calcium signaling: an early sign of impaired glia-neuronal crosstalk in ammonia 
neurotoxicity 
Having not yet found any sign of astrocyte dysfunction, despite strong evidence suggesting 
astrocytes bear the brunt of the ammonia load, we proceeded to explore astrocyte signaling. 
Since astrocytes are electrically silent, we used 2PLSM to image intracellular calcium transients 
in cortical astrocytes of Otcspf-ash mice loaded with calcium indicator rhod-2. The indicator 
selectively loaded astrocytes, as shown by co-localization with eGFP expressed in astrocytes as 
described above. To allow direct correlation of imaging to clinical phenotype these animals were 
again awake (Fig. 3F, Fig. S3D). Astrocyte calcium signaling is believed to modulate a range of 
functions including cerebral blood flow, synaptic activity and extracellular ion homeostasis (31-
33). However, most data has been collected from anesthetized mice or in situ preparations, and 
the role of spontaneous calcium transients in awake behaving mice is not well characterized (34).  
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We recorded several distinct patterns of spontaneous calcium transients during control 
conditions (Fig. 3F). The most striking observation in awake mice was a higher frequency of 
spontaneous calcium transients compared to anesthetized animals (Table S2, Video 2). The 
predominant pattern of signaling in awake mice was synchronous bursts, whereas anesthetized 
animals largely displayed individual calcium transients. This observation is consistent with the 
only other study that explored calcium activity in the awake cortex, which concluded that the 
synchronous bursting exhibited a delayed and variable correlation with neuronal activity (34).  
We next examined astrocyte calcium transients in awake Otcspf-ash mice receiving a 
systemic ammonia challenge. Following the ammonia administration the mice experienced a 
prolonged increase in overall calcium transient frequency from 2.67 ± 0.36 to 9.03 ± 1.16 Hz 
cell-1 10-3 (Fig. 3E, F). The increase in calcium signaling preceded the onset of ME by 1.58 ± 
0.37 min. Surprisingly, however, calcium transient frequency decreased when ME frequency 
peaked (Fig. 3E, F). Additionally, individual ME showed a weak temporal correlation of 0.15 ± 
0.10 with calcium transients (Fig. 3G, Fig. S3E). Moreover, the ammonia challenge also caused a 
pathological desynchronization of cortical calcium transients, with a reduced cell-cell (ΔF/F0) 
correlation from 0.65 ± 0.06 to 0.26 ± 0.08 compared to baseline (Fig. 3H, Video 3). Finally, 
both ammonia and saline injection triggered a brief burst of transients one minute after 
administration, likely due to animal arousal (35). Taken together, these observations indicate 
astrocytes signaling distress early in ammonia neurotoxicity, and perhaps experience an overall 
failure of signaling during the most severe clinical stage of the disorder. The decreased and 
desynchronized signaling when ME activity is peaking could represent pathological neuron-to-
glia signaling evoked by excessive neuronal firing (32).  
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Astrocytes overloaded with ammonia fail to buffer potassium 
Using awake intact mouse models we have so far shown that acute ammonia toxicity is 
associated with 1) severe neurological impairment, 2) neuronal disinhibition and 3) astrocyte 
distress and/or dysfunction, but not swelling. We therefore proceeded to examine the link 
between astrocyte and neuronal dysfunction. Extracellular potassium homeostasis ([K+]o) is a 
vital function of astrocytes with important implications for neuronal function (36-41). Previous 
in situ and in vitro studies have also indicated that ammonia may compromise astrocyte 
potassium buffering (42, 43). Using NH4+ and K+-ISM electrodes in awake mice we found that 
both systemically (7.5 mmol kg-1) and cortically (10 mM) applied ammonia directly impaired 
potassium homeostasis in the cortex (Fig. 4A-C). Systemic administration caused a 1.93 ± 0.19 
mM [K+]o increase in the Otcspf-ash mice (subtracted for NH4+ interference), above a resting level 
of 3.91 ± 0.27 mM (Fig. 4B) (44). Direct cortical administration caused a 2.24 ± 0.17 mM 
increase in [K+]o, which recovered to a level slightly below baseline upon washout as the 
neurological manifestations including ME subsided (Fig. 4C, Fig. S4C). More importantly, this 
[K+]o increase preceded ME onset by 4.91 ± 0.35 min and 2.875 ± 0.201 min in the systemic and 
cortical models, respectively (Fig. S4A-C). Additionally, the [K+]o increase we observed showed 
a strong correlation with ME frequency (Fig. 4D). Similar observations could be reproduced in 
wild-type mice, indicating that the is  not an artifact of the Otcspf-ash strain (Fig. S4D).  
Next, we wanted to assess the role of astrocyte ammonia sequestration (via GS) in the 
potassium accumulation. Reduced activity of GS in gliotic brain tissue has previously been 
implicated in the initiation of temporal lobe epilepsy (45). Similarly, we found that administering 
MSO prior to the ammonia challenge exacerbated both the [NH4+]o and the [K+]o increase (Fig. 
S4DE, F). This observation may reflect that decreasing the influx of ammonia into astrocytes 
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with MSO increases the overall cation load (NH4+ or K+) on neurons, as less NH4+ is trapped in 
glutamine. Finally, ammonia is also known to exert pH effects in brain (46). We therefore used 
H+ ISMs and found an extracellular alkalization following ammonia injection. However, this 
effect was mild, delayed and correlated poorly with clinical phenotype (Fig. S4G). Thus, we 
confirmed that astrocytes play a key role in enzymatic ammonia removal, and show that 
ammonia neurotoxicity causes a profound cortical [K+]o increase that precedes and correlates 
strongly disease severity.   
 
Potassium replicates the neuronal impairment in ammonia toxicity 
Our data indicate that ammonia-related neurological changes are preceded by an increase in 
cortical [K+]o. We therefore superfused KCl (12.5 mM) across the cortex of awake mice to 
explore whether increased [K+]o is sufficient by itself to replicate the adverse effects of ammonia 
(Fig. 4A). Strikingly, when [K+]o was increased by 2.37 ± 0.03 mM using KCl superfusion, the 
mice developed ME similar to our ammonia superfusion model (Fig. 4E, F). With higher doses 
(20 mM) they would also develop tonic-clonic seizures (Fig. 4F). We subsequently proceeded to 
explore whether potassium-related seizures were also associated with disinhibition of neuronal 
firing. Using the paired-pulse paradigm we described above, we demonstrated that KCl 
superfusion caused a disinhibition similar to ammonia with a mean PPR of 1.48 ± 0.22, which 
recovered to 0.63 ± 0.14 after washout (Fig. 4G). In conclusion, for the first time in vivo we 
show that increasing [K+]o alone is sufficient to generate neuronal disinhibition, seizures, and 
thus replicate the neuronal impairment seen in ammonia toxicity. These observations were 
entirely dependent on using awake intact animals, as the clinical phenotype was masked by 
anesthesia.  
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Ammonia competes with potassium for uptake in astrocytes 
We subsequently used a combination of in vitro assays to determine the mechanism of the 
ammonia-induced [K+]o increase. Interestingly, previous radioisotope studies revealed that 
almost immediately following an acute ammonia load, 4x as much 13N-labelled ammonia is fixed 
in glutamine than exists as the free ionized form NH4+ (1). Given that glutamine is only formed 
in astrocytes (via GS), this observation means that >4x as much ammonia crosses astrocyte 
membranes than any other cell type (including neurons). Previous studies have used this insight 
to focus principally on the toxic effects of excess ammonia and/or glutamine in the astrocyte 
cytosol (25). However, the >4x higher flux of ammonia across astrocyte membranes provides 
perhaps the most bioenergetically challenging load, and this is often overlooked.  
To explain how the excess ammonia load on astrocyte membranes could lead to 
decreased K+ uptake we hypothesized that ammonia would either indirectly impair (pump 
failure) or directly compete (pump overactivity) for uptake with K+. Because the gradients 
driving astrocyte uptake of potassium inevitably all depend on Na+-K+-ATPase (NKA) activity, 
we chose to focus on this transporter as a proof of principle. NKA-mediated potassium clearance, 
but not clearance via K+-channels or  (Na+)-K+-Cl—cotransporters, is for instance known to be 
most important during epileptic activity (47). Surprisingly, when NH4Cl was substituted KCl in a 
cell-free NKA assay, we found that NH4Cl alone was able to maintain normal NKA activity, 
indicating that K+ can be substituted by NH4+ without an effect on ATPase function (Fig. 4I). 
This observation is further supported by previous studies in kidney showing that NH4+ can 
replace K+ as a substrate for the renal NKA (48, 49). Notably, NH4+ and K+ ions have a similar 
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hydrated radius and charge, and can also permeate potassium channels with similar efficacy (3, 
50). 
Given that both K+ and NH4+ ions can bind to the Na+-K+-ATPase, we would predict that 
Na+-K+-ATPase activity is increased during ammonia toxicity, as there is more overall substrate 
([NH4+]o and [K+]o) available for transport. Interestingly, increased Na+-K+-ATPase activity has 
been shown in both congenital and acquired ammonia disorders (51). Indeed, the transient 
shrinkage of ammonia-exposed astrocytes shown above is consistent with increased activity of 
the Na+-K+-ATPase, which exports 3 Na+ and imports 2 K+ ions. Furthermore, we would predict 
that ammonia decreases potassium uptake in a dose-dependent fashion. Consistent with this 
hypothesis we found that biologically relevant ammonia concentrations (0.5-10 mM) inhibited 
NKA-dependent (ouabain-sensitive) potassium analogue rubidium (86Rb+) uptake in cultured 
astrocytes in a dose-dependent fashion (Fig. 4H). In contrast, neuronal 86Rb+ uptake was more 
inconsistently reduced, compatible with the hypothesis that neurons play a less prominent role in 
potassium buffering than astrocytes (Fig. S4H) (37). Combined, our observations indicate that 
NH4+ short circuits the astrocytic K+ buffering, causing the sustained increase in [K+]o observed 
in vivo (Fig. 4J). 
 
Ammonia depolarizes EGABA in cortical neurons 
We next wanted to explore the link between impaired astrocyte potassium buffering and 
neuronal disinhibition by using neuronal patch clamping in cortical slices perfused with 
ammonia. Adding 7 mM ammonia to the perfusate reproduced the increase in [NH4+]o and [K+]o 
observed in vivo (3.67 ± 0.53 mM and 1.88 ± 0.13 mM respectively) (Fig. 5A).  
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The inhibitory action of GABA is dependent on a hyperpolarized EGABA (10). Using 
whole-cell patch clamping of pyramidal neurons with ramp voltage and GABA application we 
found that ammonia depolarized EGABA by 12.33 ± 3.66 mV (Fig. 5B). This effect was GABAA-
receptor dependent as bicuculline, a GABAA-receptor antagonist, completely blocked the 
GABA-induced current (Fig. S5A, B). Similar to previous studies using moderate ammonia 
concentrations, we found no consistent change in neuronal resting membrane potential or input 
resistance (22, 52).  
Because EGABA is heavily dependent on chloride transporters, we next tested the diuretic 
bumetanide, a highly specific NKCC1 inhibitor used in clinical practice to treat heart failure 
(11). In our study, bumetanide (5 μM) pre-incubation successfully prevented the depolarizing 
effect of ammonia on EGABA (Fig. 5B). Using immunohistochemistry we found that NKCC1 is 
present in cortex (Fig 5C), confirming previous studies indicating NKCC1 expression in adult 
brain, although at lower levels than in developing tissue (53-55). We observed no obvious 
differences in the expression pattern of NKCC1 between wild-type and Otcspf-ash mice throughout 
the cortex. Interestingly, chronic low elevations of ammonia similar to the resting levels seen in 
our Otcspf-ash mice have been shown to increase NKCC1 activity up to 3 fold, perhaps explaining 
some of the baseline learning deficit in these mice (56). On the basis of these observations, we 
hypothesize that elevated [K+]o and [NH4+]o overactivate neuronal NKCC1, leading to an 
intracellular accumulation of chloride that depolarizes EGABA (Fig. 5D). Supporting this 
conclusion, previous in vivo, in situ and in vitro work has shown that neurons exposed to 
elevated ammonia levels have significantly increased intracellular chloride content (52, 57, 58). 
 
NKCC1 inhibition improves clinically relevant features of ammonia neurotoxicity 
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To test the validity of our in situ model we returned to awake animals, and asked whether 
blocking NKCC1 with bumetanide reducing disinhibition in vivo (Fig. 6A). Using the previously 
described paired-pulse paradigm, we found that adding bumetanide to the superfusate 
significantly improved disinhibition following cortical application of both ammonia and 
potassium (Fig. 6B-C, Fig. S6A). With ammonia application PPR increased maximally to 0.88 ± 
0.15 when bumetanide was co-administered, and recovered to a control level of 0.59 ± 0.17 after 
washout of both ammonia and bumetanide. Similarly, when potassium alone was co-applied with 
bumetanide the mean PPR only increased to 0.92 ± 0.18. Taken together, these data indicate that 
bumetanide effectively treats the neuronal dysfunction seen in ammonia neurotoxicity.  
Next, we wanted to investigate whether this improvement of neuronal function translated 
into a clinically relevant improvement in disease phenotype. Employing the same phenotype 
measures outline in Figure 1 we demonstrated that NKCC1 inhibition increases spontaneous 
mouse movement, reduces the sensory-motor phenotype score, decreases ME frequency and 
increases survival following an ammonia overdose (Fig. 6E-H). Spontaneous movement 
increased from 0.42 ± 0.22 to 3.17 ± 0.46 m min-1 and phenotype score was reduced from 9.00 ± 
0.46 to 6.00 ± 0.72 (Fig. 6E, F). ME frequency was reduced from 0.78 ± 0.05 to 0.13 ± 0.03 
(with cortical KCl), 1.02 ± 0.07 to 0.10 ± 0.02 (with cortical NH4Cl) and 2.66 ± 0.14 to 0.32 ± 
0.02 ME min-1 (with systemic NH4Cl) (Fig. 6G). Survival over a 45 min period after ammonia 
overdose (10 mmol kg-1) increased by a factor of 3.87 (hazard rate ratio 0.26, 95% confidence 
interval 0.08 to 0.87). These clinically relevant improvements were observed both when 
bumetanide was administered systemically (i.p., 30 mg kg-1) and cortically (5 μM), indicating 
that the drug exerts its beneficial action principally in the cortex. Moreover, the therapeutic effect 
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of bumetanide could not be attributed to a normalization of [K+]o, [NH4+]o or brain amino acids, 
which were unaltered by the treatment (Fig. 6I, J, Table S1 and Table S3).  
These in vivo data demonstrate that an elevation of ammonia in the cortex is sufficient to 
induce NKCC1-dependent and bumetanide-sensitive neuronal impairment, supporting the model 
developed from the in situ data (see Fig. 4g). 
 
Discussion 
Ammonia neurotoxicity is an almost universal phenomenon that occurs in all animals from fish 
to humans, and has previously been extensively studied in vitro, in situ, and using biochemical or 
histological methods. This work has produced important clues as to the cellular mechanisms 
underlying ammonia neurotoxicity, but the continued lack of treatment illustrates clearly that the 
overall picture is still incomplete. What we have tried to do in our study is to test and extend 
individual ex vivo observations using in vivo models, where we can continuously correlate 
experimental observations with clinical phenotype. In this way we attempted to piece together a 
more complete picture of what cellular and subcellular changes are necessary and sufficient to 
produce the neurological dysfunction seen in acute ammonia neurotoxicity (e.g. elevated [K+]o), 
and which are not (e.g. astrocyte swelling). All anesthetics tested in our study masked the 
ammonia-induced neurological phenotype and disrupted normal astrocyte signaling. Thus, the 
use of awake animals in our in vivo models was critical to identify the pathological chain of 
events involving both astrocytes and neurons that leads to ammonia neurotoxicity. 
First, we chose a childhood disorder, X-linked OTC deficiency, and used this to develop 
a clean mouse model of acute ammonia neurotoxicity that was unconfounded by hemodynamic 
or hepatic complications (9). Using behavioral and biochemical methods we show that this 
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model replicates all the pathognomic features of ammonia neurotoxicity. This relatively rare 
disorder thus represents an important opportunity to try and understand the larger phenomenon 
of ammonia toxic effects on neural tissue. 
Second, using paired-pulse whisker stimulation in awake mice we show that an acute 
ammonia challenge causes disinhibition of neuronal firing and consequently ME similar to those 
observed in children with OTC deficiency (2). Additionally, we provide evidence suggesting that 
these ME originate in the cortex, likely due to the rapid influx of ammonia into cortical 
astrocytes driven by the enzyme GS. Finally, we show that the neurological phenotype in 
ammonia neurotoxicity can be reproduced using a novel model where we apply ammonia 
directly to cortex of awake mice.  
Third, due to the putatively four times larger ammonia-load on astrocyte membranes than 
all other cell type, we next asked how astrocytes contribute to or cause the neuronal dysfunction. 
Extensive ex vivo literature suggests that ammonia causes brisk astrocyte swelling (7, 25-27). To 
our surprise, however, we found that ammonia does not cause astrocyte swelling, but instead 
produces novel changes in astrocyte calcium signaling. We suggest that the signaling changes 
represent astrocytic responses to neuronal hyperexciteability, astrocyte distress and/or 
dysfunction of astrocytes early in the disease process. To our knowledge this is the first 
examination of astrocyte volume and signaling changes in vivo during ammonia neurotoxicity. 
Fourth, we proceeded to explore whether dysfunctional astrocyte signaling was indicative 
of impaired astrocyte potassium uptake, as the two are closely linked (36). Using our awake 
mouse models of systemic and direct cortical ammonia neurotoxicity we observed that a ∼2 mM 
[K+]o increase preceded symptom onset. Notably, the magnitude of the [K+]o increase correlated 
closely with disease severity. We were also able to reproduce the neural and clinical features of 
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ammonia neurotoxicity by cortical application of potassium alone. We thus provide the first 
direct link between potassium and neural dysfunction, including seizures, in ammonia 
intoxication.   
Fifth, we demonstrate that NH4+ can compete with K+ ions for active uptake on astrocyte 
membranes. This competition short circuits the astrocytic Na+-K+-ATPase pump with severe 
consequences, including compromised [K+]o buffering and seizures.  A similar competition has 
been shown in kidney and retina, suggesting that an accumulation of ammonia may act as a 
universal hazard that can disrupt potassium homeostasis in any organ and almost any animal (3, 
48).  
Finally, we show that there is currently no effective way (e.g. MSO) of protecting 
astrocytes from ammonia without increasing the ammonia-load on neurons. Instead, we find that 
inhibiting the downstream effects of ammonia and potassium on neurons is the most effective 
therapeutic strategy. These downstream effects appear to depend most critically on a potassium-
driven depolarizing shift in EGABA that impairs neural inhibition. We show that inhibiting the 
chloride importer NKCC1 with the clinically used diuretic bumetanide not only rescues the shift 
in EGABA, but also improves all aspects of the neurological phenotype.  
ME are characterized by generalized SWD on the EEG (16). SWD are observed in a 
group of seizure disorders, including childhood absence seizures, which have recently been 
shown to involve early cortical activation (18). This led to the hypothesis that SWD originate 
from a focus in the cortex, before recruiting the thalamus leading to generalized seizures. 
Notably, during SWD, injection of lidocaine into the cortex to locally inhibit neuronal firing is 
able to suppress all seizure activity in the brain (19). In our study, two lines of evidence suggest 
that the ME we observed during ammonia neurotoxicity are cortical in origin. First, we recorded 
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SWD in the cortex ∼8 ms prior to the thalamus. Second, direct application of ammonia or 
potassium on the cortex replicated the SWD activity seen in systemic ammonia toxicity. Taken 
together, these data suggest that an impairment of potassium homeostasis in the cortex is 
sufficient to generate ME in our model.  
In our study we find that ammonia- and potassium-induced neurological impairment is 
preceded by a depolarizing shift in neuronal EGABA. A similar shift in EGABA has been shown in 
resected hippocampi from patients with temporal lobe epilepsy (59). Interestingly, administration 
of the astrocyte toxin fluoroacetate or insulin-induced hypoglycemia also depolarize EGABA (60). 
In adults, the inhibitory action of GABA is dependent on a hyperpolarized EGABA. In early 
development, however, cortical neurons have a depolarized EGABA due to the high activity of 
NKCC1, which causes an intracellular accumulation of chloride (61). Early studies using 
radiolabelled 36Cl- and intracellular electrodes found a similar chloride accumulation during 
acute ammonia exposure, although the mechanism was not known (52, 57). Later in 
development, decreased activity of NKCC1 and increased activity of K+-Cl- cotransporter 
isoform 2 (KCC2), cause a developmental switch in EGABA making it hyperpolarized (62). 
Inhibition of NKCC1 has therefore been suggested as a therapy for seizures in early development 
(neonates) (53). Moreover, KCC2 expression is reduced following nerve injury in adults, 
depolarizing EGABA, causing inappropriate neuronal firing and neuropathic pain (63). In our 
model, increased [NH4+]o and [K+]o drive an NKCC1-dependent depolarizing shift in EGABA, 
resembling early development. Using awake behaving adult mice, we demonstrate that this 
depolarizing shift is followed by a severe impairment of cortical inhibitory neurotransmission 
and seizures.  
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The FDA-approved diuretic bumetanide considerably improved clinically relevant 
behavioral measures in our awake models of ammonia- and potassium-induced neurotoxicity. 
During childhood an accumulation of ammonia is most frequently caused by enzyme 
deficiencies such as the Otc mutation explored in our study. These devastating conditions have 
attracted limited research focus, and consequently the disease mechanisms are incompletely 
understood (7, 29). Few mechanism-specific therapies have been developed for acute ammonia 
neurotoxicity, and bumetanide may bridge the gap in ammonia-related translational research, 
providing a safe, effective and mechanism-targeted therapeutic option. Our results provide clear 
impetus for the initiation of clinical trials investigating the therapeutic potential of bumetanide in 
ammonia neurotoxicity. 
 
Materials and Methods 
 
Rodent breeding and behavioral studies 
All animal experiments were approved by the Animal Care and Use Committee of the University 
of Rochester. Otcspf-ash B6C3-F1 mice were bred as described previously, and males from 8-12 
weeks were used (9). Otcspf-ash mice were crossed with Glt-1-eGFP mice for imaging 
experiments. C57BL/6J mouse and Wistar rat pups were obtained from Jackson Laboratories. To 
analyze cognitive abilities in OTC mice, two commercial conditioning chambers (H10-11M-TC, 
Coulbourn Instruments) were adapted for contextual fear conditioning. Over the course of 4 
days, mice were trained via a tone/shock protocol and trained to fear contextual and auditory 
cues. Better trained mice exhibited higher freezing percentages in the precesense of auditory or 
contextual cues (64, 65). Automated movement analysis was performed using AnyMaze™ 
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software analysis of CCD-camera recordings in a standard mouse cage. We developed a sensory-
motor phenotype score to quantify the severity of ammonia neurotoxicity based on two previous 
studies (9, 14). Each animal gets scored every 15 minutes based on the severity of the following 
phenotypes: hyperacusis (0-2), imbalance (0-3), ataxia / tremor (0-3) and level of consciousness 
(0-3). A maximum score of 11 represents deep coma (no corneal reflex) whilst 0 represents 
normal wakefulness.  
 
Animal preparation for awake in vivo recordings  
Mouse preparation was modified from published protocols (8, 34). Briefly, mice were 
anesthetized using isoflurane (1.5% mixed with 1-2 L/min O2), head restrained with a custom-
made mini-frame, habituated over 2 days, a 1.5 mm craniotomy was then opened over the 
somatosensory cortex, and the mice were allowed 60 min recovery prior to conducting the 
experiments. Body temperature was maintained with a heating pad. For systemic drug treatment, 
a polyethylene intraperitoneal (i.p.) catheter was surgically implanted to deliver drugs accurately 
and with minimal manipulation. For cortical drug application artificial cerebrospinal fluid 
(aCSF) was perfused across the cortex of awake mice at a rate of 2 mL/min, into a custom-made 
well with ~200 μL volume, through tubing with ~100 μL volume, meaning the entire volume 
bathing the brain was exchanged every ~9 s. The aCSF solution contained (in mM) 126 NaCl, 
2.5 KCl, 1.25 NaH2PO4, 2 MgCl2, 2 CaCl2, 10 glucose, and 26 NaHCO3, pH 7.4. For imaging, 
calcium indicator rhod-2 AM (Invitrogen, 2 mM) was loaded onto exposed cortex for 45 min 
before applying agarose (1.5%, type III-A, Sigma) and a coverslip (28).  
 
Biochemical and hemodynamic analysis 
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Plasma ammonia analysis was performed on blood samples collected using 50 μL heparinized 
tubes from the femoral artery. A L-glutamate dehydrogenase based kit (Sigma) was used for the 
quantification of ammonia in plasma. For 1H-NMR mouse forebrains were extracted, frozen, 
homogenized and lyophilized before being reconstituted with D2O as described previously (23). 
1H-NMR spectra were acquired at 25oC using a 600 mHz Varian UnityINOVA spectrometer 
(7200 Hz spectral width, 32K data points, 64 signals averaged for each spectrum). For 
hemodynamic recordings an intracranial pressure probe (Millar) was inserted through a small 0.5 
mm craniotomy over the somatosensory cortex. Cerebral blood flow was assessed using a 
fiberoptic laser Doppler probe (PF5010, Perimed) and connected to an infrared laser doppler 
flowmeter. Blood pressure was monitored through the femoral artery cannula (SYS-BP1, WPI), 
and cerebral perfusion pressure was deduced by subtracting ICP from blood pressure. All signals 
were digitized (Digidata 1332A, Axon Instruments) and analyzed (pClamp 10.2). Brain water 
content was assessed using wet-to-dry ratios (WDR) of brain weight as described previously.(66) 
 
Electrophysiological recordings 
In vivo recordings were obtained from layer II somatosensory cortex. In situ recordings were 
obtained from layer II in coronal cortical slices prepared from P21-30 mice. ISMs of K+ and 
NH4+ were pulled from double-barreled pipette glass  (PB150-6, WPI) with a tip of 1-3 μm. The 
pipettes were silanized (coated) with dimethylsilane I (Fluka, Sigma) and filled with either K+ 
ionophore I cocktail B (Fluka, selectivity coefficient -1.8 log(K+/NH4+)) or NH4+ ionophore I 
cocktail B (Fluka, -0.9 log(NH4+/K+)). All ISMs were calibrated before and after each 
experiment (a < 5% difference was acceptable) using standard solutions and the calibration data 
were fitted to the Nikolsky equation to determine electrode slope and interference (44). Whole-
 25 
cell patch-clamp recordings were performed as described previously (67). Electroencephalogram 
(EEG) signals were externally filtered at 6 Hz (Filter Butterworth Model by Encore, Axopatch 
200B by Axon Instruments), bandpass filtered at 1-100 Hz and digitized (Digidata 1440A by 
Axon Instruments). Ion-sensitive microelectrode (ISM) signals were amplified (FD223a by 
WPI), externally filtered and digitized as above, and reference field potential traces were 
subtracted. In selected experiments, wireless electromyogram (EMG) and electroencephalogram 
(EEG) electrodes were implanted (DSI Physiotel®), and an extracellular microelectrode was 
placed in the thalamus (ventrobasal complex). Recordings were analyzed offline using pClamp 
10.2. Myoclonic events (ME) were defined on the EEG as single or multiple 3-9 Hz polyspike 
and wave discharges (SWD) of 0.2-2 s duration associated with myoclonic jerks determined by 
video recording, EMG or direct observation. Whisker stimulation was delivered using a 
picospritzer III (Parken Instrumentation) and Master 8 (A.M.P.I.). Stimuli consisted of paired 50 
μs air pulses with an inter-stimulus interval of 150 ms, and paired-pulse ratio (PPR) was 
calculated as previously described (24). NH4Cl/NH4Ac solutions were pH (7.4) and osmolarity 
adjusted. 
 
Two-photon laser scanning microscopy  
A Mai Tai laser (SpectraPhysics) attached to a confocal scanning system (Fluoview 300, 
Olympus) and an upright microscope (IX51W) was used. In vivo volume changes and calcium 
activity were imaged in cortex 100 μm below the pial surface, using a 60x (1.1NA) and a 20x 
(0.95NA) lens, respectively. For in vivo volumetry we collected xyzt image series (z-step 1.5 μm, 
every 5 min) with acquisition time <20 seconds and laser power <40 mW. For in vivo calcium 
imaging we collected dual channel (rhod-2 and eGFP) frames at 0.2 or 1 Hz. A low sampling 
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rate and <20 mW laser were used to avoid photodamage. A calcium transient was defined as an 
event where the relative ratio between the rhod-2 and eGFP signal intensities (∆F/F0) was >2 
standard deviations (σ) from baseline. Beginning and end were defined as ∆F/F0 >0.5 σ and <0.5 
σ respectively. Amplitude was taken as the peak ΔF/F0 in this interval. For in situ volumentric 
imaging acute cortical slices were loaded with texas red hydrazide (1.5 µM, a fixable 
sulforhodamine 101 derivative) in aCSF for 50 minutes. Volume and calcium recordings were 
analyzed using previously described custom-made software (MatLab Inc.) (28). 
 
Cell culture assays 
Cultured neocortical astrocytes were prepared from P1-2 mouse and rat pups as previously 
described (36, 68). For 86Rb+ experiments the cultures were incubated for 10 min ± ouabain (1 
mM). The potassium analogue 86Rb+ was then added to each well plate for 15 min (1 μCi, Perkin 
Elmer). The reaction was stopped by placing the cells on ice and washed with ice-cold aCSF. 
The cells were lysed and 86Rb+ uptake quantified by liquid scintillation counting (Beckman 
Coulter). For Na+-K+-ATPase activity, astrocyte cultures were utilized as previously described, 
and enzyme activity was quantified using the malachite green reaction (Sigma) and analyzed 
using spectrophotometry (69).  
 
Immunohistochemistry  
Mice were anesthesized and perfused transcardially with 4% paraformaldehyde, and the brains 
were post-fixed overnight. Serial 16 µm sagittal cryostat sections were cut after overnight 
cryoprotection in 30% sucrose. Sections were incubated with goat anti-NKCC1 primary antibody 
(1:200, Sta. Cruz Biotechnology) overnight at 4°C, followed by incubation with an Alexa-488 
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donkey anti-goat secondary antibody (1:500, Invitrogen). Vectashield containing DAPI (Vector) 
was used for mounting. Images were taken with a 10x lens in a BX53 Olympus system 
microscope attached to a DP72 Olympus digital camera. 
 
Statistical analysis 
All analysis was performed using IBM SPSS Statistics 19 and all tests were two-tailed where 
significance was achieved at α = 0.05 level. Where n ≥ 10 for normally distributed data, the 
unpaired t test or ANOVA were used for independent samples, and paired t test for paired 
samples. Where n < 10 non-parametric tests including Mann-Whitney U and Kruskall-Wallis 
were used for independent samples, and Wilcoxon signed ranks test for paired samples. 
Overdose survival was compared using Cox regression model (controlling for the confounding 
effect of mouse weight). 
 
Supplementary Materials 
Materials and methods 
Fig. S1. Behavioral and biochemical characterization of acute ammonia neurotoxicity. 
Fig. S2. Myoclonic phenotype associated with ammonia intoxication. 
Fig. S3. Deletion of astrocyte water channel aquaporin 4 (AQP4) is not protective in acute 
ammonia toxicity. 
Fig. S4. Ammonia impairs cortical potassium buffering. 
Fig. S5. GABA-currents recorded during ramp voltage are entirely GABAA-receptor dependent. 
Fig. S6. Bumetanide treats potassium-induced neural disinhibition. 
Table S1. Biochemical changes during acute ammonia neurotoxicity. 
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Table S2. Astrocyte calcium signaling during acute ammonia neurotoxicity in awake mice. 
Table S3. Bumetanide treatment does not affect cortical ammonia or potassium concentrations. 
Movie S1. Myoclonic phenotype induced by 7.5 mmol kg-1 ammonia injection in an Otcspf-ash 
mice. 
Movie S2. Spontaneous calcium transients in cortical astrocytes prior to 7.5 mmol kg-1 ammonia 
injection (control). 
Movie S3. Calcium transients in cortical astrocytes after 7.5 mmol kg-1 ammonia injection. 
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Figure legends 
 
Fig. 1. Acute ammonia neurotoxicity is characterized by severe neurological impairment and 
pathognomic biochemical changes. (A) Otcspf-ash mice deficient in the liver enzyme ornithine 
transcarbamylase (OTC) are unable to metabolize ammonia to urea and excrete it via the kidney. 
Following an acute systemic ammonia load the Otcspf-ash mice therefore accumulate ammonia in 
the brain, where it is only metabolized in astrocytes via the amination of glutamate (Glu) to 
glutamine (Gln) catalyzed by glutamine synthetase (GS). Ammonia neurotoxicity progresses 
through stages characterized by stereotypical neurological features (e.g. ataxia). (B) Ammonia 
levels in blood plasma and (C) brain before and after 7.5 mmol kg-1 NH4Cl. ***P < 0.001, n = 7 
for each group, Mann-Whitney U test. (D) Brain [glutamine] measured by 1H-NMR 30 minutes 
after saline (ctrl) or ammonia. *P = 0.015, n = 6 for each group, Kruskall-Wallis test. (E) 
Baseline deficit in spatial learning in Otcspf-ash mice shown using fear chamber conditioning. *P 
= 0.014, n = 5 for each group, Mann-Whitney U test. (F) No significant change in global 
hemodynamic parameters in our model of acute ammonia neurotoxicity (cerebral perfusion 
pressure: CPP, cerebral bloodflow: CBF and intracranial pressure: ICP). (G) Left panel, diagram 
illustrating automated video movement analysis. Right panel, decreased spontaneous mouse 
movement is an early feature of ammonia neurotoxicity. ***P < 0.001, n = 8 (NH4Cl) and 5 
(Ctrl), Mann-Whitney U test. (H) Left panel, diagrams illustrating elements of the sensory-motor 
phenotype score we developed to follow disease severity after the ammonia load. Right panel, 
phenotype score increases sensitively after the ammonia load (7.5 mmol kg-1) in Otcspf-ash mice, 
followed by a slow recovery. ***P < 0.001, n = 8 (NH4Cl) and 5 (Ctrl), Mann-Whitney U test. 
Data are shown as mean ± SEM. 
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Fig. 2. Ammonia potently triggers seizure activity by causing an impairment of neural inhibition 
(disinhibition). (A) Double-barreled ion-sensitive microelectrodes (ISM), electroencephalogram 
(EEG) and electromyogram (EMG) electrodes were used to record seizure activity during acute 
ammonia neurotoxicity in awake mice. The ammonia was either applied systemically (7.5 mmol 
kg-1) or cortically (10 mM), and EEG electrodes were placed in both cortex (Ctx) and thalamus 
(Tha). (B) Acute ammonia administration triggers tonic-clonic seizures and myoclonic events 
(ME). (C) ME are associated with polyspike and wave discharges (SWD) on EEG that are 
occasionally followed by a delayed EMG discharge. n = 10. (D) ME and behavioral phenotypes 
worsen with increasing doses of ammonia, but are suppressed when animals are anesthetized 
(pooled data for ketamine, isoflurane, urethane). *P < 0.01, n = 6 for each group, Kruskall-
Wallis test. (E) [NH4+]o at different depths in the brain during direct cortical application of 
ammonia. The ammonia gradient in the brain dissipates when glutamine synthetase is inhibited 
with 1.5 mM MSO. Depth 0 μm represents ISM in the solution. *P = 0.019, **P < 0.01, n = 5 
for each depth, Mann-Whitney U test.  (F) Inhibiting GS with MSO (0.83 mmol kg-1 i.p.) 
induces ME in awake mice. The ME phenotype was exacerbated when ammonia is co-
administered. *P = 0.00022, n = 7 (MSO), 22 (NH4Cl) and 7 (NH4Cl + MSO), Kruskall-Wallis 
test. (G) Extracellular recordings demonstrate that SWD in the cortex (Ctx) precede those in the 
thalamus (Tha). n = 478 events, 6 mice. (H) 10 consecutive sweeps of field excitatory post-
synaptic potentials (fEPSP) elicited by paired-pulse whisker stimulation before, during, and after 
cortical NH4Cl application (10 mM, red box). (I) The paired-pulse ratio (PPR) increases during 
ammonia superfusion, indicating an impairment of cortical inhibitory networks. *P < 0.001, n = 
10, paired t test. Data are shown as mean ± SEM. 
 36 
 
Fig. 3. Astrocyte ammonia toxicity is associated with impaired calcium signaling, but not 
swelling in vivo. (A) Two-photon laser scanning microscopy (2PLSM) was performed following 
a systemic ammonia load (7.5 mmol kg-1) in awake Otcspf-ash mice expressing eGFP under the 
Glt-1 promoter. (B) 3D real-time volume analysis using xyzt scans of eGFP expressing 
astrocytes during ammonia neurotoxicity reveals no astrocyte swelling, only transient shrinkage. 
Representative images are shown below. Red outline represents volume at time 0. Scale bar 
represents 5 μm. ***P < 0.001, n = 12 for each group, unpaired t test. (C) Equivalent volume 
analysis of texas red hydrazide (TxR) loaded astrocytes in cortical slices. Left panel, texas red 
selectively labels astrocytes expressing eGFP under the Glt-1 promoter. Scale bar represents 10 
μm. Right panel, 10 mM NH4Cl is not associated with acute astrocyte swelling, which was only 
observed in conjunction with cell lysis when 50 mM NH4Cl was applied. **P = 0.0019 (50 mM 
NH4Cl vs. Ctrl), n = 13 (Control), 12 (10 mM), 10 (50 mM), unpaired t test. (D) Brain water 
content is not increased 30 min after mild to moderate ammonia intoxication, but is elevated 
when a lethal dose is administered. **P = 0.0025, n.s. = not significant, n = 7 (0 mmol kg-1), 5 (5 
mmol kg-1), 6 (7.5 mmol kg-1), 5 (10 mmol kg-1), Mann-Whitney U test. (E) Left panel, 
representative image showing eGFP expressing astrocytes loaded with calcium indicator rhod-2 
imaged 100 μm below the pial surface using 2PLSM. Scale bar represents 30 μm. Right panel, 
corresponding rhod-2 intensity traces showing calcium transients. (F) Increased calcium activity 
is an early sign of ammonia neurotoxicity, but calcium activity paradoxically decreases during 
the period with peak ME frequency, before increasing again. Red box indicates time of i.p. 
injection. Heat bar indicates mean ME frequency per minute. ***P < 0.0001, n = 52 (ammonia) 
and 62 (control) cells sampled from 12 animals, unpaired t test with Bonferroni correction. (G) 
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Representative calcium (ΔF/F0) and corresponding EEG trace demonstrate a weak temporal 
correlation between individual ME and calcium transients (coefficient < 0.3). (H) Ammonia 
injection desynchronizes calcium transients, as assessed by Pearson correlation of ΔF/F0. *P < 
0.0001, n = 52 (ammonia) and 62 (control) cells, paired t test. Data are shown as mean ± SEM. 
 
Fig. 4. Ammonia compromises astrocyte potassium buffering by competing with potassium for 
uptake. (A) Double-barreled ISM were used to record [NH4+]o, [K+]o and electroencephalogram 
(EEG) from layer II cortex of awake mice either receiving 7.5 mmol kg-1 i.p. or 10 mM cortical 
NH4Cl. The calibration curves for NH4+ and K+ ISMs are shown. (B) Representative NH4+ (top 
panel) and K+ (bottom panel) ISM traces following i.p. injection (red box) of either ammonia 
(NH4Cl) or saline (Ctrl). Vertical red lines indicate individual ME. (C) Representative ISM trace 
(top panel) and scatterplot (bottom panel) showing an increase in [K+]o during cortical 
application of ammonia (red box) in an awake mouse. Red lines indicate individual ME. Red 
arrow indicates mean onset of ME. [K+]o increases prior to seizure onset. *P < 0.001, n = 10 
(ammonia) and 7 (control), Mann-Whitney U test. (D) Linear regression showing that seizure 
frequency correlates strongly with [K+]o concentrations recorded during ammonia neurotoxicity. 
n = 8 (NH4Cl i.p.) and 10 (cortical NH4Cl application, Ctx). (E) Representative K+ ISM trace 
(top panel) during direct potassium application to the cortex of an awake mouse. KCl application 
(red box) causes multiple ME (red lines). Line graph (bottom panel) showing that cortical 
application of 12.5 mM KCl replicates the cortical [K+]o  increase seen following 10 mM NH4Cl 
application at different depths in the brain. n = 5 for each depth. (F) Representative traces 
illustrating tonic-clonic (top) and ME (bottom) induced by direct cortical application of KCl in 
awake mice. Seizure discharges are detect in the cortex (Ctx) prior to the thalamus (Tha) and 
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muscle (EMG). (G) 10 consecutive sweeps of fEPSP elicited by paired-pulse whisker 
stimulation before, during, and after cortical KCl application (12.5 mM, red box). *P = 0.028, n 
= 6, Wilcoxon signed ranks test. (H) NH4Cl (15 mM) can substitute KCl (15 mM) as a substrate 
for the Na+-K+-ATPase in a cell-free assay of astrocyte cultures. n.s. = not significant, P = 0.49, 
n = 4 for each group, Mann-Whitney U test. (I) Na+-K+-ATPase-dependent (ouabain-sensitive) 
uptake of potassium analogue rubidium (86Rb+) in cultured astrocytes, normalized to vehicle. *P 
< 0.0001, n = 23 (0 mM), 17 (0.5 mM), 16 (2 mM), 10 (5 mM), 10 (10 mM), one-way analysis 
of variance (ANOVA). (J) Diagram illustrating how excess ammonia would anatomically (via 
end-feet, e.f.) and enzymatically (via glutamine synthetase, GS) be drawn into astrocytes and 
trapped as glutamine (Gln). This cation influx compromises the ability of astrocytes to buffer 
potassium generated by normal neuronal firing. Data are shown as mean ± SEM. 
 
Fig. 5. Excess ammonia and potassium cause a depolarization of the neuronal GABA reversal 
potential (EGABA). (A) Top panel, cortical slices from WT mice (>P21) were superfused with 7 
mM NH4Cl. Bottom panel, representative ISM recordings for [NH4+]o and [K+]o illustrating 
similar ionic changes observed in vivo. (B) Mean Δ[ion]o recorded following ammonia 
superfusion. [NH4+]o (n = 9) and [K+]o (n = 18). (C) Representative traces show that ammonia 
reduces the chloride current induced by ramp voltage with application of GABA. (D) Ammonia 
causes a right shift of the I-V curve. NKCC1 antagonist bumetanide (BUM) reverses this effect. 
(E) Bumetanide prevents the ammonia-induced depolarization of EGABA. **P = 0.0034, n = 11 
(control), 11 (NH4Cl), 7 (BUM), 7 (NH4Cl + BUM), Wilcoxon signed ranks test. (F) 
Immunofluorescence micrograph of adult Otcspf-ash and wild-type mouse cortex labeled with 
primary antibody against NKCC1 and DAPI-stained nuclei. Scale bar represents 100 μm. Inset 
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shows NKCC1 labeling in choroid plexus (positive control). Scale bar represents 250 μm. (G) 
Diagram showing the proposed mechanism for ammonia neurotoxicity. NH4+ competes with K+ 
ions for active uptake, impairing astrocyte potassium buffering. This leads to an increase in 
[K+]o, overactivating neuronal NKCC1, which depolarizes EGABA rendering GABAergic 
(inhibitory) neurotransmission less effective. Na+-K+-ATPase (NKA), glutamate (Glu), 
glutamine synthetase (GS), glutamine (Gln), Na+-K+-2Cl-cotransporter isoform 1 (NKCC1), 
GABAA receptor (GABAAR), K+-Cl- cotransporter isoform 2 (KCC2), bumetanide (BUM), 
membrane potential (Vm), GABA reversal potential (EGABA). Data are shown as mean ± SEM. 
 
Fig. 6. NKCC1 inhibition with bumetanide (BUM) potently treats the electrophysiological and 
clinical features of ammonia neurotoxicity. (A) Awake mice were treated with either systemic 
NH4Cl (7.5 mmol kg-1), cortical NH4Cl (10 mM), or cortical KCl (12.5 mM) ± bumetanide (30 
mg kg-1 i.p. or 5 μM cortically), while electrophysiological and behavioral changes were 
recorded. (B) 10 consecutive sweeps of field excitatory post-synaptic potentials (fEPSP) elicited 
by paired-pulse whisker stimulation before, during, and after cortical application of NH4Cl with 
(blue box). (C) The facilitating (increased) paired-pulse ratio (PPR) induced by NH4Cl cortical 
application (blue box) is reversed by bumetanide. ***P < 0.001, n = 10 for both groups, unpaired 
t test. (D) The PPR facilitation seen following KCl cortical application (blue box) is similarly 
reduced by bumetanide. **P = 0.0022, n = 6 (KCl) and 5 (KCl + BUM), Mann-Whitney U test. 
(E) Bumetanide improves spontaneous mouse movement after a systemic NH4Cl load (blue box) 
in Otcspf-ash mice. **P < 0.01, n = 8 (NH4Cl) and 7 (NH4Cl + BUM), Mann-Whitney U test. (F) 
Following a systemic NH4Cl load in Otcspf-ash mice sensory-motor phenotype score is reduced by 
bumetanide treatment. **P < 0.01, n = 8 (NH4Cl) and 7 (NH4Cl + BUM), Mann-Whitney U test. 
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(G) Frequency of MEs induced by ammonia and/or potassium is reduced by bumetanide 
treatment. ***P < 0.001, **P < 0.01, n = 10 (systemic NH4Cl), 10 (cortical NH4Cl) and 6 
(cortical KCl). Mann-Whitney U test. (H) Cox regression analysis of  Otcspf-ash mouse survival 
time after a NH4Cl overdose (10 mmol kg-1). *P = 0.021, n = 9 (NH4Cl) and 10 (NH4Cl + 
bumetanide). (I) Increase in cortical [K+]o following a systemic NH4Cl load in Otcspf-ash mice is 
unchanged by bumetanide. (J) Increase in cortical [K+]o following a cortical NH4Cl is unchanged 
by bumetanide. Data are shown as mean ± SEM. 
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Supplementary Materials  
Title: Ammonia compromises astrocyte potassium buffering and impairs neuronal inhibition without 
causing swelling in vivo. Authors: V. Rangroo Thrane, A. S. Thrane, F. Wang, M. L. Cotrina, N. A. 
Smith, T. Fujita, M. Chen, E. A. Nagelhus, M. Nedergaard  
 
Materials and Methods 
Animal preparation 
Otcspf-ash mice and wild-type littermates were generated as outlined by Wilson et al. (1). Aqp4-/- mice 
and wild-type littermates were generated as described previously (2). Mice subjected to studies were 
males from 8 to 12 weeks of age. Mice were anesthetized with isoflurane (1.5% mixed with 1-2 
L/min O2) via nose cone. A custom-made mini-frame was secured to the skull. The animals were 
habituated to the head-restraint for 3-4 hours, in multiple sessions over 2 days. The mice were then re-
anesthetized and a craniotomy was opened, 1.5 mm in diameter, 3 mm lateral and 1.5 mm posterior to 
the bregma with the dura carefully removed. The latter procedure lasted <20 minutes. Animals were 
then head-restrained, placed in a behavioral tube and moved to the set-up located in a dark quiet 
room, where they were allowed to recover from the anesthetic for 60 minutes prior to commencing 
recordings. The short surgery time and multiple recovery periods were used to minimize the effects of 
isoflurane on cortical electrical activity. 
 
Sensory-motor phenotype score  
We developed composite sensory-motor phenotype score based on two previous studies (1, 3). Mouse 
movement and seizure activity were omitted from this score, because we wanted to represent these 
manifestations independently and more quantitatively. The score thus consisted of 4 elements: 
 6
hyperacusis, imbalance, ataxia/tremor and level of consciousness. Each animal was scored after the 
first 5 min and then every 15 min as they progressed through the stereotypical stages of ammonia 
neurotoxicity. Hyperacusis was score from 0 if the mouse did not display a startle response to 30-60 
dB sound, 1 if the mouse responded to only 60 dB and 2 if it responded to 30 dB as well. Imbalance 
was scored using a ledge test, and the mice were given 0 if the balanced on the ledge and let 
themselves down in a controlled fashion, 1 if they loose their footing whilst walking on the ledge, 2 if 
it does not effectively walk on or let itself down from the ledge, and 3 if it is unable to walk, get 
down, or just falls off. Ataxia/tremor was scored using a gait test, where the mouse is encouraged to 
walk for a short distance. The mouse gets 0 if it walks effectively, 1 if it has a slight tremor, 2 if it has 
a broad based gait or severe tremor, 3 if it drags its abdomen on the ground or is unable to walk. 
Consciousness was scored as either 0 for awake, 1 loss of scatter reflex, 2 loss of righting reflex 
(LORR), 3 loss of corneal reflex.  
 
Ion sensitive microelectrode (ISM) fabrication 
ISMs of K+, NH4+ and H+ were made from double-barreled pipette glass  (PB150-6, WPI) and pulled 
to a tip of 1-3 μm. The pipettes were silanized (coated) with dimethylsilane I (Fluka, Sigma). The 
ionophore used for K+ was Fluka 60398 (potassium ionophore I cocktail B), for NH4+ was Fluka 
09882 (ammonium ionophore I cocktail B) and for H+/pH was Fluka 95291 (hydrogen ionophore I 
cocktail A) all obtained from Sigma. The K+ ionophore has a selectivity coefficient relative to NH4+ 
of -1.8 log(K+/NH4+), and the NH4+ ionophore has a selectivity coefficient relative to K+ of -0.9 
log(NH4+/ K+). The backfill solutions for the K+, NH4+ and H+ ISMs were 0.15 M KCl, 0.5 M NH4Cl 
and phosphate-buffered saline (PBS) with a pH of 7.4 respectively. The reference barrels were used to 
record the DC potentials and were filled with 0.15 M NaCl. In selected experiments, single barrel 
 7
electrodes were also used in combination with single reference electrodes. K+ and NH4+ ISM traces 
were subtracted for interference by calculating the mV response to the increase of the other ion in 
calibration solutions. All ISMs were calibrated before and after each experiment. K+ calibrations 
were done in 150 mM NaCl that contained doubling steps of K+ over a range of concentrations 
appropriate for the experiment, usually from 3-48 mM.  NH4+ calibrations were carried out in 150 
mM NaCl and aCSF from 0.1-10 mM to determine the sensitivity during the in vivo environment. H+ 
calibrations were carried out in phosphate buffers from pH 5 to 9, where >90% had a response time of 
1-5 seconds and a 51-59 mV response to 1 pH unit change. Calibration data were fitted to the 
Nikolsky equation to determine electrode slope and interference (4). In all experiments, recordings 
were used only if the post-experiment calibration did not differ >5% from the pre-experiment 
calibration.  
 
Two-photon laser scanning microscopy (2PLSM)  
Normal calcium signaling was easily abolished if the astrocytes were loaded too long with calcium 
indicator, the craniotomy diameter was too large and with laser or mechanical injury. We therefore 
tested each animal for optimal loading by performing whisker stimulation, to verify a physiological 
calcium response (5).   
 
1H-NMR spectroscopy 
Mice were anesthetized using 1.5% isoflurane and decapitated. Forebrains (whole brain minus 
cerebellum/brainstem) were quickly extracted, frozen in liquid nitrogen, and homogenized in 7.5 mL 
12% PCA at 0oC using a micro-sonicator. The homogenate was centrifuged at 25,000G for 15 
minutes, and the supernatants were neutralized to pH 7.0 with KOH over an ice bath. A further 15-
 8
minute centrifugation (25,000G) separated the resultant KClO4, and the supernatant was lyophilized 
before being reconstituted with 0.65 ml D2O. 1H-NMR spectra were acquired using a 600 mHz 
Varian UnityINOVA spectrometer equipped with a triple-axis gradient HCN probe (standard room 
temperature).  Signals were acquired following a 90o pulse with a spectral width of 7200 Hz and 32K 
data points.  The time between pulses was 15 seconds and 64 signals were averaged for each 
spectrum. The sample temperature was 25oC. Integrals of the relevant peaks were converted to 
μmol/gram wet-weight and normalized NAA (methyl) to increase inter-sample consistency.  
 
In situ electrophysiology 
Coronal cortical slices were prepared from P21-30 mice as described previously (6). This age was 
chosen as in younger pups the GABA reversal potential can be depolarizing (excitatory) (7). Whole-
cell patch-clamp recordings were done using electrodes with 3-5 MΩ resistance, and an intracellular 
solution containing 135 mM K-methylsulfate, 10 mM KCl, 10 mM hepes, 5 mM NaCl, 2.5 mM Mg-
ATP, 0.3 mM Na-GTP (pH 7.3), containing Alexa Fluor® 350 (Invitrogen). Signals were low-pass 
filtered at 2 kHz and digitized at 10 kHz using Axopatch MultiClamp 700A and Digidata 1320A 
(Axon Instruments).  
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Fig. S1. Behavioral and biochemical characterization of acute ammonia neurotoxicity. (A) Cortical 
[NH4+]o increase in NH4Cl and NH4Ac injected mice. P = 0.88, n = 7 (NH4Cl) and 5 (NH4Ac), Mann-
Whitney U test. (B) Representative 1H-NMR spectra 30 minutes after injection with saline or 
ammonia in Otcspf-ash mice. ppm (parts per million), aspartate (Asp), glutamine (Gln), glutamate 
(Glu), γ-aminobutyric acid (GABA), glutamine + glutamate (Glx), N-acetylaspartic acid (NAA), N-
acetylaspartylglutamate (NAAG), alanine (Ala), lactate (Lac). (C) Otcspf-ash and WT mouse freezing 
behavior upon being placed in the fear chamber where they receive a shock through 4 days of 
training. (D) Otcspf-ash and WT mouse freezing behavior upon hearing the noise associated wtih shock 
treatment through 4 days of training. (E) Ammonium chloride (NH4Cl) and ammonium acetate 
(NH4Ac) induce a similar phenotype in Otcspf-ash mice (7.5 mmol kg-1 i.p.). Data are shown as mean ± 
SEM. 
 
Fig. S2. Seizure phenotype associated with ammonia intoxication. (A) Representative EEG and EMG 
trace showing myoclonic seizures in an Otcspf-ash mouse following 7.5 mmol kg-1 NH4Cl. (B) 
Myoclonic seizure frequency in Otcspf-ash and WT littermates following 7.5 mmol kg-1 ammonia 
injection. ***P < 0.001, n = 22 (Otcspf-ash) and 10 (WT), unpaired t test. (C) Seizure frequency 
following 7.5 mmol kg-1 NH4Cl and NH4Ac intraperitoneally (i.p.). P = 0.83, n = 22 (NH4Cl) and 5 
(NH4Ac), Mann-Whitney U test. Data are shown as mean ± SEM. 
 
Fig. S3. Deletion of astrocyte water channel aquaporin 4 (AQP4) is not protective in acute ammonia 
toxicity. (A) Seizure frequency and phenotype score in wild-type (WT) and Aqp4-/- mice injected with 
7.5 mmol kg-1 NH4Cl i.p. P = 0.829 (seizures), P = 0.357 (encephalopathy), n = 10 (ctrl) and 9 (Aqp4-
 :
/-), Mann-Whitney U test. (B) Cortical [NH4+]o in WT and Aqp4-/- mice before and after ammonia 
injection. P = 0.94, n = 6 for each group, Mann-Whitney U test. (C) Brain water content measured by 
wet-to-dry ratios in control and ammonia injected WT and Aqp4-/- mice. Ammonia injection does not 
cause increased brain water content. Aqp4-/- mice have increased brain water content in the control 
setting as we have described previously (8). P = 0.59 (WT), P = 0.69 (Aqp4-/-), n = 10 (WT ctrl), 5 
(WT NH4Cl), 5 (Aqp4-/- ctrl) and 5 (Aqp4-/- NH4Cl), Mann-Whitney U test. (D) For awake calcium 
imaging change in rhod-2 flourescence (ΔF/F0) was normalized to eGFP to reduce movement 
artifacts. Calcium transients were defined as ΔF/F0 > 2 standard deviations (σ) from baseline. (E) 
Pearson correlation of astrocyte calcium transients (cell) and ECoG seizure recordings. n = 52 cells. 
Data are shown as mean ± SEM. 
 
Fig. S4. Ammonia impairs cortical potassium buffering. (A) Scatterplot of [NH4+]o increase following 
ammonia (7.5 mmol kg-1) or saline administration (red box). n = 7 for each group. Red arrow 
indicates mean onset of seizures. (B) Scatterplot of [K+]o increase following ammonia (7.5 mmol kg-1) 
or saline administration (red box). n = 10 (ammonia) and 7 (control). (C) Scatterplot of [NH4+]o 
increase following cortical application of ammonia (10 mM, red box). n = 4. (D) [K+]o increase 
following ammonia injection in Otcspf-ash and WT littermates. ***P < 0.001, n = 10 (Otcspf-ash) and 5 
(WT), Mann-Whitney U test. (E) Glutamine synthetase inhibition further compromises potassium 
buffering by preventing ammonia removal in astrocytes. [NH4+]o increase following ammonia ± L-
methionine sulfoximine (MSO) (0.83 mmol kg-1, administered 3 h before the ammonia) i.p. in Otcspf-
ash mice. *P = 0.0043, **P = 0.048, n = 6 (Ctrl), 6 (MSO), 7 (NH4Cl) and 5 (NH4Cl + MSO), Mann-
Whitney U test. (F) [K+]o increase following ammonia injection and/or MSO in Otcspf-ash mice. *P = 
0.0016, **P = 0.013, n = 9 (Ctrl), 6 (MSO), 10 (NH4Cl) and 5 (NH4Cl + MSO), Mann-Whitney U 
 ;
test. (G) Ammonia-induced pH effects are mild and delayed. Linear regression of seizure frequency 
on pHo. Otcspf-ash mice show a mild extracellular brain alkalinization and peripheral (blood) acidosis, 
following 7.5 mmol kg-1 ammonia i.p. Both pH changes correlate weakly with seizure frequency. (H) 
Ammonia causes a variable reduction in the potassium uptake of neurons. Na+-K+-ATPase-dependent 
(ouabain-sensitive) uptake of potassium analogue 86Rb+ in cultured neurons, normalized to vehicle (0 
mM NH4Cl). *P <0.0001, n = 20 (0 mM), n = 4 (0.5 mM), n = 4 (2 mM), n = 16 (5 mM), n = 4 (10 
mM), Kruskall-Wallis test. Data are shown as mean ± SEM. 
 
Fig. S5. GABA-currents recorded during ramp voltage are entirely GABAA-receptor dependent. (A) 
Representative traces show that bicuculline blocks the current induced by ramp voltage after GABA 
application. (B) I-V curve shows that bicuculline blocks all GABA-induced current.  
 
Fig. S6. Bumetanide treats potassium-induced neural disinhibition. (A) 10 consecutive sweeps 
following paired-pulse whisker stimulation shows KCl superfusion (12.5 mM, blue box) no longer 
evokes a facilitating sensory response (disinhibition) when co-administered with bumetanide (BUM, 
5 μM).  
 
Table S1. Biochemical changes during acute ammonia neurotoxicity. 1H-NMR was used to determine 
amino acid concentrations (μmol g-1 wet weight) 30 minutes after saline (Ctrl) or ammonia 
administration (7.5 mmol kg-1 i.p.). Data are shown as mean ± SEM. 
Genotype: 
Exposure: 
WT 
Ctrl 
WT 
BUM 
WT 
NH4 
Otcspf-ash 
Ctrl 
Otcspf-ash 
BUM 
Otcspf-ash 
NH4 
Otcspf-ash 
BUM 
NH4 
Glutamate 14.29 ± 
0.19 
14.38 ± 
0.22 
12.49 ± 
0.15 
14.67 ± 
0.68 
14.27 ± 
0.23 
13.24 ± 
0.33 
12.51 ± 
0.37 
 <
Glutamine 4.85 ± 
0.47 
4.52 ± 
0.18 
8.69 ± 
0.33 
7.58 ± 
0.52 
8.70 ± 
1.54 
9.25 ± 
0.34 
11.44 ± 
0.46 
GABA 2.00 ± 
0.13 
2.55 ± 
0.05 
2.19 ± 
0.12 
2.53 ± 
0.12 
2.39 ± 
0.13 
2.46 ± 
0.13 
2.23 ± 
0.08 
 
 
Table S2. Astrocyte calcium signaling during acute ammonia neurotoxicity in awake mice. Data from 
analysis of 2PLSM xyt series, where calcium indicator rhod-2 was used to detect astrocyte calcium 
transients 100 μm below the pial surface. Data are shown as mean ± SEM 
 Ctrl 
(n = 62) 
NH4Cl 
(n = 52) 
Freq. (Hz cell-1 x 10-3) 2.67 ± 0.36 9.03 ± 1.16 
Amplitude (ΔF/F0) 0.48 ± 0.11 0.47  ± 0.32 
Duration (s) 18.98 ± 3.05 21.51 ± 4.55 
Cell-cell correlation 0.65 ± 0.06 0.26 ± 0.08 
 
 
Table S3. Bumetanide treatment does not affect cortical ammonia or potassium concentrations. NH4+ 
and K+ ISMs recordings from cortex of awake Otcspf-ash mice. Data are shown as mean ± SEM. 
 
CORTICAL SUPERFUSION 
 [NH4+]o 
(mM) 
n 
(animals
) 
P value 
Mann-Whitney U 
test 
Δ[K+]o 
(mM) 
n 
(animals
) 
P value 
Mann-Whitney U 
test 
Control 0.45 ± 0.17 6  0.0058±0.01
9 
6  
BUM 0.52 ± 0.11 6 0.59 0.0025±0.01
8 
6 0.94 
NH4Cl 5.82 ± 0.18 6  2.24 ± 0.17 10  
NH4Cl 
+ BUM 
5.78 ±0.13 6 0.87 2.17 ± 0.12 9 0.66 
INTRAPERITONEAL INJECTION 
 [NH4+]o 
(mM) 
n 
(animals
) 
P value 
Mann-Whitney U 
test 
Δ[K+]o 
(mM) 
n 
(animals
) 
P value 
Mann-Whitney U 
test 
Control 0.48 ± 0.12 6  0.015 ± 
0.025 
9  
BUM 0.42 ± 0.16 6 0.39 0.0073± 
0.015 
6 0.53 
 =
NH4Cl 4.83 ± 0.52 7  1.93 ± 0.19 10  
NH4Cl 
+ BUM 
4.70 ± 0.32 6 0.83 1.97 ± 0.17 6 0.92 
 
 
Supplementary Movies 
Movie S1. Seizure phenotype induced by 7.5 mmol kg-1 ammonia injection in an Otcspf-ash mice. 
Movie S2. Spontaneous calcium transients in cortical astrocytes prior to 7.5 mmol kg-1 ammonia 
injection (control). 
Movie S3. Calcium transients in cortical astrocytes after 7.5 mmol kg-1 ammonia injection. 
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